GO:0000002,mitochondrial genome maintenance,HP:0000590,Progressive external ophthalmoplegia
GO:0000002,mitochondrial genome maintenance,HP:0003546,Exercise intolerance
GO:0000002,mitochondrial genome maintenance,HP:0003689,Multiple mitochondrial DNA deletions
GO:0000041,transition metal ion transport,HP:0003281,Increased serum ferritin
GO:0000050,urea cycle,HP:0001254,Lethargy
GO:0000050,urea cycle,HP:0001259,Coma
GO:0000050,urea cycle,HP:0001950,Respiratory alkalosis
GO:0000050,urea cycle,HP:0001951,Episodic ammonia intoxication
GO:0000050,urea cycle,HP:0001987,Hyperammonemia
GO:0000050,urea cycle,HP:0002013,Vomiting
GO:0000050,urea cycle,HP:0002038,Protein avoidance
GO:0000050,urea cycle,HP:0002181,Cerebral edema
GO:0000086,G2/M transition of mitotic cell cycle,HP:0000252,Microcephaly
GO:0000226,microtubule cytoskeleton organization,HP:0000012,Urinary urgency
GO:0000226,microtubule cytoskeleton organization,HP:0000246,Sinusitis
GO:0000226,microtubule cytoskeleton organization,HP:0000403,Recurrent otitis media
GO:0000226,microtubule cytoskeleton organization,HP:0001696,Situs inversus totalis
GO:0000226,microtubule cytoskeleton organization,HP:0002110,Bronchiectasis
GO:0000226,microtubule cytoskeleton organization,HP:0003391,Gowers sign
GO:0000226,microtubule cytoskeleton organization,HP:0011108,Recurrent sinusitis
GO:0000226,microtubule cytoskeleton organization,HP:0012263,Immotile cilia
GO:0000226,microtubule cytoskeleton organization,HP:0012265,Ciliary dyskinesia
GO:0000226,microtubule cytoskeleton organization,HP:0200073,Respiratory insufficiency due to defective ciliary clearance
GO:0000226,microtubule cytoskeleton organization,HP:0012384,Rhinitis
GO:0000266,mitochondrial fission,HP:0001284,Areflexia
GO:0000266,mitochondrial fission,HP:0002936,Distal sensory impairment
GO:0000271,polysaccharide biosynthetic process,HP:0001528,Hemihypertrophy
GO:0000271,polysaccharide biosynthetic process,HP:0006765,Chondrosarcoma
GO:0000272,polysaccharide catabolic process,HP:0006568,Increased hepatic glycogen content
GO:0000302,response to reactive oxygen species,HP:0003095,Septic arthritis
GO:0000578,embryonic axis specification,HP:0000149,Ovarian gonadoblastoma
GO:0000959,mitochondrial RNA metabolic process,HP:0002151,Increased serum lactate
GO:0000959,mitochondrial RNA metabolic process,HP:0003128,Lactic acidosis
GO:0001501,skeletal system development,HP:0000006,Autosomal dominant inheritance
GO:0001501,skeletal system development,HP:0000074,Ureteropelvic junction obstruction
GO:0001501,skeletal system development,HP:0000175,Cleft palate
GO:0001501,skeletal system development,HP:0000189,Narrow palate
GO:0001501,skeletal system development,HP:0000243,Trigonocephaly
GO:0001501,skeletal system development,HP:0000272,Malar flattening
GO:0001501,skeletal system development,HP:0000316,Hypertelorism
GO:0001501,skeletal system development,HP:0000405,Conductive hearing impairment
GO:0001501,skeletal system development,HP:0000501,Glaucoma
GO:0001501,skeletal system development,HP:0000668,Hypodontia
GO:0001501,skeletal system development,HP:0000703,Dentinogenesis imperfecta
GO:0001501,skeletal system development,HP:0000926,Platyspondyly
GO:0001501,skeletal system development,HP:0001083,Ectopia lentis
GO:0001501,skeletal system development,HP:0001156,Brachydactyly syndrome
GO:0001501,skeletal system development,HP:0002408,Cerebral arteriovenous malformation
GO:0001501,skeletal system development,HP:0002676,Cloverleaf skull
GO:0001501,skeletal system development,HP:0002677,Small foramen magnum
GO:0001501,skeletal system development,HP:0002681,Deformed sella turcica
GO:0001501,skeletal system development,HP:0002857,Genu valgum
GO:0001501,skeletal system development,HP:0003319,Abnormality of the cervical spine
GO:0001501,skeletal system development,HP:0003762,Uterus didelphys
GO:0001501,skeletal system development,HP:0004322,Short stature
GO:0001501,skeletal system development,HP:0004635,Cervical C5/C6 vertebrae fusion
GO:0001501,skeletal system development,HP:0005116,Arterial tortuosity
GO:0001501,skeletal system development,HP:0005217,Duplication of internal organs
GO:0001501,skeletal system development,HP:0005280,Depressed nasal bridge
GO:0001501,skeletal system development,HP:0005474,Decreased calvarial ossification
GO:0001501,skeletal system development,HP:0005731,Cortical irregularity
GO:0001501,skeletal system development,HP:0005736,Short tibia
GO:0001501,skeletal system development,HP:0005871,Metaphyseal chondrodysplasia
GO:0001501,skeletal system development,HP:0008368,Tarsal synostosis
GO:0001501,skeletal system development,HP:0008873,Disproportionate short-limb short stature
GO:0001501,skeletal system development,HP:0010049,Short metacarpal
GO:0001501,skeletal system development,HP:0011800,Midface retrusion
GO:0001501,skeletal system development,HP:0012385,Camptodactyly
GO:0001502,cartilage condensation,HP:0000926,Platyspondyly
GO:0001503,ossification,HP:0000006,Autosomal dominant inheritance
GO:0001503,ossification,HP:0000175,Cleft palate
GO:0001503,ossification,HP:0000272,Malar flattening
GO:0001503,ossification,HP:0000316,Hypertelorism
GO:0001503,ossification,HP:0000405,Conductive hearing impairment
GO:0001503,ossification,HP:0000501,Glaucoma
GO:0001503,ossification,HP:0000668,Hypodontia
GO:0001503,ossification,HP:0000703,Dentinogenesis imperfecta
GO:0001503,ossification,HP:0000926,Platyspondyly
GO:0001503,ossification,HP:0002007,Frontal bossing
GO:0001503,ossification,HP:0002677,Small foramen magnum
GO:0001503,ossification,HP:0003015,Flared metaphysis
GO:0001503,ossification,HP:0003319,Abnormality of the cervical spine
GO:0001503,ossification,HP:0005116,Arterial tortuosity
GO:0001503,ossification,HP:0005217,Duplication of internal organs
GO:0001503,ossification,HP:0005280,Depressed nasal bridge
GO:0001503,ossification,HP:0005465,Facial hyperostosis
GO:0001503,ossification,HP:0005871,Metaphyseal chondrodysplasia
GO:0001503,ossification,HP:0006765,Chondrosarcoma
GO:0001503,ossification,HP:0011800,Midface retrusion
GO:0001505,regulation of neurotransmitter levels,HP:0001300,Parkinsonism
GO:0001508,action potential,HP:0000006,Autosomal dominant inheritance
GO:0001508,action potential,HP:0001279,Syncope
GO:0001508,action potential,HP:0001645,Sudden cardiac death
GO:0001508,action potential,HP:0001657,Prolonged QT interval
GO:0001508,action potential,HP:0001663,Ventricular fibrillation
GO:0001508,action potential,HP:0001664,Torsade de pointes
GO:0001508,action potential,HP:0001962,Palpitations
GO:0001508,action potential,HP:0002069,Generalized tonic-clonic seizures
GO:0001508,action potential,HP:0003391,Gowers sign
GO:0001508,action potential,HP:0004749,Atrial flutter
GO:0001508,action potential,HP:0005110,Atrial fibrillation
GO:0001508,action potential,HP:0012232,Shortened QT interval
GO:0001525,angiogenesis,HP:0000006,Autosomal dominant inheritance
GO:0001525,angiogenesis,HP:0002408,Cerebral arteriovenous malformation
GO:0001558,regulation of cell growth,HP:0000149,Ovarian gonadoblastoma
GO:0001558,regulation of cell growth,HP:0004814,Fava bean-induced hemolytic anemia
GO:0001558,regulation of cell growth,HP:0005116,Arterial tortuosity
GO:0001558,regulation of cell growth,HP:0005465,Facial hyperostosis
GO:0001569,branching involved in blood vessel morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0001570,vasculogenesis,HP:0000006,Autosomal dominant inheritance
GO:0001570,vasculogenesis,HP:0000149,Ovarian gonadoblastoma
GO:0001578,microtubule bundle formation,HP:0000246,Sinusitis
GO:0001578,microtubule bundle formation,HP:0000403,Recurrent otitis media
GO:0001578,microtubule bundle formation,HP:0000789,Infertility
GO:0001578,microtubule bundle formation,HP:0001696,Situs inversus totalis
GO:0001578,microtubule bundle formation,HP:0002110,Bronchiectasis
GO:0001578,microtubule bundle formation,HP:0002257,Chronic rhinitis
GO:0001578,microtubule bundle formation,HP:0004469,Chronic bronchitis
GO:0001578,microtubule bundle formation,HP:0011108,Recurrent sinusitis
GO:0001578,microtubule bundle formation,HP:0011109,Chronic sinusitis
GO:0001578,microtubule bundle formation,HP:0012263,Immotile cilia
GO:0001578,microtubule bundle formation,HP:0012265,Ciliary dyskinesia
GO:0001578,microtubule bundle formation,HP:0100582,Nasal polyposis
GO:0001578,microtubule bundle formation,HP:0200073,Respiratory insufficiency due to defective ciliary clearance
GO:0001578,microtubule bundle formation,HP:0012384,Rhinitis
GO:0001649,osteoblast differentiation,HP:0000006,Autosomal dominant inheritance
GO:0001649,osteoblast differentiation,HP:0005465,Facial hyperostosis
GO:0001654,eye development,HP:0000006,Autosomal dominant inheritance
GO:0001654,eye development,HP:0000149,Ovarian gonadoblastoma
GO:0001654,eye development,HP:0000501,Glaucoma
GO:0001654,eye development,HP:0000505,Visual impairment
GO:0001654,eye development,HP:0000510,Rod-cone dystrophy
GO:0001654,eye development,HP:0000568,Microphthalmia
GO:0001654,eye development,HP:0001083,Ectopia lentis
GO:0001654,eye development,HP:0005116,Arterial tortuosity
GO:0001654,eye development,HP:0005217,Duplication of internal organs
GO:0001654,eye development,HP:0007780,Cortical pulverulent cataract
GO:0001654,eye development,HP:0007971,Lamellar cataract
GO:0001654,eye development,HP:0008031,Posterior Y-sutural cataract
GO:0001654,eye development,HP:0008499,High-grade hypermetropia
GO:0001654,eye development,HP:0010695,Sutural cataract
GO:0001654,eye development,HP:0012038,Corneal guttata
GO:0001655,urogenital system development,HP:0000006,Autosomal dominant inheritance
GO:0001655,urogenital system development,HP:0000074,Ureteropelvic junction obstruction
GO:0001655,urogenital system development,HP:0000100,Nephrotic syndrome
GO:0001655,urogenital system development,HP:0000149,Ovarian gonadoblastoma
GO:0001655,urogenital system development,HP:0000243,Trigonocephaly
GO:0001655,urogenital system development,HP:0001083,Ectopia lentis
GO:0001655,urogenital system development,HP:0005116,Arterial tortuosity
GO:0001655,urogenital system development,HP:0005217,Duplication of internal organs
GO:0001655,urogenital system development,HP:0008659,Multiple small medullary renal cysts
GO:0001655,urogenital system development,HP:0100775,Dural ectasia
GO:0001656,metanephros development,HP:0000006,Autosomal dominant inheritance
GO:0001656,metanephros development,HP:0000149,Ovarian gonadoblastoma
GO:0001656,metanephros development,HP:0001083,Ectopia lentis
GO:0001657,ureteric bud development,HP:0000006,Autosomal dominant inheritance
GO:0001657,ureteric bud development,HP:0000149,Ovarian gonadoblastoma
GO:0001657,ureteric bud development,HP:0000243,Trigonocephaly
GO:0001658,branching involved in ureteric bud morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0001658,branching involved in ureteric bud morphogenesis,HP:0000149,Ovarian gonadoblastoma
GO:0001666,response to hypoxia,HP:0000006,Autosomal dominant inheritance
GO:0001666,response to hypoxia,HP:0005116,Arterial tortuosity
GO:0001667,ameboidal-type cell migration,HP:0000006,Autosomal dominant inheritance
GO:0001667,ameboidal-type cell migration,HP:0000034,Hydrocele testis
GO:0001667,ameboidal-type cell migration,HP:0001054,Numerous nevi
GO:0001667,ameboidal-type cell migration,HP:0001528,Hemihypertrophy
GO:0001701,in utero embryonic development,HP:0000006,Autosomal dominant inheritance
GO:0001701,in utero embryonic development,HP:0000243,Trigonocephaly
GO:0001701,in utero embryonic development,HP:0000501,Glaucoma
GO:0001701,in utero embryonic development,HP:0000668,Hypodontia
GO:0001701,in utero embryonic development,HP:0002208,Coarse hair
GO:0001701,in utero embryonic development,HP:0004635,Cervical C5/C6 vertebrae fusion
GO:0001701,in utero embryonic development,HP:0005465,Facial hyperostosis
GO:0001704,formation of primary germ layer,HP:0000006,Autosomal dominant inheritance
GO:0001707,mesoderm formation,HP:0000006,Autosomal dominant inheritance
GO:0001708,cell fate specification,HP:0000006,Autosomal dominant inheritance
GO:0001708,cell fate specification,HP:0000243,Trigonocephaly
GO:0001754,eye photoreceptor cell differentiation,HP:0000505,Visual impairment
GO:0001754,eye photoreceptor cell differentiation,HP:0000510,Rod-cone dystrophy
GO:0001754,eye photoreceptor cell differentiation,HP:0000662,Nyctalopia
GO:0001754,eye photoreceptor cell differentiation,HP:0008499,High-grade hypermetropia
GO:0001755,neural crest cell migration,HP:0001053,Hypopigmented skin patches
GO:0001755,neural crest cell migration,HP:0001100,Heterochromia iridis
GO:0001755,neural crest cell migration,HP:0002211,White forelock
GO:0001755,neural crest cell migration,HP:0002226,White eyebrow
GO:0001755,neural crest cell migration,HP:0002227,White eyelashes
GO:0001755,neural crest cell migration,HP:0002251,Aganglionic megacolon
GO:0001763,morphogenesis of a branching structure,HP:0000006,Autosomal dominant inheritance
GO:0001763,morphogenesis of a branching structure,HP:0000074,Ureteropelvic junction obstruction
GO:0001763,morphogenesis of a branching structure,HP:0000149,Ovarian gonadoblastoma
GO:0001763,morphogenesis of a branching structure,HP:0000243,Trigonocephaly
GO:0001763,morphogenesis of a branching structure,HP:0000668,Hypodontia
GO:0001819,positive regulation of cytokine production,HP:0000006,Autosomal dominant inheritance
GO:0001819,positive regulation of cytokine production,HP:0001894,Thrombocytosis
GO:0001819,positive regulation of cytokine production,HP:0002721,Immunodeficiency
GO:0001819,positive regulation of cytokine production,HP:0002849,Absence of lymph node germinal center
GO:0001819,positive regulation of cytokine production,HP:0003292,Decreased serum leptin
GO:0001819,positive regulation of cytokine production,HP:0004845,Acute monocytic leukemia
GO:0001822,kidney development,HP:0000006,Autosomal dominant inheritance
GO:0001822,kidney development,HP:0000100,Nephrotic syndrome
GO:0001822,kidney development,HP:0000149,Ovarian gonadoblastoma
GO:0001822,kidney development,HP:0000243,Trigonocephaly
GO:0001822,kidney development,HP:0001083,Ectopia lentis
GO:0001822,kidney development,HP:0005116,Arterial tortuosity
GO:0001822,kidney development,HP:0005217,Duplication of internal organs
GO:0001822,kidney development,HP:0008659,Multiple small medullary renal cysts
GO:0001822,kidney development,HP:0100775,Dural ectasia
GO:0001823,mesonephros development,HP:0000006,Autosomal dominant inheritance
GO:0001823,mesonephros development,HP:0000149,Ovarian gonadoblastoma
GO:0001823,mesonephros development,HP:0000243,Trigonocephaly
GO:0001837,epithelial to mesenchymal transition,HP:0000006,Autosomal dominant inheritance
GO:0001837,epithelial to mesenchymal transition,HP:0003250,Aplasia of the vagina
GO:0001837,epithelial to mesenchymal transition,HP:0005116,Arterial tortuosity
GO:0001840,neural plate development,HP:0008368,Tarsal synostosis
GO:0001894,tissue homeostasis,HP:0000510,Rod-cone dystrophy
GO:0001895,retina homeostasis,HP:0000510,Rod-cone dystrophy
GO:0001895,retina homeostasis,HP:0000662,Nyctalopia
GO:0001935,endothelial cell proliferation,HP:0005465,Facial hyperostosis
GO:0001936,regulation of endothelial cell proliferation,HP:0005465,Facial hyperostosis
GO:0001942,hair follicle development,HP:0000535,Sparse and thin eyebrow
GO:0001942,hair follicle development,HP:0000668,Hypodontia
GO:0001942,hair follicle development,HP:0001006,Hypotrichosis
GO:0001942,hair follicle development,HP:0002561,Absent nipple
GO:0001946,lymphangiogenesis,HP:0001004,Lymphedema
GO:0001947,heart looping,HP:0010445,Primum atrial septal defect
GO:0001958,endochondral ossification,HP:0000926,Platyspondyly
GO:0001958,endochondral ossification,HP:0001156,Brachydactyly syndrome
GO:0001958,endochondral ossification,HP:0002677,Small foramen magnum
GO:0001958,endochondral ossification,HP:0003015,Flared metaphysis
GO:0002027,regulation of heart rate,HP:0000006,Autosomal dominant inheritance
GO:0002027,regulation of heart rate,HP:0001279,Syncope
GO:0002027,regulation of heart rate,HP:0001644,Dilated cardiomyopathy
GO:0002027,regulation of heart rate,HP:0001645,Sudden cardiac death
GO:0002027,regulation of heart rate,HP:0001657,Prolonged QT interval
GO:0002027,regulation of heart rate,HP:0001663,Ventricular fibrillation
GO:0002027,regulation of heart rate,HP:0001664,Torsade de pointes
GO:0002027,regulation of heart rate,HP:0001699,Sudden death
GO:0002027,regulation of heart rate,HP:0001962,Palpitations
GO:0002027,regulation of heart rate,HP:0004308,Ventricular arrhythmia
GO:0002027,regulation of heart rate,HP:0004749,Atrial flutter
GO:0002027,regulation of heart rate,HP:0004756,Ventricular tachycardia
GO:0002027,regulation of heart rate,HP:0005110,Atrial fibrillation
GO:0002027,regulation of heart rate,HP:0011663,Right ventricular cardiomyopathy
GO:0002027,regulation of heart rate,HP:0012232,Shortened QT interval
GO:0002028,regulation of sodium ion transport,HP:0000006,Autosomal dominant inheritance
GO:0002028,regulation of sodium ion transport,HP:0001279,Syncope
GO:0002028,regulation of sodium ion transport,HP:0001663,Ventricular fibrillation
GO:0002028,regulation of sodium ion transport,HP:0004749,Atrial flutter
GO:0002053,positive regulation of mesenchymal cell proliferation,HP:0000006,Autosomal dominant inheritance
GO:0002062,chondrocyte differentiation,HP:0000006,Autosomal dominant inheritance
GO:0002062,chondrocyte differentiation,HP:0000243,Trigonocephaly
GO:0002062,chondrocyte differentiation,HP:0000272,Malar flattening
GO:0002062,chondrocyte differentiation,HP:0000773,Short ribs
GO:0002062,chondrocyte differentiation,HP:0000926,Platyspondyly
GO:0002062,chondrocyte differentiation,HP:0001156,Brachydactyly syndrome
GO:0002062,chondrocyte differentiation,HP:0002676,Cloverleaf skull
GO:0002062,chondrocyte differentiation,HP:0002677,Small foramen magnum
GO:0002062,chondrocyte differentiation,HP:0005736,Short tibia
GO:0002062,chondrocyte differentiation,HP:0011800,Midface retrusion
GO:0002064,epithelial cell development,HP:0000668,Hypodontia
GO:0002064,epithelial cell development,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0002065,columnar/cuboidal epithelial cell differentiation,HP:0000006,Autosomal dominant inheritance
GO:0002088,lens development in camera-type eye,HP:0000006,Autosomal dominant inheritance
GO:0002088,lens development in camera-type eye,HP:0000519,Congenital cataract
GO:0002088,lens development in camera-type eye,HP:0007780,Cortical pulverulent cataract
GO:0002088,lens development in camera-type eye,HP:0008031,Posterior Y-sutural cataract
GO:0002200,somatic diversification of immune receptors,HP:0002849,Absence of lymph node germinal center
GO:0002200,somatic diversification of immune receptors,HP:0002959,Impaired Ig class switch recombination
GO:0002204,somatic recombination of immunoglobulin genes involved in immune response,HP:0002849,Absence of lymph node germinal center
GO:0002204,somatic recombination of immunoglobulin genes involved in immune response,HP:0002959,Impaired Ig class switch recombination
GO:0002208,somatic diversification of immunoglobulins involved in immune response,HP:0002849,Absence of lymph node germinal center
GO:0002208,somatic diversification of immunoglobulins involved in immune response,HP:0002959,Impaired Ig class switch recombination
GO:0002237,response to molecule of bacterial origin,HP:0001045,Vitiligo
GO:0002237,response to molecule of bacterial origin,HP:0001894,Thrombocytosis
GO:0002237,response to molecule of bacterial origin,HP:0002716,Lymphadenopathy
GO:0002237,response to molecule of bacterial origin,HP:0005959,Impaired gluconeogenesis
GO:0002250,adaptive immune response,HP:0001287,Meningitis
GO:0002250,adaptive immune response,HP:0001894,Thrombocytosis
GO:0002250,adaptive immune response,HP:0002716,Lymphadenopathy
GO:0002250,adaptive immune response,HP:0002718,Recurrent bacterial infections
GO:0002250,adaptive immune response,HP:0002721,Immunodeficiency
GO:0002250,adaptive immune response,HP:0002725,Systemic lupus erythematosus
GO:0002250,adaptive immune response,HP:0002849,Absence of lymph node germinal center
GO:0002250,adaptive immune response,HP:0003095,Septic arthritis
GO:0002250,adaptive immune response,HP:0004315,IgG deficiency
GO:0002250,adaptive immune response,HP:0004431,Complement deficiency
GO:0002250,adaptive immune response,HP:0005421,Decreased serum complement C3
GO:0002262,myeloid cell homeostasis,HP:0001894,Thrombocytosis
GO:0002262,myeloid cell homeostasis,HP:0004814,Fava bean-induced hemolytic anemia
GO:0002443,leukocyte mediated immunity,HP:0001287,Meningitis
GO:0002443,leukocyte mediated immunity,HP:0002716,Lymphadenopathy
GO:0002443,leukocyte mediated immunity,HP:0002718,Recurrent bacterial infections
GO:0002443,leukocyte mediated immunity,HP:0002721,Immunodeficiency
GO:0002443,leukocyte mediated immunity,HP:0002725,Systemic lupus erythematosus
GO:0002443,leukocyte mediated immunity,HP:0002849,Absence of lymph node germinal center
GO:0002443,leukocyte mediated immunity,HP:0003095,Septic arthritis
GO:0002443,leukocyte mediated immunity,HP:0004431,Complement deficiency
GO:0002443,leukocyte mediated immunity,HP:0005421,Decreased serum complement C3
GO:0002449,lymphocyte mediated immunity,HP:0002716,Lymphadenopathy
GO:0002449,lymphocyte mediated immunity,HP:0002718,Recurrent bacterial infections
GO:0002449,lymphocyte mediated immunity,HP:0002721,Immunodeficiency
GO:0002449,lymphocyte mediated immunity,HP:0002725,Systemic lupus erythematosus
GO:0002449,lymphocyte mediated immunity,HP:0002849,Absence of lymph node germinal center
GO:0002449,lymphocyte mediated immunity,HP:0003095,Septic arthritis
GO:0002449,lymphocyte mediated immunity,HP:0004431,Complement deficiency
GO:0002449,lymphocyte mediated immunity,HP:0005421,Decreased serum complement C3
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,HP:0001287,Meningitis
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,HP:0002716,Lymphadenopathy
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,HP:0002718,Recurrent bacterial infections
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,HP:0002721,Immunodeficiency
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,HP:0002725,Systemic lupus erythematosus
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,HP:0002849,Absence of lymph node germinal center
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,HP:0003095,Septic arthritis
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,HP:0004431,Complement deficiency
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,HP:0005421,Decreased serum complement C3
GO:0002521,leukocyte differentiation,HP:0000006,Autosomal dominant inheritance
GO:0002521,leukocyte differentiation,HP:0001045,Vitiligo
GO:0002521,leukocyte differentiation,HP:0001083,Ectopia lentis
GO:0002521,leukocyte differentiation,HP:0002090,Pneumonia
GO:0002521,leukocyte differentiation,HP:0002716,Lymphadenopathy
GO:0002521,leukocyte differentiation,HP:0002718,Recurrent bacterial infections
GO:0002521,leukocyte differentiation,HP:0003095,Septic arthritis
GO:0002521,leukocyte differentiation,HP:0007807,Optic nerve compression
GO:0002521,leukocyte differentiation,HP:0100658,Cellulitis
GO:0002526,acute inflammatory response,HP:0002725,Systemic lupus erythematosus
GO:0002526,acute inflammatory response,HP:0003095,Septic arthritis
GO:0002526,acute inflammatory response,HP:0004431,Complement deficiency
GO:0002526,acute inflammatory response,HP:0005421,Decreased serum complement C3
GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,HP:0002849,Absence of lymph node germinal center
GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,HP:0002959,Impaired Ig class switch recombination
GO:0002573,myeloid leukocyte differentiation,HP:0000006,Autosomal dominant inheritance
GO:0002573,myeloid leukocyte differentiation,HP:0001083,Ectopia lentis
GO:0002573,myeloid leukocyte differentiation,HP:0007807,Optic nerve compression
GO:0002673,regulation of acute inflammatory response,HP:0002725,Systemic lupus erythematosus
GO:0002673,regulation of acute inflammatory response,HP:0003095,Septic arthritis
GO:0002673,regulation of acute inflammatory response,HP:0004431,Complement deficiency
GO:0002673,regulation of acute inflammatory response,HP:0005421,Decreased serum complement C3
GO:0002694,regulation of leukocyte activation,HP:0001528,Hemihypertrophy
GO:0002694,regulation of leukocyte activation,HP:0002716,Lymphadenopathy
GO:0002694,regulation of leukocyte activation,HP:0002718,Recurrent bacterial infections
GO:0002694,regulation of leukocyte activation,HP:0002721,Immunodeficiency
GO:0002694,regulation of leukocyte activation,HP:0002849,Absence of lymph node germinal center
GO:0002694,regulation of leukocyte activation,HP:0003095,Septic arthritis
GO:0002696,positive regulation of leukocyte activation,HP:0001528,Hemihypertrophy
GO:0002696,positive regulation of leukocyte activation,HP:0002716,Lymphadenopathy
GO:0002696,positive regulation of leukocyte activation,HP:0002718,Recurrent bacterial infections
GO:0002696,positive regulation of leukocyte activation,HP:0002721,Immunodeficiency
GO:0002696,positive regulation of leukocyte activation,HP:0002849,Absence of lymph node germinal center
GO:0002696,positive regulation of leukocyte activation,HP:0003095,Septic arthritis
GO:0002697,regulation of immune effector process,HP:0001894,Thrombocytosis
GO:0002697,regulation of immune effector process,HP:0002721,Immunodeficiency
GO:0002697,regulation of immune effector process,HP:0002725,Systemic lupus erythematosus
GO:0002697,regulation of immune effector process,HP:0002849,Absence of lymph node germinal center
GO:0002697,regulation of immune effector process,HP:0003095,Septic arthritis
GO:0002697,regulation of immune effector process,HP:0004431,Complement deficiency
GO:0002697,regulation of immune effector process,HP:0005421,Decreased serum complement C3
GO:0002700,regulation of production of molecular mediator of immune response,HP:0002849,Absence of lymph node germinal center
GO:0002700,regulation of production of molecular mediator of immune response,HP:0003095,Septic arthritis
GO:0002790,peptide secretion,HP:0000006,Autosomal dominant inheritance
GO:0002790,peptide secretion,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0002790,peptide secretion,HP:0001894,Thrombocytosis
GO:0002791,regulation of peptide secretion,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0002791,regulation of peptide secretion,HP:0001894,Thrombocytosis
GO:0002791,regulation of peptide secretion,HP:0004904,Maturity-onset diabetes of the young
GO:0002821,positive regulation of adaptive immune response,HP:0003095,Septic arthritis
GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,HP:0003095,Septic arthritis
GO:0002920,regulation of humoral immune response,HP:0002725,Systemic lupus erythematosus
GO:0002920,regulation of humoral immune response,HP:0004431,Complement deficiency
GO:0002920,regulation of humoral immune response,HP:0005381,Recurrent meningococcal disease
GO:0002920,regulation of humoral immune response,HP:0005421,Decreased serum complement C3
GO:0003002,regionalization,HP:0000006,Autosomal dominant inheritance
GO:0003002,regionalization,HP:0000074,Ureteropelvic junction obstruction
GO:0003002,regionalization,HP:0000149,Ovarian gonadoblastoma
GO:0003002,regionalization,HP:0000243,Trigonocephaly
GO:0003002,regionalization,HP:0000668,Hypodontia
GO:0003002,regionalization,HP:0004635,Cervical C5/C6 vertebrae fusion
GO:0003007,heart morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0003007,heart morphogenesis,HP:0000243,Trigonocephaly
GO:0003007,heart morphogenesis,HP:0000501,Glaucoma
GO:0003007,heart morphogenesis,HP:0000668,Hypodontia
GO:0003007,heart morphogenesis,HP:0001684,Secundum atrial septal defect
GO:0003007,heart morphogenesis,HP:0002408,Cerebral arteriovenous malformation
GO:0003007,heart morphogenesis,HP:0005116,Arterial tortuosity
GO:0003007,heart morphogenesis,HP:0010445,Primum atrial septal defect
GO:0003009,skeletal muscle contraction,HP:0003391,Gowers sign
GO:0003012,muscle system process,HP:0000006,Autosomal dominant inheritance
GO:0003012,muscle system process,HP:0000408,Progressive sensorineural hearing impairment
GO:0003012,muscle system process,HP:0001279,Syncope
GO:0003012,muscle system process,HP:0001644,Dilated cardiomyopathy
GO:0003012,muscle system process,HP:0001645,Sudden cardiac death
GO:0003012,muscle system process,HP:0001657,Prolonged QT interval
GO:0003012,muscle system process,HP:0001663,Ventricular fibrillation
GO:0003012,muscle system process,HP:0001684,Secundum atrial septal defect
GO:0003012,muscle system process,HP:0001699,Sudden death
GO:0003012,muscle system process,HP:0003391,Gowers sign
GO:0003012,muscle system process,HP:0003458,EMG: myopathic abnormalities
GO:0003012,muscle system process,HP:0003803,Type 1 muscle fiber predominance
GO:0003012,muscle system process,HP:0004749,Atrial flutter
GO:0003012,muscle system process,HP:0004756,Ventricular tachycardia
GO:0003012,muscle system process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0003012,muscle system process,HP:0005110,Atrial fibrillation
GO:0003012,muscle system process,HP:0010445,Primum atrial septal defect
GO:0003012,muscle system process,HP:0012232,Shortened QT interval
GO:0003012,muscle system process,HP:0012727,Thoracic aortic aneurysm
GO:0003013,circulatory system process,HP:0000006,Autosomal dominant inheritance
GO:0003013,circulatory system process,HP:0001279,Syncope
GO:0003013,circulatory system process,HP:0001528,Hemihypertrophy
GO:0003013,circulatory system process,HP:0001644,Dilated cardiomyopathy
GO:0003013,circulatory system process,HP:0001645,Sudden cardiac death
GO:0003013,circulatory system process,HP:0001657,Prolonged QT interval
GO:0003013,circulatory system process,HP:0001663,Ventricular fibrillation
GO:0003013,circulatory system process,HP:0001894,Thrombocytosis
GO:0003013,circulatory system process,HP:0003391,Gowers sign
GO:0003013,circulatory system process,HP:0004749,Atrial flutter
GO:0003013,circulatory system process,HP:0004756,Ventricular tachycardia
GO:0003013,circulatory system process,HP:0005110,Atrial fibrillation
GO:0003013,circulatory system process,HP:0005465,Facial hyperostosis
GO:0003013,circulatory system process,HP:0006673,Reduced systolic function
GO:0003013,circulatory system process,HP:0010445,Primum atrial septal defect
GO:0003013,circulatory system process,HP:0012232,Shortened QT interval
GO:0003013,circulatory system process,HP:0012727,Thoracic aortic aneurysm
GO:0003014,renal system process,HP:0001955,Unexplained fevers
GO:0003015,heart process,HP:0000006,Autosomal dominant inheritance
GO:0003015,heart process,HP:0001279,Syncope
GO:0003015,heart process,HP:0001644,Dilated cardiomyopathy
GO:0003015,heart process,HP:0001645,Sudden cardiac death
GO:0003015,heart process,HP:0001657,Prolonged QT interval
GO:0003015,heart process,HP:0001663,Ventricular fibrillation
GO:0003015,heart process,HP:0001699,Sudden death
GO:0003015,heart process,HP:0001894,Thrombocytosis
GO:0003015,heart process,HP:0003391,Gowers sign
GO:0003015,heart process,HP:0004749,Atrial flutter
GO:0003015,heart process,HP:0004756,Ventricular tachycardia
GO:0003015,heart process,HP:0005110,Atrial fibrillation
GO:0003015,heart process,HP:0006673,Reduced systolic function
GO:0003015,heart process,HP:0010445,Primum atrial septal defect
GO:0003015,heart process,HP:0012232,Shortened QT interval
GO:0003018,vascular process in circulatory system,HP:0005465,Facial hyperostosis
GO:0003018,vascular process in circulatory system,HP:0012727,Thoracic aortic aneurysm
GO:0003091,renal water homeostasis,HP:0001955,Unexplained fevers
GO:0003143,embryonic heart tube morphogenesis,HP:0010445,Primum atrial septal defect
GO:0003148,outflow tract septum morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0003151,outflow tract morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0003156,regulation of animal organ formation,HP:0000149,Ovarian gonadoblastoma
GO:0003158,endothelium development,HP:0002408,Cerebral arteriovenous malformation
GO:0003170,heart valve development,HP:0000006,Autosomal dominant inheritance
GO:0003171,atrioventricular valve development,HP:0000006,Autosomal dominant inheritance
GO:0003179,heart valve morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0003197,endocardial cushion development,HP:0000006,Autosomal dominant inheritance
GO:0003197,endocardial cushion development,HP:0002408,Cerebral arteriovenous malformation
GO:0003198,epithelial to mesenchymal transition involved in endocardial cushion formation,HP:0000006,Autosomal dominant inheritance
GO:0003203,endocardial cushion morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0003203,endocardial cushion morphogenesis,HP:0002408,Cerebral arteriovenous malformation
GO:0003205,cardiac chamber development,HP:0000006,Autosomal dominant inheritance
GO:0003205,cardiac chamber development,HP:0000501,Glaucoma
GO:0003205,cardiac chamber development,HP:0001684,Secundum atrial septal defect
GO:0003206,cardiac chamber morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0003206,cardiac chamber morphogenesis,HP:0000501,Glaucoma
GO:0003206,cardiac chamber morphogenesis,HP:0001684,Secundum atrial septal defect
GO:0003208,cardiac ventricle morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0003209,cardiac atrium morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0003229,ventricular cardiac muscle tissue development,HP:0000006,Autosomal dominant inheritance
GO:0003229,ventricular cardiac muscle tissue development,HP:0001644,Dilated cardiomyopathy
GO:0003230,cardiac atrium development,HP:0000006,Autosomal dominant inheritance
GO:0003231,cardiac ventricle development,HP:0000006,Autosomal dominant inheritance
GO:0003231,cardiac ventricle development,HP:0000501,Glaucoma
GO:0003254,regulation of membrane depolarization,HP:0004749,Atrial flutter
GO:0003272,endocardial cushion formation,HP:0000006,Autosomal dominant inheritance
GO:0003279,cardiac septum development,HP:0000006,Autosomal dominant inheritance
GO:0003281,ventricular septum development,HP:0000006,Autosomal dominant inheritance
GO:0003300,cardiac muscle hypertrophy,HP:0004814,Fava bean-induced hemolytic anemia
GO:0003338,metanephros morphogenesis,HP:0000149,Ovarian gonadoblastoma
GO:0003341,cilium movement,HP:0000403,Recurrent otitis media
GO:0003341,cilium movement,HP:0001696,Situs inversus totalis
GO:0003341,cilium movement,HP:0002110,Bronchiectasis
GO:0003341,cilium movement,HP:0002257,Chronic rhinitis
GO:0003341,cilium movement,HP:0011108,Recurrent sinusitis
GO:0003341,cilium movement,HP:0012265,Ciliary dyskinesia
GO:0003341,cilium movement,HP:0200073,Respiratory insufficiency due to defective ciliary clearance
GO:0003352,regulation of cilium movement,HP:0012265,Ciliary dyskinesia
GO:0003356,regulation of cilium beat frequency,HP:0012265,Ciliary dyskinesia
GO:0003401,axis elongation,HP:0000074,Ureteropelvic junction obstruction
GO:0003416,endochondral bone growth,HP:0002677,Small foramen magnum
GO:0003416,endochondral bone growth,HP:0003015,Flared metaphysis
GO:0005976,polysaccharide metabolic process,HP:0001528,Hemihypertrophy
GO:0005976,polysaccharide metabolic process,HP:0006568,Increased hepatic glycogen content
GO:0005976,polysaccharide metabolic process,HP:0006765,Chondrosarcoma
GO:0005977,glycogen metabolic process,HP:0001528,Hemihypertrophy
GO:0005977,glycogen metabolic process,HP:0006568,Increased hepatic glycogen content
GO:0005978,glycogen biosynthetic process,HP:0001528,Hemihypertrophy
GO:0005980,glycogen catabolic process,HP:0006568,Increased hepatic glycogen content
GO:0005996,monosaccharide metabolic process,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0005996,monosaccharide metabolic process,HP:0000952,Jaundice
GO:0005996,monosaccharide metabolic process,HP:0001082,Cholecystitis
GO:0005996,monosaccharide metabolic process,HP:0001528,Hemihypertrophy
GO:0005996,monosaccharide metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0005996,monosaccharide metabolic process,HP:0005959,Impaired gluconeogenesis
GO:0005996,monosaccharide metabolic process,HP:0012024,Hypergalactosemia
GO:0006006,glucose metabolic process,HP:0000952,Jaundice
GO:0006006,glucose metabolic process,HP:0001082,Cholecystitis
GO:0006006,glucose metabolic process,HP:0001528,Hemihypertrophy
GO:0006006,glucose metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0006006,glucose metabolic process,HP:0005959,Impaired gluconeogenesis
GO:0006007,glucose catabolic process,HP:0000952,Jaundice
GO:0006007,glucose catabolic process,HP:0001082,Cholecystitis
GO:0006022,aminoglycan metabolic process,HP:0000280,Coarse facial features
GO:0006022,aminoglycan metabolic process,HP:0000365,Hearing impairment
GO:0006022,aminoglycan metabolic process,HP:0000501,Glaucoma
GO:0006022,aminoglycan metabolic process,HP:0000943,Dysostosis multiplex
GO:0006022,aminoglycan metabolic process,HP:0001387,Joint stiffness
GO:0006022,aminoglycan metabolic process,HP:0001654,Abnormality of the heart valves
GO:0006022,aminoglycan metabolic process,HP:0002159,Heparan sulfate excretion in urine
GO:0006022,aminoglycan metabolic process,HP:0002208,Coarse hair
GO:0006022,aminoglycan metabolic process,HP:0002673,Coxa valga
GO:0006022,aminoglycan metabolic process,HP:0002857,Genu valgum
GO:0006022,aminoglycan metabolic process,HP:0006765,Chondrosarcoma
GO:0006023,aminoglycan biosynthetic process,HP:0006765,Chondrosarcoma
GO:0006024,glycosaminoglycan biosynthetic process,HP:0006765,Chondrosarcoma
GO:0006026,aminoglycan catabolic process,HP:0000280,Coarse facial features
GO:0006026,aminoglycan catabolic process,HP:0000365,Hearing impairment
GO:0006026,aminoglycan catabolic process,HP:0000900,Thickened ribs
GO:0006026,aminoglycan catabolic process,HP:0000943,Dysostosis multiplex
GO:0006026,aminoglycan catabolic process,HP:0001007,Hirsutism
GO:0006026,aminoglycan catabolic process,HP:0001387,Joint stiffness
GO:0006026,aminoglycan catabolic process,HP:0001654,Abnormality of the heart valves
GO:0006026,aminoglycan catabolic process,HP:0002159,Heparan sulfate excretion in urine
GO:0006026,aminoglycan catabolic process,HP:0002208,Coarse hair
GO:0006026,aminoglycan catabolic process,HP:0002673,Coxa valga
GO:0006026,aminoglycan catabolic process,HP:0002788,Recurrent upper respiratory tract infections
GO:0006027,glycosaminoglycan catabolic process,HP:0000280,Coarse facial features
GO:0006027,glycosaminoglycan catabolic process,HP:0000365,Hearing impairment
GO:0006027,glycosaminoglycan catabolic process,HP:0000900,Thickened ribs
GO:0006027,glycosaminoglycan catabolic process,HP:0000943,Dysostosis multiplex
GO:0006027,glycosaminoglycan catabolic process,HP:0001007,Hirsutism
GO:0006027,glycosaminoglycan catabolic process,HP:0001387,Joint stiffness
GO:0006027,glycosaminoglycan catabolic process,HP:0001654,Abnormality of the heart valves
GO:0006027,glycosaminoglycan catabolic process,HP:0002159,Heparan sulfate excretion in urine
GO:0006027,glycosaminoglycan catabolic process,HP:0002208,Coarse hair
GO:0006027,glycosaminoglycan catabolic process,HP:0002673,Coxa valga
GO:0006027,glycosaminoglycan catabolic process,HP:0002788,Recurrent upper respiratory tract infections
GO:0006029,proteoglycan metabolic process,HP:0000501,Glaucoma
GO:0006029,proteoglycan metabolic process,HP:0000926,Platyspondyly
GO:0006029,proteoglycan metabolic process,HP:0002655,Spondyloepiphyseal dysplasia
GO:0006029,proteoglycan metabolic process,HP:0002673,Coxa valga
GO:0006029,proteoglycan metabolic process,HP:0004233,Advanced ossification of carpal bones
GO:0006029,proteoglycan metabolic process,HP:0006765,Chondrosarcoma
GO:0006029,proteoglycan metabolic process,HP:0010049,Short metacarpal
GO:0006066,alcohol metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0006066,alcohol metabolic process,HP:0008258,Congenital adrenal hyperplasia
GO:0006066,alcohol metabolic process,HP:0200044,Porokeratosis
GO:0006073,cellular glucan metabolic process,HP:0001528,Hemihypertrophy
GO:0006073,cellular glucan metabolic process,HP:0006568,Increased hepatic glycogen content
GO:0006081,cellular aldehyde metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0006084,acetyl-CoA metabolic process,HP:0003128,Lactic acidosis
GO:0006084,acetyl-CoA metabolic process,HP:0200044,Porokeratosis
GO:0006085,acetyl-CoA biosynthetic process,HP:0003128,Lactic acidosis
GO:0006090,pyruvate metabolic process,HP:0000952,Jaundice
GO:0006090,pyruvate metabolic process,HP:0001082,Cholecystitis
GO:0006090,pyruvate metabolic process,HP:0005959,Impaired gluconeogenesis
GO:0006091,generation of precursor metabolites and energy,HP:0000131,Uterine leiomyoma
GO:0006091,generation of precursor metabolites and energy,HP:0000952,Jaundice
GO:0006091,generation of precursor metabolites and energy,HP:0001082,Cholecystitis
GO:0006091,generation of precursor metabolites and energy,HP:0001528,Hemihypertrophy
GO:0006091,generation of precursor metabolites and energy,HP:0003128,Lactic acidosis
GO:0006091,generation of precursor metabolites and energy,HP:0003546,Exercise intolerance
GO:0006091,generation of precursor metabolites and energy,HP:0006568,Increased hepatic glycogen content
GO:0006091,generation of precursor metabolites and energy,HP:0009051,Increased muscle glycogen content
GO:0006094,gluconeogenesis,HP:0005959,Impaired gluconeogenesis
GO:0006096,glycolytic process,HP:0000952,Jaundice
GO:0006096,glycolytic process,HP:0001081,Cholelithiasis
GO:0006096,glycolytic process,HP:0001082,Cholecystitis
GO:0006099,tricarboxylic acid cycle,HP:0000131,Uterine leiomyoma
GO:0006112,energy reserve metabolic process,HP:0001528,Hemihypertrophy
GO:0006112,energy reserve metabolic process,HP:0006568,Increased hepatic glycogen content
GO:0006165,nucleoside diphosphate phosphorylation,HP:0000952,Jaundice
GO:0006165,nucleoside diphosphate phosphorylation,HP:0001081,Cholelithiasis
GO:0006165,nucleoside diphosphate phosphorylation,HP:0001082,Cholecystitis
GO:0006260,DNA replication,HP:0000590,Progressive external ophthalmoplegia
GO:0006260,DNA replication,HP:0001511,Intrauterine growth retardation
GO:0006260,DNA replication,HP:0006498,Aplasia/Hypoplasia of the patella
GO:0006260,DNA replication,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0006261,DNA-dependent DNA replication,HP:0000590,Progressive external ophthalmoplegia
GO:0006261,DNA-dependent DNA replication,HP:0006498,Aplasia/Hypoplasia of the patella
GO:0006261,DNA-dependent DNA replication,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0006264,mitochondrial DNA replication,HP:0000590,Progressive external ophthalmoplegia
GO:0006275,regulation of DNA replication,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0006399,tRNA metabolic process,HP:0000007,Autosomal recessive inheritance
GO:0006399,tRNA metabolic process,HP:0000252,Microcephaly
GO:0006399,tRNA metabolic process,HP:0000253,Progressive microcephaly
GO:0006399,tRNA metabolic process,HP:0000639,Nystagmus
GO:0006399,tRNA metabolic process,HP:0001252,Muscular hypotonia
GO:0006399,tRNA metabolic process,HP:0001257,Spasticity
GO:0006399,tRNA metabolic process,HP:0001263,Global developmental delay
GO:0006399,tRNA metabolic process,HP:0001347,Hyperreflexia
GO:0006399,tRNA metabolic process,HP:0001508,Failure to thrive
GO:0006399,tRNA metabolic process,HP:0002079,Hypoplasia of the corpus callosum
GO:0006399,tRNA metabolic process,HP:0002151,Increased serum lactate
GO:0006399,tRNA metabolic process,HP:0003128,Lactic acidosis
GO:0006399,tRNA metabolic process,HP:0003577,Congenital onset
GO:0006399,tRNA metabolic process,HP:0003676,Progressive
GO:0006399,tRNA metabolic process,HP:0011968,Feeding difficulties
GO:0006486,protein glycosylation,HP:0000007,Autosomal recessive inheritance
GO:0006486,protein glycosylation,HP:0000158,Macroglossia
GO:0006486,protein glycosylation,HP:0001083,Ectopia lentis
GO:0006486,protein glycosylation,HP:0001252,Muscular hypotonia
GO:0006486,protein glycosylation,HP:0001321,Cerebellar hypoplasia
GO:0006486,protein glycosylation,HP:0002350,Cerebellar cyst
GO:0006486,protein glycosylation,HP:0003236,Elevated serum creatine phosphokinase
GO:0006486,protein glycosylation,HP:0003391,Gowers sign
GO:0006486,protein glycosylation,HP:0003560,Muscular dystrophy
GO:0006486,protein glycosylation,HP:0003642,Type I transferrin isoform profile
GO:0006486,protein glycosylation,HP:0003741,Congenital muscular dystrophy
GO:0006486,protein glycosylation,HP:0006765,Chondrosarcoma
GO:0006486,protein glycosylation,HP:0007033,Cerebellar dysplasia
GO:0006486,protein glycosylation,HP:0007260,Type II lissencephaly
GO:0006486,protein glycosylation,HP:0007973,Retinal dysplasia
GO:0006486,protein glycosylation,HP:0010970,Blood group antigen abnormality
GO:0006488,dolichol-linked oligosaccharide biosynthetic process,HP:0000007,Autosomal recessive inheritance
GO:0006488,dolichol-linked oligosaccharide biosynthetic process,HP:0003642,Type I transferrin isoform profile
GO:0006490,oligosaccharide-lipid intermediate biosynthetic process,HP:0003642,Type I transferrin isoform profile
GO:0006520,cellular amino acid metabolic process,HP:0000007,Autosomal recessive inheritance
GO:0006520,cellular amino acid metabolic process,HP:0001250,Seizures
GO:0006520,cellular amino acid metabolic process,HP:0001252,Muscular hypotonia
GO:0006520,cellular amino acid metabolic process,HP:0001263,Global developmental delay
GO:0006520,cellular amino acid metabolic process,HP:0001508,Failure to thrive
GO:0006520,cellular amino acid metabolic process,HP:0001951,Episodic ammonia intoxication
GO:0006520,cellular amino acid metabolic process,HP:0001987,Hyperammonemia
GO:0006520,cellular amino acid metabolic process,HP:0003231,Hypertyrosinemia
GO:0006520,cellular amino acid metabolic process,HP:0003607,4-Hydroxyphenylacetic aciduria
GO:0006520,cellular amino acid metabolic process,HP:0004911,Episodic metabolic acidosis
GO:0006520,cellular amino acid metabolic process,HP:0004923,Hyperphenylalaninemia
GO:0006520,cellular amino acid metabolic process,HP:0006846,Acute encephalopathy
GO:0006525,arginine metabolic process,HP:0001950,Respiratory alkalosis
GO:0006525,arginine metabolic process,HP:0001951,Episodic ammonia intoxication
GO:0006525,arginine metabolic process,HP:0001987,Hyperammonemia
GO:0006525,arginine metabolic process,HP:0002013,Vomiting
GO:0006525,arginine metabolic process,HP:0002038,Protein avoidance
GO:0006525,arginine metabolic process,HP:0002181,Cerebral edema
GO:0006525,arginine metabolic process,HP:0003218,Oroticaciduria
GO:0006558,L-phenylalanine metabolic process,HP:0003231,Hypertyrosinemia
GO:0006558,L-phenylalanine metabolic process,HP:0003607,4-Hydroxyphenylacetic aciduria
GO:0006559,L-phenylalanine catabolic process,HP:0003231,Hypertyrosinemia
GO:0006559,L-phenylalanine catabolic process,HP:0003607,4-Hydroxyphenylacetic aciduria
GO:0006575,cellular modified amino acid metabolic process,HP:0000853,Goiter
GO:0006575,cellular modified amino acid metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0006575,cellular modified amino acid metabolic process,HP:0008191,Thyroid agenesis
GO:0006582,melanin metabolic process,HP:0001022,Albinism
GO:0006590,thyroid hormone generation,HP:0000853,Goiter
GO:0006590,thyroid hormone generation,HP:0008191,Thyroid agenesis
GO:0006606,protein import into nucleus,HP:0000006,Autosomal dominant inheritance
GO:0006606,protein import into nucleus,HP:0001894,Thrombocytosis
GO:0006606,protein import into nucleus,HP:0004749,Atrial flutter
GO:0006606,protein import into nucleus,HP:0005116,Arterial tortuosity
GO:0006625,protein targeting to peroxisome,HP:0001250,Seizures
GO:0006625,protein targeting to peroxisome,HP:0008935,Generalized neonatal hypotonia
GO:0006625,protein targeting to peroxisome,HP:0010655,Epiphyseal stippling
GO:0006631,fatty acid metabolic process,HP:0000007,Autosomal recessive inheritance
GO:0006631,fatty acid metabolic process,HP:0001254,Lethargy
GO:0006631,fatty acid metabolic process,HP:0001528,Hemihypertrophy
GO:0006635,fatty acid beta-oxidation,HP:0001528,Hemihypertrophy
GO:0006637,acyl-CoA metabolic process,HP:0001942,Metabolic acidosis
GO:0006637,acyl-CoA metabolic process,HP:0003128,Lactic acidosis
GO:0006637,acyl-CoA metabolic process,HP:0200044,Porokeratosis
GO:0006638,neutral lipid metabolic process,HP:0003124,Hypercholesterolemia
GO:0006638,neutral lipid metabolic process,HP:0012184,Hyperalphalipoproteinemia
GO:0006639,acylglycerol metabolic process,HP:0003124,Hypercholesterolemia
GO:0006639,acylglycerol metabolic process,HP:0012184,Hyperalphalipoproteinemia
GO:0006641,triglyceride metabolic process,HP:0001397,Hepatic steatosis
GO:0006641,triglyceride metabolic process,HP:0003124,Hypercholesterolemia
GO:0006641,triglyceride metabolic process,HP:0012184,Hyperalphalipoproteinemia
GO:0006643,membrane lipid metabolic process,HP:0000007,Autosomal recessive inheritance
GO:0006643,membrane lipid metabolic process,HP:0001250,Seizures
GO:0006643,membrane lipid metabolic process,HP:0002059,Cerebral atrophy
GO:0006643,membrane lipid metabolic process,HP:0002074,Increased neuronal autofluorescent lipopigment
GO:0006643,membrane lipid metabolic process,HP:0010729,Cherry red spot of the macula
GO:0006644,phospholipid metabolic process,HP:0002676,Cloverleaf skull
GO:0006644,phospholipid metabolic process,HP:0002677,Small foramen magnum
GO:0006644,phospholipid metabolic process,HP:0002716,Lymphadenopathy
GO:0006644,phospholipid metabolic process,HP:0003319,Abnormality of the cervical spine
GO:0006644,phospholipid metabolic process,HP:0200044,Porokeratosis
GO:0006650,glycerophospholipid metabolic process,HP:0002676,Cloverleaf skull
GO:0006650,glycerophospholipid metabolic process,HP:0002677,Small foramen magnum
GO:0006650,glycerophospholipid metabolic process,HP:0003319,Abnormality of the cervical spine
GO:0006661,phosphatidylinositol biosynthetic process,HP:0002676,Cloverleaf skull
GO:0006661,phosphatidylinositol biosynthetic process,HP:0002677,Small foramen magnum
GO:0006661,phosphatidylinositol biosynthetic process,HP:0003319,Abnormality of the cervical spine
GO:0006664,glycolipid metabolic process,HP:0001744,Splenomegaly
GO:0006664,glycolipid metabolic process,HP:0008166,Decreased beta-galactosidase activity
GO:0006664,glycolipid metabolic process,HP:0010729,Cherry red spot of the macula
GO:0006665,sphingolipid metabolic process,HP:0001336,Myoclonus
GO:0006665,sphingolipid metabolic process,HP:0002074,Increased neuronal autofluorescent lipopigment
GO:0006665,sphingolipid metabolic process,HP:0008166,Decreased beta-galactosidase activity
GO:0006665,sphingolipid metabolic process,HP:0010729,Cherry red spot of the macula
GO:0006672,ceramide metabolic process,HP:0002069,Generalized tonic-clonic seizures
GO:0006672,ceramide metabolic process,HP:0002074,Increased neuronal autofluorescent lipopigment
GO:0006672,ceramide metabolic process,HP:0003205,Curvilinear intracellular accumulation of autofluorescent lipopigment storage material
GO:0006687,glycosphingolipid metabolic process,HP:0001744,Splenomegaly
GO:0006687,glycosphingolipid metabolic process,HP:0002240,Hepatomegaly
GO:0006687,glycosphingolipid metabolic process,HP:0008166,Decreased beta-galactosidase activity
GO:0006687,glycosphingolipid metabolic process,HP:0010729,Cherry red spot of the macula
GO:0006694,steroid biosynthetic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0006694,steroid biosynthetic process,HP:0008258,Congenital adrenal hyperplasia
GO:0006694,steroid biosynthetic process,HP:0008668,"Gonadal dysgenesis, male"
GO:0006694,steroid biosynthetic process,HP:0200044,Porokeratosis
GO:0006695,cholesterol biosynthetic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0006695,cholesterol biosynthetic process,HP:0200044,Porokeratosis
GO:0006704,glucocorticoid biosynthetic process,HP:0000822,Hypertension
GO:0006704,glucocorticoid biosynthetic process,HP:0000840,Adrenogenital syndrome
GO:0006704,glucocorticoid biosynthetic process,HP:0008221,Adrenal hyperplasia
GO:0006720,isoprenoid metabolic process,HP:0200044,Porokeratosis
GO:0006732,coenzyme metabolic process,HP:0000007,Autosomal recessive inheritance
GO:0006732,coenzyme metabolic process,HP:0000952,Jaundice
GO:0006732,coenzyme metabolic process,HP:0001082,Cholecystitis
GO:0006732,coenzyme metabolic process,HP:0001083,Ectopia lentis
GO:0006732,coenzyme metabolic process,HP:0001332,Dystonia
GO:0006732,coenzyme metabolic process,HP:0003128,Lactic acidosis
GO:0006732,coenzyme metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0006732,coenzyme metabolic process,HP:0004923,Hyperphenylalaninemia
GO:0006732,coenzyme metabolic process,HP:0008297,Transient hyperphenylalaninemia
GO:0006732,coenzyme metabolic process,HP:0200044,Porokeratosis
GO:0006733,oxidoreduction coenzyme metabolic process,HP:0000952,Jaundice
GO:0006733,oxidoreduction coenzyme metabolic process,HP:0001082,Cholecystitis
GO:0006733,oxidoreduction coenzyme metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0006734,NADH metabolic process,HP:0000952,Jaundice
GO:0006734,NADH metabolic process,HP:0001082,Cholecystitis
GO:0006735,NADH regeneration,HP:0000952,Jaundice
GO:0006735,NADH regeneration,HP:0001081,Cholelithiasis
GO:0006735,NADH regeneration,HP:0001082,Cholecystitis
GO:0006757,ATP generation from ADP,HP:0000952,Jaundice
GO:0006757,ATP generation from ADP,HP:0001081,Cholelithiasis
GO:0006757,ATP generation from ADP,HP:0001082,Cholecystitis
GO:0006766,vitamin metabolic process,HP:0001254,Lethargy
GO:0006766,vitamin metabolic process,HP:0001889,Megaloblastic anemia
GO:0006766,vitamin metabolic process,HP:0001992,Organic aciduria
GO:0006766,vitamin metabolic process,HP:0002156,Homocystinuria
GO:0006766,vitamin metabolic process,HP:0002160,Hyperhomocystinemia
GO:0006766,vitamin metabolic process,HP:0002912,Methylmalonic acidemia
GO:0006766,vitamin metabolic process,HP:0003145,Decreased adenosylcobalamin
GO:0006766,vitamin metabolic process,HP:0003223,Decreased methylcobalamin
GO:0006766,vitamin metabolic process,HP:0003524,Decreased methionine synthase activity
GO:0006766,vitamin metabolic process,HP:0003658,Hypomethioninemia
GO:0006766,vitamin metabolic process,HP:0005518,Increased mean corpuscular volume
GO:0006766,vitamin metabolic process,HP:0012120,Methylmalonic aciduria
GO:0006767,water-soluble vitamin metabolic process,HP:0000007,Autosomal recessive inheritance
GO:0006767,water-soluble vitamin metabolic process,HP:0001250,Seizures
GO:0006767,water-soluble vitamin metabolic process,HP:0001252,Muscular hypotonia
GO:0006767,water-soluble vitamin metabolic process,HP:0001254,Lethargy
GO:0006767,water-soluble vitamin metabolic process,HP:0001263,Global developmental delay
GO:0006767,water-soluble vitamin metabolic process,HP:0001873,Thrombocytopenia
GO:0006767,water-soluble vitamin metabolic process,HP:0001889,Megaloblastic anemia
GO:0006767,water-soluble vitamin metabolic process,HP:0001992,Organic aciduria
GO:0006767,water-soluble vitamin metabolic process,HP:0002156,Homocystinuria
GO:0006767,water-soluble vitamin metabolic process,HP:0002160,Hyperhomocystinemia
GO:0006767,water-soluble vitamin metabolic process,HP:0002912,Methylmalonic acidemia
GO:0006767,water-soluble vitamin metabolic process,HP:0003145,Decreased adenosylcobalamin
GO:0006767,water-soluble vitamin metabolic process,HP:0003210,Decreased methylmalonyl-CoA mutase activity
GO:0006767,water-soluble vitamin metabolic process,HP:0003223,Decreased methylcobalamin
GO:0006767,water-soluble vitamin metabolic process,HP:0003524,Decreased methionine synthase activity
GO:0006767,water-soluble vitamin metabolic process,HP:0003658,Hypomethioninemia
GO:0006767,water-soluble vitamin metabolic process,HP:0005518,Increased mean corpuscular volume
GO:0006767,water-soluble vitamin metabolic process,HP:0008872,Feeding difficulties in infancy
GO:0006767,water-soluble vitamin metabolic process,HP:0012120,Methylmalonic aciduria
GO:0006775,fat-soluble vitamin metabolic process,HP:0000007,Autosomal recessive inheritance
GO:0006790,sulfur compound metabolic process,HP:0000007,Autosomal recessive inheritance
GO:0006790,sulfur compound metabolic process,HP:0001083,Ectopia lentis
GO:0006790,sulfur compound metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0006790,sulfur compound metabolic process,HP:0006765,Chondrosarcoma
GO:0006790,sulfur compound metabolic process,HP:0200044,Porokeratosis
GO:0006801,superoxide metabolic process,HP:0001400,Hepatic abscesses due to immunodeficiency
GO:0006801,superoxide metabolic process,HP:0002716,Lymphadenopathy
GO:0006801,superoxide metabolic process,HP:0002723,Absence of bactericidal oxidative 'respiratory burst' in phagocytes
GO:0006801,superoxide metabolic process,HP:0002724,Recurrent Aspergillus infections
GO:0006801,superoxide metabolic process,HP:0002740,Recurrent E. coli infections
GO:0006801,superoxide metabolic process,HP:0002741,Recurrent Serratia marcescens infections
GO:0006801,superoxide metabolic process,HP:0002742,Recurrent Klebsiella infections
GO:0006801,superoxide metabolic process,HP:0002755,Osteomyelitis due to immunodeficiency
GO:0006801,superoxide metabolic process,HP:0002840,Lymphadenitis
GO:0006801,superoxide metabolic process,HP:0002842,Recurrent Burkholderia cepacia infections
GO:0006801,superoxide metabolic process,HP:0002955,Granulomatosis
GO:0006801,superoxide metabolic process,HP:0003203,Negative nitroblue tetrazolium reduction test
GO:0006801,superoxide metabolic process,HP:0003206,Decreased activity of NADPH oxidase
GO:0006801,superoxide metabolic process,HP:0003553,Cellulitis due to immunodeficiency
GO:0006813,potassium ion transport,HP:0000006,Autosomal dominant inheritance
GO:0006813,potassium ion transport,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0006813,potassium ion transport,HP:0001279,Syncope
GO:0006813,potassium ion transport,HP:0001657,Prolonged QT interval
GO:0006814,sodium ion transport,HP:0000006,Autosomal dominant inheritance
GO:0006814,sodium ion transport,HP:0001279,Syncope
GO:0006814,sodium ion transport,HP:0002069,Generalized tonic-clonic seizures
GO:0006814,sodium ion transport,HP:0004749,Atrial flutter
GO:0006816,calcium ion transport,HP:0000006,Autosomal dominant inheritance
GO:0006816,calcium ion transport,HP:0001279,Syncope
GO:0006816,calcium ion transport,HP:0003391,Gowers sign
GO:0006816,calcium ion transport,HP:0004814,Fava bean-induced hemolytic anemia
GO:0006820,anion transport,HP:0000117,Renal phosphate wasting
GO:0006820,anion transport,HP:0000952,Jaundice
GO:0006820,anion transport,HP:0001528,Hemihypertrophy
GO:0006869,lipid transport,HP:0001528,Hemihypertrophy
GO:0006869,lipid transport,HP:0012184,Hyperalphalipoproteinemia
GO:0006874,cellular calcium ion homeostasis,HP:0000006,Autosomal dominant inheritance
GO:0006874,cellular calcium ion homeostasis,HP:0001894,Thrombocytosis
GO:0006874,cellular calcium ion homeostasis,HP:0003391,Gowers sign
GO:0006875,cellular metal ion homeostasis,HP:0000006,Autosomal dominant inheritance
GO:0006875,cellular metal ion homeostasis,HP:0000408,Progressive sensorineural hearing impairment
GO:0006875,cellular metal ion homeostasis,HP:0001300,Parkinsonism
GO:0006875,cellular metal ion homeostasis,HP:0001894,Thrombocytosis
GO:0006875,cellular metal ion homeostasis,HP:0003391,Gowers sign
GO:0006875,cellular metal ion homeostasis,HP:0006999,Basal ganglia gliosis
GO:0006879,cellular iron ion homeostasis,HP:0003281,Increased serum ferritin
GO:0006885,regulation of pH,HP:0002074,Increased neuronal autofluorescent lipopigment
GO:0006885,regulation of pH,HP:0008341,Distal renal tubular acidosis
GO:0006887,exocytosis,HP:0001008,Accumulation of melanosomes in melanocytes
GO:0006887,exocytosis,HP:0001300,Parkinsonism
GO:0006887,exocytosis,HP:0003095,Septic arthritis
GO:0006887,exocytosis,HP:0011999,Paranoia
GO:0006888,ER to Golgi vesicle-mediated transport,HP:0012233,Intramuscular hematoma
GO:0006888,ER to Golgi vesicle-mediated transport,HP:0100724,Hypercoagulability
GO:0006936,muscle contraction,HP:0000006,Autosomal dominant inheritance
GO:0006936,muscle contraction,HP:0000408,Progressive sensorineural hearing impairment
GO:0006936,muscle contraction,HP:0001279,Syncope
GO:0006936,muscle contraction,HP:0001644,Dilated cardiomyopathy
GO:0006936,muscle contraction,HP:0001645,Sudden cardiac death
GO:0006936,muscle contraction,HP:0001657,Prolonged QT interval
GO:0006936,muscle contraction,HP:0001663,Ventricular fibrillation
GO:0006936,muscle contraction,HP:0001699,Sudden death
GO:0006936,muscle contraction,HP:0003391,Gowers sign
GO:0006936,muscle contraction,HP:0003458,EMG: myopathic abnormalities
GO:0006936,muscle contraction,HP:0003803,Type 1 muscle fiber predominance
GO:0006936,muscle contraction,HP:0004749,Atrial flutter
GO:0006936,muscle contraction,HP:0004756,Ventricular tachycardia
GO:0006936,muscle contraction,HP:0005110,Atrial fibrillation
GO:0006936,muscle contraction,HP:0010445,Primum atrial septal defect
GO:0006936,muscle contraction,HP:0012232,Shortened QT interval
GO:0006936,muscle contraction,HP:0012727,Thoracic aortic aneurysm
GO:0006937,regulation of muscle contraction,HP:0000006,Autosomal dominant inheritance
GO:0006937,regulation of muscle contraction,HP:0001279,Syncope
GO:0006937,regulation of muscle contraction,HP:0001644,Dilated cardiomyopathy
GO:0006937,regulation of muscle contraction,HP:0001645,Sudden cardiac death
GO:0006937,regulation of muscle contraction,HP:0001657,Prolonged QT interval
GO:0006937,regulation of muscle contraction,HP:0001699,Sudden death
GO:0006937,regulation of muscle contraction,HP:0004749,Atrial flutter
GO:0006937,regulation of muscle contraction,HP:0004756,Ventricular tachycardia
GO:0006937,regulation of muscle contraction,HP:0005110,Atrial fibrillation
GO:0006939,smooth muscle contraction,HP:0012727,Thoracic aortic aneurysm
GO:0006941,striated muscle contraction,HP:0000006,Autosomal dominant inheritance
GO:0006941,striated muscle contraction,HP:0001279,Syncope
GO:0006941,striated muscle contraction,HP:0001644,Dilated cardiomyopathy
GO:0006941,striated muscle contraction,HP:0001645,Sudden cardiac death
GO:0006941,striated muscle contraction,HP:0001657,Prolonged QT interval
GO:0006941,striated muscle contraction,HP:0001663,Ventricular fibrillation
GO:0006941,striated muscle contraction,HP:0001664,Torsade de pointes
GO:0006941,striated muscle contraction,HP:0001699,Sudden death
GO:0006941,striated muscle contraction,HP:0003391,Gowers sign
GO:0006941,striated muscle contraction,HP:0004308,Ventricular arrhythmia
GO:0006941,striated muscle contraction,HP:0004749,Atrial flutter
GO:0006941,striated muscle contraction,HP:0004756,Ventricular tachycardia
GO:0006941,striated muscle contraction,HP:0005110,Atrial fibrillation
GO:0006941,striated muscle contraction,HP:0010445,Primum atrial septal defect
GO:0006941,striated muscle contraction,HP:0012232,Shortened QT interval
GO:0006942,regulation of striated muscle contraction,HP:0000006,Autosomal dominant inheritance
GO:0006942,regulation of striated muscle contraction,HP:0001279,Syncope
GO:0006942,regulation of striated muscle contraction,HP:0001644,Dilated cardiomyopathy
GO:0006942,regulation of striated muscle contraction,HP:0001645,Sudden cardiac death
GO:0006942,regulation of striated muscle contraction,HP:0001657,Prolonged QT interval
GO:0006942,regulation of striated muscle contraction,HP:0001699,Sudden death
GO:0006942,regulation of striated muscle contraction,HP:0004308,Ventricular arrhythmia
GO:0006942,regulation of striated muscle contraction,HP:0004749,Atrial flutter
GO:0006942,regulation of striated muscle contraction,HP:0004756,Ventricular tachycardia
GO:0006942,regulation of striated muscle contraction,HP:0005110,Atrial fibrillation
GO:0006942,regulation of striated muscle contraction,HP:0011663,Right ventricular cardiomyopathy
GO:0006956,complement activation,HP:0002725,Systemic lupus erythematosus
GO:0006956,complement activation,HP:0004431,Complement deficiency
GO:0006956,complement activation,HP:0005421,Decreased serum complement C3
GO:0006979,response to oxidative stress,HP:0000012,Urinary urgency
GO:0006979,response to oxidative stress,HP:0001300,Parkinsonism
GO:0006979,response to oxidative stress,HP:0001894,Thrombocytosis
GO:0006979,response to oxidative stress,HP:0003095,Septic arthritis
GO:0006979,response to oxidative stress,HP:0004814,Fava bean-induced hemolytic anemia
GO:0007018,microtubule-based movement,HP:0000012,Urinary urgency
GO:0007018,microtubule-based movement,HP:0000510,Rod-cone dystrophy
GO:0007018,microtubule-based movement,HP:0001696,Situs inversus totalis
GO:0007018,microtubule-based movement,HP:0002110,Bronchiectasis
GO:0007018,microtubule-based movement,HP:0012265,Ciliary dyskinesia
GO:0007031,peroxisome organization,HP:0000007,Autosomal recessive inheritance
GO:0007031,peroxisome organization,HP:0000348,High forehead
GO:0007031,peroxisome organization,HP:0000407,Sensorineural hearing impairment
GO:0007031,peroxisome organization,HP:0001250,Seizures
GO:0007031,peroxisome organization,HP:0001410,Decreased liver function
GO:0007031,peroxisome organization,HP:0002240,Hepatomegaly
GO:0007031,peroxisome organization,HP:0003455,Elevated long chain fatty acids
GO:0007031,peroxisome organization,HP:0008935,Generalized neonatal hypotonia
GO:0007031,peroxisome organization,HP:0010655,Epiphyseal stippling
GO:0007033,vacuole organization,HP:0000007,Autosomal recessive inheritance
GO:0007033,vacuole organization,HP:0001300,Parkinsonism
GO:0007033,vacuole organization,HP:0002074,Increased neuronal autofluorescent lipopigment
GO:0007033,vacuole organization,HP:0004684,Talipes valgus
GO:0007040,lysosome organization,HP:0002074,Increased neuronal autofluorescent lipopigment
GO:0007040,lysosome organization,HP:0003205,Curvilinear intracellular accumulation of autofluorescent lipopigment storage material
GO:0007040,lysosome organization,HP:0003208,Fingerprint intracellular accumulation of autofluorescent lipopigment storage material
GO:0007098,centrosome cycle,HP:0000252,Microcephaly
GO:0007098,centrosome cycle,HP:0000340,Sloping forehead
GO:0007099,centriole replication,HP:0000252,Microcephaly
GO:0007099,centriole replication,HP:0000340,Sloping forehead
GO:0007159,leukocyte cell-cell adhesion,HP:0001047,Atopic dermatitis
GO:0007159,leukocyte cell-cell adhesion,HP:0001528,Hemihypertrophy
GO:0007159,leukocyte cell-cell adhesion,HP:0002716,Lymphadenopathy
GO:0007159,leukocyte cell-cell adhesion,HP:0002718,Recurrent bacterial infections
GO:0007159,leukocyte cell-cell adhesion,HP:0002721,Immunodeficiency
GO:0007160,cell-matrix adhesion,HP:0000243,Trigonocephaly
GO:0007162,negative regulation of cell adhesion,HP:0000006,Autosomal dominant inheritance
GO:0007162,negative regulation of cell adhesion,HP:0001894,Thrombocytosis
GO:0007162,negative regulation of cell adhesion,HP:0002716,Lymphadenopathy
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,HP:0000006,Autosomal dominant inheritance
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,HP:0001083,Ectopia lentis
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,HP:0001684,Secundum atrial septal defect
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,HP:0001719,Double outlet right ventricle
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,HP:0002408,Cerebral arteriovenous malformation
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,HP:0005116,Arterial tortuosity
GO:0007179,transforming growth factor beta receptor signaling pathway,HP:0000006,Autosomal dominant inheritance
GO:0007179,transforming growth factor beta receptor signaling pathway,HP:0001083,Ectopia lentis
GO:0007179,transforming growth factor beta receptor signaling pathway,HP:0001634,Mitral valve prolapse
GO:0007179,transforming growth factor beta receptor signaling pathway,HP:0001653,Mitral regurgitation
GO:0007179,transforming growth factor beta receptor signaling pathway,HP:0002408,Cerebral arteriovenous malformation
GO:0007179,transforming growth factor beta receptor signaling pathway,HP:0005116,Arterial tortuosity
GO:0007204,positive regulation of cytosolic calcium ion concentration,HP:0000006,Autosomal dominant inheritance
GO:0007204,positive regulation of cytosolic calcium ion concentration,HP:0001894,Thrombocytosis
GO:0007204,positive regulation of cytosolic calcium ion concentration,HP:0003391,Gowers sign
GO:0007219,Notch signaling pathway,HP:0000006,Autosomal dominant inheritance
GO:0007219,Notch signaling pathway,HP:0000668,Hypodontia
GO:0007219,Notch signaling pathway,HP:0040154,Acne inversa
GO:0007220,Notch receptor processing,HP:0040154,Acne inversa
GO:0007224,smoothened signaling pathway,HP:0000243,Trigonocephaly
GO:0007224,smoothened signaling pathway,HP:0001162,Postaxial hand polydactyly
GO:0007224,smoothened signaling pathway,HP:0002419,Molar tooth sign on MRI
GO:0007249,I-kappaB kinase/NF-kappaB signaling,HP:0002721,Immunodeficiency
GO:0007249,I-kappaB kinase/NF-kappaB signaling,HP:0003095,Septic arthritis
GO:0007260,tyrosine phosphorylation of STAT protein,HP:0001894,Thrombocytosis
GO:0007260,tyrosine phosphorylation of STAT protein,HP:0002677,Small foramen magnum
GO:0007271,"synaptic transmission, cholinergic",HP:0000508,Ptosis
GO:0007271,"synaptic transmission, cholinergic",HP:0002093,Respiratory insufficiency
GO:0007271,"synaptic transmission, cholinergic",HP:0003388,Easy fatigability
GO:0007272,ensheathment of neurons,HP:0001528,Hemihypertrophy
GO:0007272,ensheathment of neurons,HP:0008668,"Gonadal dysgenesis, male"
GO:0007274,neuromuscular synaptic transmission,HP:0000508,Ptosis
GO:0007274,neuromuscular synaptic transmission,HP:0003388,Easy fatigability
GO:0007281,germ cell development,HP:0000149,Ovarian gonadoblastoma
GO:0007281,germ cell development,HP:0008668,"Gonadal dysgenesis, male"
GO:0007292,female gamete generation,HP:0000786,Primary amenorrhea
GO:0007292,female gamete generation,HP:0008209,Premature ovarian failure
GO:0007368,determination of left/right symmetry,HP:0000481,Abnormality of the cornea
GO:0007368,determination of left/right symmetry,HP:0000510,Rod-cone dystrophy
GO:0007368,determination of left/right symmetry,HP:0001696,Situs inversus totalis
GO:0007368,determination of left/right symmetry,HP:0001719,Double outlet right ventricle
GO:0007368,determination of left/right symmetry,HP:0002110,Bronchiectasis
GO:0007368,determination of left/right symmetry,HP:0010445,Primum atrial septal defect
GO:0007368,determination of left/right symmetry,HP:0012265,Ciliary dyskinesia
GO:0007369,gastrulation,HP:0000006,Autosomal dominant inheritance
GO:0007369,gastrulation,HP:0000148,Vaginal atresia
GO:0007369,gastrulation,HP:0001719,Double outlet right ventricle
GO:0007369,gastrulation,HP:0004635,Cervical C5/C6 vertebrae fusion
GO:0007369,gastrulation,HP:0006765,Chondrosarcoma
GO:0007389,pattern specification process,HP:0000006,Autosomal dominant inheritance
GO:0007389,pattern specification process,HP:0000074,Ureteropelvic junction obstruction
GO:0007389,pattern specification process,HP:0000148,Vaginal atresia
GO:0007389,pattern specification process,HP:0000149,Ovarian gonadoblastoma
GO:0007389,pattern specification process,HP:0000243,Trigonocephaly
GO:0007389,pattern specification process,HP:0000481,Abnormality of the cornea
GO:0007389,pattern specification process,HP:0000501,Glaucoma
GO:0007389,pattern specification process,HP:0000668,Hypodontia
GO:0007389,pattern specification process,HP:0001032,Absent distal interphalangeal creases
GO:0007389,pattern specification process,HP:0001159,Syndactyly
GO:0007389,pattern specification process,HP:0001719,Double outlet right ventricle
GO:0007389,pattern specification process,HP:0002444,Hypothalamic hamartoma
GO:0007389,pattern specification process,HP:0004383,Hypoplastic left heart
GO:0007389,pattern specification process,HP:0004635,Cervical C5/C6 vertebrae fusion
GO:0007389,pattern specification process,HP:0010445,Primum atrial septal defect
GO:0007389,pattern specification process,HP:0030084,Clinodactyly
GO:0007405,neuroblast proliferation,HP:0000006,Autosomal dominant inheritance
GO:0007405,neuroblast proliferation,HP:0000243,Trigonocephaly
GO:0007409,axonogenesis,HP:0000006,Autosomal dominant inheritance
GO:0007409,axonogenesis,HP:0000012,Urinary urgency
GO:0007409,axonogenesis,HP:0001054,Numerous nevi
GO:0007409,axonogenesis,HP:0002300,Mutism
GO:0007411,axon guidance,HP:0000006,Autosomal dominant inheritance
GO:0007422,peripheral nervous system development,HP:0001528,Hemihypertrophy
GO:0007423,sensory organ development,HP:0000006,Autosomal dominant inheritance
GO:0007423,sensory organ development,HP:0000149,Ovarian gonadoblastoma
GO:0007423,sensory organ development,HP:0000243,Trigonocephaly
GO:0007423,sensory organ development,HP:0000501,Glaucoma
GO:0007423,sensory organ development,HP:0000510,Rod-cone dystrophy
GO:0007423,sensory organ development,HP:0000512,Abnormal electroretinogram
GO:0007423,sensory organ development,HP:0000568,Microphthalmia
GO:0007423,sensory organ development,HP:0000668,Hypodontia
GO:0007423,sensory organ development,HP:0001083,Ectopia lentis
GO:0007423,sensory organ development,HP:0004635,Cervical C5/C6 vertebrae fusion
GO:0007423,sensory organ development,HP:0005116,Arterial tortuosity
GO:0007423,sensory organ development,HP:0005217,Duplication of internal organs
GO:0007423,sensory organ development,HP:0007780,Cortical pulverulent cataract
GO:0007423,sensory organ development,HP:0007971,Lamellar cataract
GO:0007423,sensory organ development,HP:0008031,Posterior Y-sutural cataract
GO:0007423,sensory organ development,HP:0008391,Dystrophic fingernails
GO:0007423,sensory organ development,HP:0008499,High-grade hypermetropia
GO:0007423,sensory organ development,HP:0010695,Sutural cataract
GO:0007423,sensory organ development,HP:0012038,Corneal guttata
GO:0007492,endoderm development,HP:0000006,Autosomal dominant inheritance
GO:0007498,mesoderm development,HP:0000006,Autosomal dominant inheritance
GO:0007498,mesoderm development,HP:0000668,Hypodontia
GO:0007498,mesoderm development,HP:0001894,Thrombocytosis
GO:0007498,mesoderm development,HP:0003095,Septic arthritis
GO:0007498,mesoderm development,HP:0004635,Cervical C5/C6 vertebrae fusion
GO:0007498,mesoderm development,HP:0006765,Chondrosarcoma
GO:0007507,heart development,HP:0000006,Autosomal dominant inheritance
GO:0007507,heart development,HP:0000149,Ovarian gonadoblastoma
GO:0007507,heart development,HP:0000243,Trigonocephaly
GO:0007507,heart development,HP:0000501,Glaucoma
GO:0007507,heart development,HP:0000668,Hypodontia
GO:0007507,heart development,HP:0001083,Ectopia lentis
GO:0007507,heart development,HP:0001644,Dilated cardiomyopathy
GO:0007507,heart development,HP:0001651,Dextrocardia
GO:0007507,heart development,HP:0001684,Secundum atrial septal defect
GO:0007507,heart development,HP:0001723,Restrictive cardiomyopathy
GO:0007507,heart development,HP:0002408,Cerebral arteriovenous malformation
GO:0007507,heart development,HP:0002888,Ependymoma
GO:0007507,heart development,HP:0004749,Atrial flutter
GO:0007507,heart development,HP:0004814,Fava bean-induced hemolytic anemia
GO:0007507,heart development,HP:0005116,Arterial tortuosity
GO:0007507,heart development,HP:0005547,Myeloproliferative disorder
GO:0007507,heart development,HP:0010445,Primum atrial septal defect
GO:0007517,muscle organ development,HP:0000006,Autosomal dominant inheritance
GO:0007517,muscle organ development,HP:0000149,Ovarian gonadoblastoma
GO:0007517,muscle organ development,HP:0000501,Glaucoma
GO:0007517,muscle organ development,HP:0001644,Dilated cardiomyopathy
GO:0007517,muscle organ development,HP:0001684,Secundum atrial septal defect
GO:0007517,muscle organ development,HP:0003236,Elevated serum creatine phosphokinase
GO:0007517,muscle organ development,HP:0003391,Gowers sign
GO:0007517,muscle organ development,HP:0003458,EMG: myopathic abnormalities
GO:0007517,muscle organ development,HP:0003560,Muscular dystrophy
GO:0007517,muscle organ development,HP:0004383,Hypoplastic left heart
GO:0007517,muscle organ development,HP:0004814,Fava bean-induced hemolytic anemia
GO:0007517,muscle organ development,HP:0005116,Arterial tortuosity
GO:0007517,muscle organ development,HP:0009183,Joint contracture of the 5th finger
GO:0007519,skeletal muscle tissue development,HP:0000006,Autosomal dominant inheritance
GO:0007528,neuromuscular junction development,HP:0003391,Gowers sign
GO:0007530,sex determination,HP:0000133,Gonadal dysgenesis
GO:0007530,sex determination,HP:0000149,Ovarian gonadoblastoma
GO:0007530,sex determination,HP:0000150,Gonadoblastoma
GO:0007530,sex determination,HP:0008668,"Gonadal dysgenesis, male"
GO:0007530,sex determination,HP:0012245,Sex reversal
GO:0007548,sex differentiation,HP:0000006,Autosomal dominant inheritance
GO:0007548,sex differentiation,HP:0000013,Hypoplasia of the uterus
GO:0007548,sex differentiation,HP:0000133,Gonadal dysgenesis
GO:0007548,sex differentiation,HP:0000149,Ovarian gonadoblastoma
GO:0007548,sex differentiation,HP:0000150,Gonadoblastoma
GO:0007548,sex differentiation,HP:0000668,Hypodontia
GO:0007548,sex differentiation,HP:0000786,Primary amenorrhea
GO:0007548,sex differentiation,HP:0001470,Sex-limited autosomal dominant
GO:0007548,sex differentiation,HP:0008668,"Gonadal dysgenesis, male"
GO:0007548,sex differentiation,HP:0011682,Perimembranous ventricular septal defect
GO:0007548,sex differentiation,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0007548,sex differentiation,HP:0012245,Sex reversal
GO:0007568,aging,HP:0000006,Autosomal dominant inheritance
GO:0007568,aging,HP:0000668,Hypodontia
GO:0007569,cell aging,HP:0000668,Hypodontia
GO:0007588,excretion,HP:0000103,Polyuria
GO:0007588,excretion,HP:0000121,Nephrocalcinosis
GO:0007588,excretion,HP:0001955,Unexplained fevers
GO:0007588,excretion,HP:0001959,Polydipsia
GO:0007596,blood coagulation,HP:0000006,Autosomal dominant inheritance
GO:0007596,blood coagulation,HP:0000132,Menorrhagia
GO:0007596,blood coagulation,HP:0000408,Progressive sensorineural hearing impairment
GO:0007596,blood coagulation,HP:0000421,Epistaxis
GO:0007596,blood coagulation,HP:0000978,Bruising susceptibility
GO:0007596,blood coagulation,HP:0001528,Hemihypertrophy
GO:0007596,blood coagulation,HP:0001894,Thrombocytosis
GO:0007596,blood coagulation,HP:0002625,Deep venous thrombosis
GO:0007596,blood coagulation,HP:0002849,Absence of lymph node germinal center
GO:0007596,blood coagulation,HP:0003010,Prolonged bleeding time
GO:0007596,blood coagulation,HP:0003645,Prolonged partial thromboplastin time
GO:0007596,blood coagulation,HP:0005261,Joint hemorrhage
GO:0007596,blood coagulation,HP:0012233,Intramuscular hematoma
GO:0007596,blood coagulation,HP:0100724,Hypercoagulability
GO:0007597,"blood coagulation, intrinsic pathway",HP:0000132,Menorrhagia
GO:0007597,"blood coagulation, intrinsic pathway",HP:0003645,Prolonged partial thromboplastin time
GO:0007597,"blood coagulation, intrinsic pathway",HP:0005261,Joint hemorrhage
GO:0007599,hemostasis,HP:0000006,Autosomal dominant inheritance
GO:0007599,hemostasis,HP:0000132,Menorrhagia
GO:0007599,hemostasis,HP:0000408,Progressive sensorineural hearing impairment
GO:0007599,hemostasis,HP:0000421,Epistaxis
GO:0007599,hemostasis,HP:0000978,Bruising susceptibility
GO:0007599,hemostasis,HP:0001528,Hemihypertrophy
GO:0007599,hemostasis,HP:0001873,Thrombocytopenia
GO:0007599,hemostasis,HP:0001894,Thrombocytosis
GO:0007599,hemostasis,HP:0001902,Giant platelets
GO:0007599,hemostasis,HP:0002625,Deep venous thrombosis
GO:0007599,hemostasis,HP:0002849,Absence of lymph node germinal center
GO:0007599,hemostasis,HP:0003010,Prolonged bleeding time
GO:0007599,hemostasis,HP:0003645,Prolonged partial thromboplastin time
GO:0007599,hemostasis,HP:0005261,Joint hemorrhage
GO:0007599,hemostasis,HP:0012233,Intramuscular hematoma
GO:0007599,hemostasis,HP:0100724,Hypercoagulability
GO:0007601,visual perception,HP:0000408,Progressive sensorineural hearing impairment
GO:0007601,visual perception,HP:0000505,Visual impairment
GO:0007601,visual perception,HP:0000510,Rod-cone dystrophy
GO:0007601,visual perception,HP:0000512,Abnormal electroretinogram
GO:0007601,visual perception,HP:0000533,Chorioretinal atrophy
GO:0007601,visual perception,HP:0000541,Retinal detachment
GO:0007601,visual perception,HP:0000545,Myopia
GO:0007601,visual perception,HP:0000548,Cone/cone-rod dystrophy
GO:0007601,visual perception,HP:0000613,Photophobia
GO:0007601,visual perception,HP:0000662,Nyctalopia
GO:0007601,visual perception,HP:0001099,Fundus atrophy
GO:0007601,visual perception,HP:0001133,Constriction of peripheral visual field
GO:0007601,visual perception,HP:0007642,Congenital stationary night blindness
GO:0007601,visual perception,HP:0007663,Reduced visual acuity
GO:0007601,visual perception,HP:0007677,Vitelliform-like macular lesions
GO:0007601,visual perception,HP:0007737,Bone spicule pigmentation of the retina
GO:0007601,visual perception,HP:0007754,Macular dystrophy
GO:0007601,visual perception,HP:0007843,Attenuation of retinal blood vessels
GO:0007601,visual perception,HP:0007971,Lamellar cataract
GO:0007601,visual perception,HP:0007984,Electronegative electroretinogram
GO:0007601,visual perception,HP:0010920,Zonular cataract
GO:0007601,visual perception,HP:0030515,Moderate visual impairment
GO:0007602,phototransduction,HP:0000510,Rod-cone dystrophy
GO:0007602,phototransduction,HP:0000662,Nyctalopia
GO:0007602,phototransduction,HP:0007642,Congenital stationary night blindness
GO:0007603,"phototransduction, visible light",HP:0000510,Rod-cone dystrophy
GO:0007603,"phototransduction, visible light",HP:0007642,Congenital stationary night blindness
GO:0007605,sensory perception of sound,HP:0000006,Autosomal dominant inheritance
GO:0007605,sensory perception of sound,HP:0000407,Sensorineural hearing impairment
GO:0007605,sensory perception of sound,HP:0000408,Progressive sensorineural hearing impairment
GO:0007605,sensory perception of sound,HP:0005217,Duplication of internal organs
GO:0007611,learning or memory,HP:0001054,Numerous nevi
GO:0007611,learning or memory,HP:0001300,Parkinsonism
GO:0007612,learning,HP:0001300,Parkinsonism
GO:0007626,locomotory behavior,HP:0001300,Parkinsonism
GO:0007626,locomotory behavior,HP:0002301,Hemiplegia
GO:0008015,blood circulation,HP:0000006,Autosomal dominant inheritance
GO:0008015,blood circulation,HP:0001279,Syncope
GO:0008015,blood circulation,HP:0001528,Hemihypertrophy
GO:0008015,blood circulation,HP:0001644,Dilated cardiomyopathy
GO:0008015,blood circulation,HP:0001645,Sudden cardiac death
GO:0008015,blood circulation,HP:0001657,Prolonged QT interval
GO:0008015,blood circulation,HP:0001663,Ventricular fibrillation
GO:0008015,blood circulation,HP:0001894,Thrombocytosis
GO:0008015,blood circulation,HP:0003391,Gowers sign
GO:0008015,blood circulation,HP:0004749,Atrial flutter
GO:0008015,blood circulation,HP:0004756,Ventricular tachycardia
GO:0008015,blood circulation,HP:0005110,Atrial fibrillation
GO:0008015,blood circulation,HP:0005465,Facial hyperostosis
GO:0008015,blood circulation,HP:0006673,Reduced systolic function
GO:0008015,blood circulation,HP:0010445,Primum atrial septal defect
GO:0008015,blood circulation,HP:0012232,Shortened QT interval
GO:0008015,blood circulation,HP:0012727,Thoracic aortic aneurysm
GO:0008016,regulation of heart contraction,HP:0000006,Autosomal dominant inheritance
GO:0008016,regulation of heart contraction,HP:0001279,Syncope
GO:0008016,regulation of heart contraction,HP:0001644,Dilated cardiomyopathy
GO:0008016,regulation of heart contraction,HP:0001645,Sudden cardiac death
GO:0008016,regulation of heart contraction,HP:0001657,Prolonged QT interval
GO:0008016,regulation of heart contraction,HP:0001663,Ventricular fibrillation
GO:0008016,regulation of heart contraction,HP:0001699,Sudden death
GO:0008016,regulation of heart contraction,HP:0001894,Thrombocytosis
GO:0008016,regulation of heart contraction,HP:0004749,Atrial flutter
GO:0008016,regulation of heart contraction,HP:0004756,Ventricular tachycardia
GO:0008016,regulation of heart contraction,HP:0005110,Atrial fibrillation
GO:0008016,regulation of heart contraction,HP:0010445,Primum atrial septal defect
GO:0008016,regulation of heart contraction,HP:0012232,Shortened QT interval
GO:0008088,axo-dendritic transport,HP:0000012,Urinary urgency
GO:0008202,steroid metabolic process,HP:0000952,Jaundice
GO:0008202,steroid metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0008202,steroid metabolic process,HP:0008258,Congenital adrenal hyperplasia
GO:0008202,steroid metabolic process,HP:0008668,"Gonadal dysgenesis, male"
GO:0008202,steroid metabolic process,HP:0200044,Porokeratosis
GO:0008203,cholesterol metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0008203,cholesterol metabolic process,HP:0008258,Congenital adrenal hyperplasia
GO:0008203,cholesterol metabolic process,HP:0200044,Porokeratosis
GO:0008211,glucocorticoid metabolic process,HP:0000127,Renal salt wasting
GO:0008211,glucocorticoid metabolic process,HP:0000822,Hypertension
GO:0008211,glucocorticoid metabolic process,HP:0000840,Adrenogenital syndrome
GO:0008211,glucocorticoid metabolic process,HP:0008221,Adrenal hyperplasia
GO:0008299,isoprenoid biosynthetic process,HP:0200044,Porokeratosis
GO:0008344,adult locomotory behavior,HP:0001300,Parkinsonism
GO:0008344,adult locomotory behavior,HP:0002301,Hemiplegia
GO:0008366,axon ensheathment,HP:0001528,Hemihypertrophy
GO:0008366,axon ensheathment,HP:0008668,"Gonadal dysgenesis, male"
GO:0008406,gonad development,HP:0000133,Gonadal dysgenesis
GO:0008406,gonad development,HP:0000149,Ovarian gonadoblastoma
GO:0008406,gonad development,HP:0000150,Gonadoblastoma
GO:0008406,gonad development,HP:0000786,Primary amenorrhea
GO:0008406,gonad development,HP:0001470,Sex-limited autosomal dominant
GO:0008406,gonad development,HP:0008668,"Gonadal dysgenesis, male"
GO:0008406,gonad development,HP:0011682,Perimembranous ventricular septal defect
GO:0008406,gonad development,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0008406,gonad development,HP:0012245,Sex reversal
GO:0008543,fibroblast growth factor receptor signaling pathway,HP:0000006,Autosomal dominant inheritance
GO:0008543,fibroblast growth factor receptor signaling pathway,HP:0002676,Cloverleaf skull
GO:0008543,fibroblast growth factor receptor signaling pathway,HP:0002677,Small foramen magnum
GO:0008543,fibroblast growth factor receptor signaling pathway,HP:0003319,Abnormality of the cervical spine
GO:0008544,epidermis development,HP:0000006,Autosomal dominant inheritance
GO:0008544,epidermis development,HP:0000502,Abnormality of the conjunctiva
GO:0008544,epidermis development,HP:0000668,Hypodontia
GO:0008544,epidermis development,HP:0002561,Absent nipple
GO:0008544,epidermis development,HP:0004635,Cervical C5/C6 vertebrae fusion
GO:0008544,epidermis development,HP:0008404,Nail dystrophy
GO:0008584,male gonad development,HP:0000133,Gonadal dysgenesis
GO:0008584,male gonad development,HP:0000149,Ovarian gonadoblastoma
GO:0008584,male gonad development,HP:0000150,Gonadoblastoma
GO:0008584,male gonad development,HP:0001470,Sex-limited autosomal dominant
GO:0008584,male gonad development,HP:0008668,"Gonadal dysgenesis, male"
GO:0008584,male gonad development,HP:0011682,Perimembranous ventricular septal defect
GO:0008584,male gonad development,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0008584,male gonad development,HP:0012245,Sex reversal
GO:0008585,female gonad development,HP:0000149,Ovarian gonadoblastoma
GO:0008589,regulation of smoothened signaling pathway,HP:0000006,Autosomal dominant inheritance
GO:0008589,regulation of smoothened signaling pathway,HP:0000007,Autosomal recessive inheritance
GO:0008589,regulation of smoothened signaling pathway,HP:0000090,Nephronophthisis
GO:0008589,regulation of smoothened signaling pathway,HP:0000243,Trigonocephaly
GO:0008589,regulation of smoothened signaling pathway,HP:0001156,Brachydactyly syndrome
GO:0008589,regulation of smoothened signaling pathway,HP:0001162,Postaxial hand polydactyly
GO:0008589,regulation of smoothened signaling pathway,HP:0001274,Agenesis of corpus callosum
GO:0008589,regulation of smoothened signaling pathway,HP:0001360,Holoprosencephaly
GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,HP:0001894,Thrombocytosis
GO:0008643,carbohydrate transport,HP:0001528,Hemihypertrophy
GO:0008652,cellular amino acid biosynthetic process,HP:0000007,Autosomal recessive inheritance
GO:0008652,cellular amino acid biosynthetic process,HP:0001250,Seizures
GO:0008652,cellular amino acid biosynthetic process,HP:0001263,Global developmental delay
GO:0008652,cellular amino acid biosynthetic process,HP:0001951,Episodic ammonia intoxication
GO:0008652,cellular amino acid biosynthetic process,HP:0001987,Hyperammonemia
GO:0008654,phospholipid biosynthetic process,HP:0002676,Cloverleaf skull
GO:0008654,phospholipid biosynthetic process,HP:0002677,Small foramen magnum
GO:0008654,phospholipid biosynthetic process,HP:0003319,Abnormality of the cervical spine
GO:0008654,phospholipid biosynthetic process,HP:0200044,Porokeratosis
GO:0009060,aerobic respiration,HP:0000131,Uterine leiomyoma
GO:0009062,fatty acid catabolic process,HP:0001254,Lethargy
GO:0009062,fatty acid catabolic process,HP:0001528,Hemihypertrophy
GO:0009063,cellular amino acid catabolic process,HP:0001942,Metabolic acidosis
GO:0009063,cellular amino acid catabolic process,HP:0003231,Hypertyrosinemia
GO:0009063,cellular amino acid catabolic process,HP:0003607,4-Hydroxyphenylacetic aciduria
GO:0009064,glutamine family amino acid metabolic process,HP:0001951,Episodic ammonia intoxication
GO:0009064,glutamine family amino acid metabolic process,HP:0001987,Hyperammonemia
GO:0009072,aromatic amino acid family metabolic process,HP:0003231,Hypertyrosinemia
GO:0009072,aromatic amino acid family metabolic process,HP:0003607,4-Hydroxyphenylacetic aciduria
GO:0009084,glutamine family amino acid biosynthetic process,HP:0001950,Respiratory alkalosis
GO:0009084,glutamine family amino acid biosynthetic process,HP:0001951,Episodic ammonia intoxication
GO:0009084,glutamine family amino acid biosynthetic process,HP:0001987,Hyperammonemia
GO:0009084,glutamine family amino acid biosynthetic process,HP:0002038,Protein avoidance
GO:0009100,glycoprotein metabolic process,HP:0000158,Macroglossia
GO:0009100,glycoprotein metabolic process,HP:0000501,Glaucoma
GO:0009100,glycoprotein metabolic process,HP:0000541,Retinal detachment
GO:0009100,glycoprotein metabolic process,HP:0000545,Myopia
GO:0009100,glycoprotein metabolic process,HP:0001083,Ectopia lentis
GO:0009100,glycoprotein metabolic process,HP:0002673,Coxa valga
GO:0009100,glycoprotein metabolic process,HP:0003236,Elevated serum creatine phosphokinase
GO:0009100,glycoprotein metabolic process,HP:0003391,Gowers sign
GO:0009100,glycoprotein metabolic process,HP:0003560,Muscular dystrophy
GO:0009100,glycoprotein metabolic process,HP:0003642,Type I transferrin isoform profile
GO:0009100,glycoprotein metabolic process,HP:0003741,Congenital muscular dystrophy
GO:0009100,glycoprotein metabolic process,HP:0004233,Advanced ossification of carpal bones
GO:0009100,glycoprotein metabolic process,HP:0006765,Chondrosarcoma
GO:0009100,glycoprotein metabolic process,HP:0007260,Type II lissencephaly
GO:0009100,glycoprotein metabolic process,HP:0010970,Blood group antigen abnormality
GO:0009101,glycoprotein biosynthetic process,HP:0000158,Macroglossia
GO:0009101,glycoprotein biosynthetic process,HP:0001083,Ectopia lentis
GO:0009101,glycoprotein biosynthetic process,HP:0002350,Cerebellar cyst
GO:0009101,glycoprotein biosynthetic process,HP:0003236,Elevated serum creatine phosphokinase
GO:0009101,glycoprotein biosynthetic process,HP:0003391,Gowers sign
GO:0009101,glycoprotein biosynthetic process,HP:0003560,Muscular dystrophy
GO:0009101,glycoprotein biosynthetic process,HP:0003642,Type I transferrin isoform profile
GO:0009101,glycoprotein biosynthetic process,HP:0003741,Congenital muscular dystrophy
GO:0009101,glycoprotein biosynthetic process,HP:0004233,Advanced ossification of carpal bones
GO:0009101,glycoprotein biosynthetic process,HP:0006765,Chondrosarcoma
GO:0009101,glycoprotein biosynthetic process,HP:0007260,Type II lissencephaly
GO:0009101,glycoprotein biosynthetic process,HP:0010970,Blood group antigen abnormality
GO:0009108,coenzyme biosynthetic process,HP:0001266,Choreoathetosis
GO:0009108,coenzyme biosynthetic process,HP:0001332,Dystonia
GO:0009108,coenzyme biosynthetic process,HP:0003128,Lactic acidosis
GO:0009108,coenzyme biosynthetic process,HP:0004923,Hyperphenylalaninemia
GO:0009108,coenzyme biosynthetic process,HP:0008297,Transient hyperphenylalaninemia
GO:0009116,nucleoside metabolic process,HP:0000952,Jaundice
GO:0009116,nucleoside metabolic process,HP:0001082,Cholecystitis
GO:0009119,ribonucleoside metabolic process,HP:0000952,Jaundice
GO:0009119,ribonucleoside metabolic process,HP:0001082,Cholecystitis
GO:0009123,nucleoside monophosphate metabolic process,HP:0000952,Jaundice
GO:0009123,nucleoside monophosphate metabolic process,HP:0001082,Cholecystitis
GO:0009126,purine nucleoside monophosphate metabolic process,HP:0000952,Jaundice
GO:0009126,purine nucleoside monophosphate metabolic process,HP:0001082,Cholecystitis
GO:0009132,nucleoside diphosphate metabolic process,HP:0000952,Jaundice
GO:0009132,nucleoside diphosphate metabolic process,HP:0001082,Cholecystitis
GO:0009135,purine nucleoside diphosphate metabolic process,HP:0000952,Jaundice
GO:0009135,purine nucleoside diphosphate metabolic process,HP:0001082,Cholecystitis
GO:0009141,nucleoside triphosphate metabolic process,HP:0000952,Jaundice
GO:0009141,nucleoside triphosphate metabolic process,HP:0001082,Cholecystitis
GO:0009144,purine nucleoside triphosphate metabolic process,HP:0000952,Jaundice
GO:0009144,purine nucleoside triphosphate metabolic process,HP:0001082,Cholecystitis
GO:0009150,purine ribonucleotide metabolic process,HP:0001082,Cholecystitis
GO:0009161,ribonucleoside monophosphate metabolic process,HP:0000952,Jaundice
GO:0009161,ribonucleoside monophosphate metabolic process,HP:0001082,Cholecystitis
GO:0009167,purine ribonucleoside monophosphate metabolic process,HP:0000952,Jaundice
GO:0009167,purine ribonucleoside monophosphate metabolic process,HP:0001082,Cholecystitis
GO:0009179,purine ribonucleoside diphosphate metabolic process,HP:0000952,Jaundice
GO:0009179,purine ribonucleoside diphosphate metabolic process,HP:0001082,Cholecystitis
GO:0009185,ribonucleoside diphosphate metabolic process,HP:0000952,Jaundice
GO:0009185,ribonucleoside diphosphate metabolic process,HP:0001081,Cholelithiasis
GO:0009185,ribonucleoside diphosphate metabolic process,HP:0001082,Cholecystitis
GO:0009199,ribonucleoside triphosphate metabolic process,HP:0000952,Jaundice
GO:0009199,ribonucleoside triphosphate metabolic process,HP:0001082,Cholecystitis
GO:0009205,purine ribonucleoside triphosphate metabolic process,HP:0000952,Jaundice
GO:0009205,purine ribonucleoside triphosphate metabolic process,HP:0001082,Cholecystitis
GO:0009235,cobalamin metabolic process,HP:0000007,Autosomal recessive inheritance
GO:0009235,cobalamin metabolic process,HP:0001254,Lethargy
GO:0009235,cobalamin metabolic process,HP:0001875,Neutropenia
GO:0009235,cobalamin metabolic process,HP:0001889,Megaloblastic anemia
GO:0009235,cobalamin metabolic process,HP:0002156,Homocystinuria
GO:0009235,cobalamin metabolic process,HP:0002160,Hyperhomocystinemia
GO:0009235,cobalamin metabolic process,HP:0002912,Methylmalonic acidemia
GO:0009235,cobalamin metabolic process,HP:0003145,Decreased adenosylcobalamin
GO:0009235,cobalamin metabolic process,HP:0003210,Decreased methylmalonyl-CoA mutase activity
GO:0009235,cobalamin metabolic process,HP:0003223,Decreased methylcobalamin
GO:0009235,cobalamin metabolic process,HP:0003524,Decreased methionine synthase activity
GO:0009235,cobalamin metabolic process,HP:0003658,Hypomethioninemia
GO:0009235,cobalamin metabolic process,HP:0005518,Increased mean corpuscular volume
GO:0009235,cobalamin metabolic process,HP:0012120,Methylmalonic aciduria
GO:0009250,glucan biosynthetic process,HP:0001528,Hemihypertrophy
GO:0009251,glucan catabolic process,HP:0006568,Increased hepatic glycogen content
GO:0009306,protein secretion,HP:0000006,Autosomal dominant inheritance
GO:0009306,protein secretion,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0009306,protein secretion,HP:0001894,Thrombocytosis
GO:0009306,protein secretion,HP:0002849,Absence of lymph node germinal center
GO:0009314,response to radiation,HP:0000510,Rod-cone dystrophy
GO:0009314,response to radiation,HP:0000512,Abnormal electroretinogram
GO:0009314,response to radiation,HP:0000613,Photophobia
GO:0009314,response to radiation,HP:0000992,Cutaneous photosensitivity
GO:0009314,response to radiation,HP:0001009,Telangiectasia
GO:0009314,response to radiation,HP:0001099,Fundus atrophy
GO:0009314,response to radiation,HP:0003079,Defective DNA repair after ultraviolet radiation damage
GO:0009314,response to radiation,HP:0007642,Congenital stationary night blindness
GO:0009314,response to radiation,HP:0007814,Retinal pigment epithelial mottling
GO:0009314,response to radiation,HP:0007984,Electronegative electroretinogram
GO:0009411,response to UV,HP:0000509,Conjunctivitis
GO:0009411,response to UV,HP:0000621,Entropion
GO:0009411,response to UV,HP:0000668,Hypodontia
GO:0009411,response to UV,HP:0000992,Cutaneous photosensitivity
GO:0009411,response to UV,HP:0001009,Telangiectasia
GO:0009411,response to UV,HP:0001029,Poikiloderma
GO:0009411,response to UV,HP:0003079,Defective DNA repair after ultraviolet radiation damage
GO:0009411,response to UV,HP:0003224,Increased cellular sensitivity to UV light
GO:0009411,response to UV,HP:0004334,Dermal atrophy
GO:0009416,response to light stimulus,HP:0000510,Rod-cone dystrophy
GO:0009416,response to light stimulus,HP:0000512,Abnormal electroretinogram
GO:0009416,response to light stimulus,HP:0000613,Photophobia
GO:0009416,response to light stimulus,HP:0000992,Cutaneous photosensitivity
GO:0009416,response to light stimulus,HP:0001009,Telangiectasia
GO:0009416,response to light stimulus,HP:0001099,Fundus atrophy
GO:0009416,response to light stimulus,HP:0003079,Defective DNA repair after ultraviolet radiation damage
GO:0009416,response to light stimulus,HP:0004334,Dermal atrophy
GO:0009416,response to light stimulus,HP:0007642,Congenital stationary night blindness
GO:0009416,response to light stimulus,HP:0007814,Retinal pigment epithelial mottling
GO:0009416,response to light stimulus,HP:0007984,Electronegative electroretinogram
GO:0009581,detection of external stimulus,HP:0000505,Visual impairment
GO:0009581,detection of external stimulus,HP:0000510,Rod-cone dystrophy
GO:0009581,detection of external stimulus,HP:0000512,Abnormal electroretinogram
GO:0009581,detection of external stimulus,HP:0000662,Nyctalopia
GO:0009581,detection of external stimulus,HP:0001099,Fundus atrophy
GO:0009581,detection of external stimulus,HP:0007642,Congenital stationary night blindness
GO:0009581,detection of external stimulus,HP:0007843,Attenuation of retinal blood vessels
GO:0009581,detection of external stimulus,HP:0007984,Electronegative electroretinogram
GO:0009582,detection of abiotic stimulus,HP:0000510,Rod-cone dystrophy
GO:0009582,detection of abiotic stimulus,HP:0000512,Abnormal electroretinogram
GO:0009582,detection of abiotic stimulus,HP:0000662,Nyctalopia
GO:0009582,detection of abiotic stimulus,HP:0001099,Fundus atrophy
GO:0009582,detection of abiotic stimulus,HP:0007642,Congenital stationary night blindness
GO:0009582,detection of abiotic stimulus,HP:0007843,Attenuation of retinal blood vessels
GO:0009582,detection of abiotic stimulus,HP:0007984,Electronegative electroretinogram
GO:0009583,detection of light stimulus,HP:0000505,Visual impairment
GO:0009583,detection of light stimulus,HP:0000510,Rod-cone dystrophy
GO:0009583,detection of light stimulus,HP:0000512,Abnormal electroretinogram
GO:0009583,detection of light stimulus,HP:0000662,Nyctalopia
GO:0009583,detection of light stimulus,HP:0001099,Fundus atrophy
GO:0009583,detection of light stimulus,HP:0007642,Congenital stationary night blindness
GO:0009583,detection of light stimulus,HP:0007843,Attenuation of retinal blood vessels
GO:0009583,detection of light stimulus,HP:0007984,Electronegative electroretinogram
GO:0009584,detection of visible light,HP:0000505,Visual impairment
GO:0009584,detection of visible light,HP:0000510,Rod-cone dystrophy
GO:0009584,detection of visible light,HP:0000512,Abnormal electroretinogram
GO:0009584,detection of visible light,HP:0000662,Nyctalopia
GO:0009584,detection of visible light,HP:0001099,Fundus atrophy
GO:0009584,detection of visible light,HP:0007642,Congenital stationary night blindness
GO:0009584,detection of visible light,HP:0007843,Attenuation of retinal blood vessels
GO:0009612,response to mechanical stimulus,HP:0000006,Autosomal dominant inheritance
GO:0009612,response to mechanical stimulus,HP:0000150,Gonadoblastoma
GO:0009612,response to mechanical stimulus,HP:0003391,Gowers sign
GO:0009612,response to mechanical stimulus,HP:0005465,Facial hyperostosis
GO:0009612,response to mechanical stimulus,HP:0010445,Primum atrial septal defect
GO:0009620,response to fungus,HP:0003095,Septic arthritis
GO:0009650,UV protection,HP:0000992,Cutaneous photosensitivity
GO:0009713,catechol-containing compound biosynthetic process,HP:0001300,Parkinsonism
GO:0009743,response to carbohydrate,HP:0000006,Autosomal dominant inheritance
GO:0009743,response to carbohydrate,HP:0005959,Impaired gluconeogenesis
GO:0009743,response to carbohydrate,HP:0010445,Primum atrial septal defect
GO:0009746,response to hexose,HP:0000006,Autosomal dominant inheritance
GO:0009746,response to hexose,HP:0005959,Impaired gluconeogenesis
GO:0009746,response to hexose,HP:0010445,Primum atrial septal defect
GO:0009749,response to glucose,HP:0010445,Primum atrial septal defect
GO:0009791,post-embryonic development,HP:0001083,Ectopia lentis
GO:0009791,post-embryonic development,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0009798,axis specification,HP:0000149,Ovarian gonadoblastoma
GO:0009799,specification of symmetry,HP:0000481,Abnormality of the cornea
GO:0009799,specification of symmetry,HP:0000510,Rod-cone dystrophy
GO:0009799,specification of symmetry,HP:0001696,Situs inversus totalis
GO:0009799,specification of symmetry,HP:0001719,Double outlet right ventricle
GO:0009799,specification of symmetry,HP:0002110,Bronchiectasis
GO:0009799,specification of symmetry,HP:0010445,Primum atrial septal defect
GO:0009799,specification of symmetry,HP:0012265,Ciliary dyskinesia
GO:0009855,determination of bilateral symmetry,HP:0000481,Abnormality of the cornea
GO:0009855,determination of bilateral symmetry,HP:0000510,Rod-cone dystrophy
GO:0009855,determination of bilateral symmetry,HP:0001696,Situs inversus totalis
GO:0009855,determination of bilateral symmetry,HP:0001719,Double outlet right ventricle
GO:0009855,determination of bilateral symmetry,HP:0002110,Bronchiectasis
GO:0009855,determination of bilateral symmetry,HP:0010445,Primum atrial septal defect
GO:0009855,determination of bilateral symmetry,HP:0012265,Ciliary dyskinesia
GO:0009880,embryonic pattern specification,HP:0000149,Ovarian gonadoblastoma
GO:0009880,embryonic pattern specification,HP:0004635,Cervical C5/C6 vertebrae fusion
GO:0009913,epidermal cell differentiation,HP:0000006,Autosomal dominant inheritance
GO:0009913,epidermal cell differentiation,HP:0000668,Hypodontia
GO:0009914,hormone transport,HP:0000006,Autosomal dominant inheritance
GO:0009914,hormone transport,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0009914,hormone transport,HP:0001894,Thrombocytosis
GO:0009914,hormone transport,HP:0002173,Hypoglycemic seizures
GO:0009914,hormone transport,HP:0003095,Septic arthritis
GO:0009948,anterior/posterior axis specification,HP:0000149,Ovarian gonadoblastoma
GO:0009952,anterior/posterior pattern specification,HP:0000006,Autosomal dominant inheritance
GO:0009952,anterior/posterior pattern specification,HP:0000074,Ureteropelvic junction obstruction
GO:0009952,anterior/posterior pattern specification,HP:0000149,Ovarian gonadoblastoma
GO:0009991,response to extracellular stimulus,HP:0000006,Autosomal dominant inheritance
GO:0009991,response to extracellular stimulus,HP:0000007,Autosomal recessive inheritance
GO:0009991,response to extracellular stimulus,HP:0004814,Fava bean-induced hemolytic anemia
GO:0010001,glial cell differentiation,HP:0000006,Autosomal dominant inheritance
GO:0010001,glial cell differentiation,HP:0001528,Hemihypertrophy
GO:0010035,response to inorganic substance,HP:0000006,Autosomal dominant inheritance
GO:0010035,response to inorganic substance,HP:0000012,Urinary urgency
GO:0010035,response to inorganic substance,HP:0001054,Numerous nevi
GO:0010035,response to inorganic substance,HP:0001300,Parkinsonism
GO:0010035,response to inorganic substance,HP:0002716,Lymphadenopathy
GO:0010035,response to inorganic substance,HP:0004814,Fava bean-induced hemolytic anemia
GO:0010035,response to inorganic substance,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0010035,response to inorganic substance,HP:0011999,Paranoia
GO:0010038,response to metal ion,HP:0001054,Numerous nevi
GO:0010038,response to metal ion,HP:0004814,Fava bean-induced hemolytic anemia
GO:0010038,response to metal ion,HP:0011999,Paranoia
GO:0010039,response to iron ion,HP:0004814,Fava bean-induced hemolytic anemia
GO:0010039,response to iron ion,HP:0011999,Paranoia
GO:0010092,specification of animal organ identity,HP:0000243,Trigonocephaly
GO:0010165,response to X-ray,HP:0000992,Cutaneous photosensitivity
GO:0010171,body morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0010453,regulation of cell fate commitment,HP:0004635,Cervical C5/C6 vertebrae fusion
GO:0010463,mesenchymal cell proliferation,HP:0000006,Autosomal dominant inheritance
GO:0010463,mesenchymal cell proliferation,HP:0000668,Hypodontia
GO:0010464,regulation of mesenchymal cell proliferation,HP:0000006,Autosomal dominant inheritance
GO:0010466,negative regulation of peptidase activity,HP:0011999,Paranoia
GO:0010631,epithelial cell migration,HP:0000006,Autosomal dominant inheritance
GO:0010631,epithelial cell migration,HP:0000034,Hydrocele testis
GO:0010631,epithelial cell migration,HP:0001528,Hemihypertrophy
GO:0010639,negative regulation of organelle organization,HP:0003764,Nevus
GO:0010639,negative regulation of organelle organization,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0010717,regulation of epithelial to mesenchymal transition,HP:0000006,Autosomal dominant inheritance
GO:0010717,regulation of epithelial to mesenchymal transition,HP:0005116,Arterial tortuosity
GO:0010718,positive regulation of epithelial to mesenchymal transition,HP:0005116,Arterial tortuosity
GO:0010720,positive regulation of cell development,HP:0000006,Autosomal dominant inheritance
GO:0010720,positive regulation of cell development,HP:0000243,Trigonocephaly
GO:0010720,positive regulation of cell development,HP:0001472,Familial predisposition
GO:0010721,negative regulation of cell development,HP:0000006,Autosomal dominant inheritance
GO:0010721,negative regulation of cell development,HP:0001083,Ectopia lentis
GO:0010721,negative regulation of cell development,HP:0004814,Fava bean-induced hemolytic anemia
GO:0010765,positive regulation of sodium ion transport,HP:0001279,Syncope
GO:0010765,positive regulation of sodium ion transport,HP:0001663,Ventricular fibrillation
GO:0010765,positive regulation of sodium ion transport,HP:0004749,Atrial flutter
GO:0010810,regulation of cell-substrate adhesion,HP:0001054,Numerous nevi
GO:0010810,regulation of cell-substrate adhesion,HP:0001894,Thrombocytosis
GO:0010817,regulation of hormone levels,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0010817,regulation of hormone levels,HP:0001894,Thrombocytosis
GO:0010817,regulation of hormone levels,HP:0003095,Septic arthritis
GO:0010817,regulation of hormone levels,HP:0008191,Thyroid agenesis
GO:0010817,regulation of hormone levels,HP:0008258,Congenital adrenal hyperplasia
GO:0010862,positive regulation of pathway-restricted SMAD protein phosphorylation,HP:0002408,Cerebral arteriovenous malformation
GO:0010876,lipid localization,HP:0000952,Jaundice
GO:0010876,lipid localization,HP:0001528,Hemihypertrophy
GO:0010876,lipid localization,HP:0003292,Decreased serum leptin
GO:0010876,lipid localization,HP:0009058,Increased muscle lipid content
GO:0010876,lipid localization,HP:0012184,Hyperalphalipoproteinemia
GO:0010881,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,HP:0001699,Sudden death
GO:0010882,regulation of cardiac muscle contraction by calcium ion signaling,HP:0001699,Sudden death
GO:0010927,cellular component assembly involved in morphogenesis,HP:0000090,Nephronophthisis
GO:0010927,cellular component assembly involved in morphogenesis,HP:0000107,Renal cyst
GO:0010927,cellular component assembly involved in morphogenesis,HP:0000246,Sinusitis
GO:0010927,cellular component assembly involved in morphogenesis,HP:0000403,Recurrent otitis media
GO:0010927,cellular component assembly involved in morphogenesis,HP:0000510,Rod-cone dystrophy
GO:0010927,cellular component assembly involved in morphogenesis,HP:0001162,Postaxial hand polydactyly
GO:0010927,cellular component assembly involved in morphogenesis,HP:0001696,Situs inversus totalis
GO:0010927,cellular component assembly involved in morphogenesis,HP:0002110,Bronchiectasis
GO:0010927,cellular component assembly involved in morphogenesis,HP:0002419,Molar tooth sign on MRI
GO:0010927,cellular component assembly involved in morphogenesis,HP:0003391,Gowers sign
GO:0010927,cellular component assembly involved in morphogenesis,HP:0005987,Multinodular goiter
GO:0010927,cellular component assembly involved in morphogenesis,HP:0010442,Polydactyly
GO:0010927,cellular component assembly involved in morphogenesis,HP:0010614,Fibroma
GO:0010927,cellular component assembly involved in morphogenesis,HP:0011108,Recurrent sinusitis
GO:0010927,cellular component assembly involved in morphogenesis,HP:0012263,Immotile cilia
GO:0010927,cellular component assembly involved in morphogenesis,HP:0012265,Ciliary dyskinesia
GO:0010927,cellular component assembly involved in morphogenesis,HP:0200073,Respiratory insufficiency due to defective ciliary clearance
GO:0010927,cellular component assembly involved in morphogenesis,HP:0012384,Rhinitis
GO:0010952,positive regulation of peptidase activity,HP:0000012,Urinary urgency
GO:0010952,positive regulation of peptidase activity,HP:0001894,Thrombocytosis
GO:0010959,regulation of metal ion transport,HP:0000006,Autosomal dominant inheritance
GO:0010959,regulation of metal ion transport,HP:0001279,Syncope
GO:0010959,regulation of metal ion transport,HP:0001645,Sudden cardiac death
GO:0010959,regulation of metal ion transport,HP:0001657,Prolonged QT interval
GO:0010959,regulation of metal ion transport,HP:0001663,Ventricular fibrillation
GO:0010959,regulation of metal ion transport,HP:0003391,Gowers sign
GO:0010959,regulation of metal ion transport,HP:0004749,Atrial flutter
GO:0010959,regulation of metal ion transport,HP:0004814,Fava bean-induced hemolytic anemia
GO:0010959,regulation of metal ion transport,HP:0005110,Atrial fibrillation
GO:0010959,regulation of metal ion transport,HP:0005465,Facial hyperostosis
GO:0010959,regulation of metal ion transport,HP:0012232,Shortened QT interval
GO:0010970,transport along microtubule,HP:0000012,Urinary urgency
GO:0010975,regulation of neuron projection development,HP:0001054,Numerous nevi
GO:0010975,regulation of neuron projection development,HP:0002561,Absent nipple
GO:0014031,mesenchymal cell development,HP:0000006,Autosomal dominant inheritance
GO:0014031,mesenchymal cell development,HP:0001053,Hypopigmented skin patches
GO:0014031,mesenchymal cell development,HP:0001100,Heterochromia iridis
GO:0014031,mesenchymal cell development,HP:0002226,White eyebrow
GO:0014032,neural crest cell development,HP:0000006,Autosomal dominant inheritance
GO:0014032,neural crest cell development,HP:0001053,Hypopigmented skin patches
GO:0014032,neural crest cell development,HP:0001100,Heterochromia iridis
GO:0014032,neural crest cell development,HP:0002226,White eyebrow
GO:0014032,neural crest cell development,HP:0002251,Aganglionic megacolon
GO:0014033,neural crest cell differentiation,HP:0000006,Autosomal dominant inheritance
GO:0014033,neural crest cell differentiation,HP:0001053,Hypopigmented skin patches
GO:0014033,neural crest cell differentiation,HP:0001100,Heterochromia iridis
GO:0014033,neural crest cell differentiation,HP:0002226,White eyebrow
GO:0014037,Schwann cell differentiation,HP:0001528,Hemihypertrophy
GO:0014044,Schwann cell development,HP:0001528,Hemihypertrophy
GO:0014065,phosphatidylinositol 3-kinase signaling,HP:0000006,Autosomal dominant inheritance
GO:0014065,phosphatidylinositol 3-kinase signaling,HP:0001528,Hemihypertrophy
GO:0014065,phosphatidylinositol 3-kinase signaling,HP:0001894,Thrombocytosis
GO:0014065,phosphatidylinositol 3-kinase signaling,HP:0002676,Cloverleaf skull
GO:0014065,phosphatidylinositol 3-kinase signaling,HP:0002677,Small foramen magnum
GO:0014065,phosphatidylinositol 3-kinase signaling,HP:0003319,Abnormality of the cervical spine
GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,HP:0000006,Autosomal dominant inheritance
GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,HP:0001528,Hemihypertrophy
GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,HP:0001894,Thrombocytosis
GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,HP:0002676,Cloverleaf skull
GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,HP:0002677,Small foramen magnum
GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,HP:0003319,Abnormality of the cervical spine
GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,HP:0001894,Thrombocytosis
GO:0014074,response to purine-containing compound,HP:0000149,Ovarian gonadoblastoma
GO:0014074,response to purine-containing compound,HP:0001054,Numerous nevi
GO:0014074,response to purine-containing compound,HP:0001279,Syncope
GO:0014075,response to amine,HP:0001981,Schistocytosis
GO:0014706,striated muscle tissue development,HP:0000006,Autosomal dominant inheritance
GO:0014706,striated muscle tissue development,HP:0000149,Ovarian gonadoblastoma
GO:0014706,striated muscle tissue development,HP:0000501,Glaucoma
GO:0014706,striated muscle tissue development,HP:0001644,Dilated cardiomyopathy
GO:0014706,striated muscle tissue development,HP:0001684,Secundum atrial septal defect
GO:0014706,striated muscle tissue development,HP:0001723,Restrictive cardiomyopathy
GO:0014706,striated muscle tissue development,HP:0003391,Gowers sign
GO:0014706,striated muscle tissue development,HP:0004383,Hypoplastic left heart
GO:0014706,striated muscle tissue development,HP:0004814,Fava bean-induced hemolytic anemia
GO:0014706,striated muscle tissue development,HP:0005116,Arterial tortuosity
GO:0014706,striated muscle tissue development,HP:0009183,Joint contracture of the 5th finger
GO:0014706,striated muscle tissue development,HP:0010445,Primum atrial septal defect
GO:0014819,regulation of skeletal muscle contraction,HP:0003236,Elevated serum creatine phosphokinase
GO:0014855,striated muscle cell proliferation,HP:0000006,Autosomal dominant inheritance
GO:0014888,striated muscle adaptation,HP:0003803,Type 1 muscle fiber predominance
GO:0014896,muscle hypertrophy,HP:0004814,Fava bean-induced hemolytic anemia
GO:0014897,striated muscle hypertrophy,HP:0004814,Fava bean-induced hemolytic anemia
GO:0014902,myotube differentiation,HP:0000006,Autosomal dominant inheritance
GO:0014902,myotube differentiation,HP:0001902,Giant platelets
GO:0015672,monovalent inorganic cation transport,HP:0000006,Autosomal dominant inheritance
GO:0015672,monovalent inorganic cation transport,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0015672,monovalent inorganic cation transport,HP:0001279,Syncope
GO:0015672,monovalent inorganic cation transport,HP:0001657,Prolonged QT interval
GO:0015672,monovalent inorganic cation transport,HP:0001663,Ventricular fibrillation
GO:0015672,monovalent inorganic cation transport,HP:0002069,Generalized tonic-clonic seizures
GO:0015672,monovalent inorganic cation transport,HP:0004749,Atrial flutter
GO:0015698,inorganic anion transport,HP:0000117,Renal phosphate wasting
GO:0015698,inorganic anion transport,HP:0002150,Hypercalciuria
GO:0015711,organic anion transport,HP:0000952,Jaundice
GO:0015711,organic anion transport,HP:0001528,Hemihypertrophy
GO:0015748,organophosphate ester transport,HP:0012184,Hyperalphalipoproteinemia
GO:0015833,peptide transport,HP:0000006,Autosomal dominant inheritance
GO:0015833,peptide transport,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0015833,peptide transport,HP:0001894,Thrombocytosis
GO:0015849,organic acid transport,HP:0000007,Autosomal recessive inheritance
GO:0015849,organic acid transport,HP:0001528,Hemihypertrophy
GO:0015849,organic acid transport,HP:0002908,Conjugated hyperbilirubinemia
GO:0015850,organic hydroxy compound transport,HP:0012184,Hyperalphalipoproteinemia
GO:0015918,sterol transport,HP:0012184,Hyperalphalipoproteinemia
GO:0015980,energy derivation by oxidation of organic compounds,HP:0000131,Uterine leiomyoma
GO:0015980,energy derivation by oxidation of organic compounds,HP:0001528,Hemihypertrophy
GO:0015980,energy derivation by oxidation of organic compounds,HP:0006568,Increased hepatic glycogen content
GO:0016042,lipid catabolic process,HP:0000007,Autosomal recessive inheritance
GO:0016042,lipid catabolic process,HP:0001528,Hemihypertrophy
GO:0016042,lipid catabolic process,HP:0002240,Hepatomegaly
GO:0016042,lipid catabolic process,HP:0003292,Decreased serum leptin
GO:0016042,lipid catabolic process,HP:0009058,Increased muscle lipid content
GO:0016049,cell growth,HP:0000006,Autosomal dominant inheritance
GO:0016049,cell growth,HP:0000149,Ovarian gonadoblastoma
GO:0016049,cell growth,HP:0004814,Fava bean-induced hemolytic anemia
GO:0016049,cell growth,HP:0005116,Arterial tortuosity
GO:0016049,cell growth,HP:0005465,Facial hyperostosis
GO:0016049,cell growth,HP:0010445,Primum atrial septal defect
GO:0016051,carbohydrate biosynthetic process,HP:0001528,Hemihypertrophy
GO:0016051,carbohydrate biosynthetic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0016051,carbohydrate biosynthetic process,HP:0005959,Impaired gluconeogenesis
GO:0016051,carbohydrate biosynthetic process,HP:0006765,Chondrosarcoma
GO:0016052,carbohydrate catabolic process,HP:0000952,Jaundice
GO:0016052,carbohydrate catabolic process,HP:0001082,Cholecystitis
GO:0016052,carbohydrate catabolic process,HP:0006568,Increased hepatic glycogen content
GO:0016052,carbohydrate catabolic process,HP:0009051,Increased muscle glycogen content
GO:0016052,carbohydrate catabolic process,HP:0012024,Hypergalactosemia
GO:0016053,organic acid biosynthetic process,HP:0000007,Autosomal recessive inheritance
GO:0016053,organic acid biosynthetic process,HP:0001951,Episodic ammonia intoxication
GO:0016054,organic acid catabolic process,HP:0000007,Autosomal recessive inheritance
GO:0016054,organic acid catabolic process,HP:0001250,Seizures
GO:0016054,organic acid catabolic process,HP:0001254,Lethargy
GO:0016054,organic acid catabolic process,HP:0001259,Coma
GO:0016054,organic acid catabolic process,HP:0001528,Hemihypertrophy
GO:0016054,organic acid catabolic process,HP:0001942,Metabolic acidosis
GO:0016054,organic acid catabolic process,HP:0001987,Hyperammonemia
GO:0016054,organic acid catabolic process,HP:0003231,Hypertyrosinemia
GO:0016054,organic acid catabolic process,HP:0003607,4-Hydroxyphenylacetic aciduria
GO:0016054,organic acid catabolic process,HP:0004911,Episodic metabolic acidosis
GO:0016055,Wnt signaling pathway,HP:0000006,Autosomal dominant inheritance
GO:0016055,Wnt signaling pathway,HP:0000074,Ureteropelvic junction obstruction
GO:0016055,Wnt signaling pathway,HP:0000668,Hypodontia
GO:0016056,rhodopsin mediated signaling pathway,HP:0000510,Rod-cone dystrophy
GO:0016056,rhodopsin mediated signaling pathway,HP:0007642,Congenital stationary night blindness
GO:0016064,immunoglobulin mediated immune response,HP:0001287,Meningitis
GO:0016064,immunoglobulin mediated immune response,HP:0002716,Lymphadenopathy
GO:0016064,immunoglobulin mediated immune response,HP:0002725,Systemic lupus erythematosus
GO:0016064,immunoglobulin mediated immune response,HP:0002849,Absence of lymph node germinal center
GO:0016064,immunoglobulin mediated immune response,HP:0003095,Septic arthritis
GO:0016064,immunoglobulin mediated immune response,HP:0004431,Complement deficiency
GO:0016064,immunoglobulin mediated immune response,HP:0005421,Decreased serum complement C3
GO:0016125,sterol metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0016125,sterol metabolic process,HP:0008258,Congenital adrenal hyperplasia
GO:0016125,sterol metabolic process,HP:0200044,Porokeratosis
GO:0016126,sterol biosynthetic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0016126,sterol biosynthetic process,HP:0200044,Porokeratosis
GO:0016202,regulation of striated muscle tissue development,HP:0000006,Autosomal dominant inheritance
GO:0016202,regulation of striated muscle tissue development,HP:0004814,Fava bean-induced hemolytic anemia
GO:0016331,morphogenesis of embryonic epithelium,HP:0000006,Autosomal dominant inheritance
GO:0016331,morphogenesis of embryonic epithelium,HP:0000668,Hypodontia
GO:0016444,somatic cell DNA recombination,HP:0002849,Absence of lymph node germinal center
GO:0016444,somatic cell DNA recombination,HP:0002959,Impaired Ig class switch recombination
GO:0016445,somatic diversification of immunoglobulins,HP:0002849,Absence of lymph node germinal center
GO:0016445,somatic diversification of immunoglobulins,HP:0002959,Impaired Ig class switch recombination
GO:0016447,somatic recombination of immunoglobulin gene segments,HP:0002849,Absence of lymph node germinal center
GO:0016447,somatic recombination of immunoglobulin gene segments,HP:0002959,Impaired Ig class switch recombination
GO:0016485,protein processing,HP:0000243,Trigonocephaly
GO:0016485,protein processing,HP:0002725,Systemic lupus erythematosus
GO:0016485,protein processing,HP:0004431,Complement deficiency
GO:0016485,protein processing,HP:0005421,Decreased serum complement C3
GO:0016485,protein processing,HP:0012233,Intramuscular hematoma
GO:0016485,protein processing,HP:0040154,Acne inversa
GO:0016558,protein import into peroxisome matrix,HP:0000407,Sensorineural hearing impairment
GO:0016558,protein import into peroxisome matrix,HP:0008935,Generalized neonatal hypotonia
GO:0016558,protein import into peroxisome matrix,HP:0010655,Epiphyseal stippling
GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,HP:0000006,Autosomal dominant inheritance
GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,HP:0001083,Ectopia lentis
GO:0017038,protein import,HP:0001820,Leukonychia
GO:0017038,protein import,HP:0001894,Thrombocytosis
GO:0017038,protein import,HP:0004749,Atrial flutter
GO:0017038,protein import,HP:0005116,Arterial tortuosity
GO:0017038,protein import,HP:0008935,Generalized neonatal hypotonia
GO:0017038,protein import,HP:0010655,Epiphyseal stippling
GO:0017187,peptidyl-glutamic acid carboxylation,HP:0002204,Pulmonary embolism
GO:0017187,peptidyl-glutamic acid carboxylation,HP:0002625,Deep venous thrombosis
GO:0017187,peptidyl-glutamic acid carboxylation,HP:0005261,Joint hemorrhage
GO:0017187,peptidyl-glutamic acid carboxylation,HP:0005305,Cerebral venous thrombosis
GO:0017187,peptidyl-glutamic acid carboxylation,HP:0012233,Intramuscular hematoma
GO:0017187,peptidyl-glutamic acid carboxylation,HP:0100724,Hypercoagulability
GO:0017187,peptidyl-glutamic acid carboxylation,HP:0002638,Superficial thrombophlebitis
GO:0018108,peptidyl-tyrosine phosphorylation,HP:0000006,Autosomal dominant inheritance
GO:0018108,peptidyl-tyrosine phosphorylation,HP:0001894,Thrombocytosis
GO:0018108,peptidyl-tyrosine phosphorylation,HP:0002676,Cloverleaf skull
GO:0018108,peptidyl-tyrosine phosphorylation,HP:0002677,Small foramen magnum
GO:0018108,peptidyl-tyrosine phosphorylation,HP:0003095,Septic arthritis
GO:0018108,peptidyl-tyrosine phosphorylation,HP:0003319,Abnormality of the cervical spine
GO:0018108,peptidyl-tyrosine phosphorylation,HP:0005547,Myeloproliferative disorder
GO:0018200,peptidyl-glutamic acid modification,HP:0002204,Pulmonary embolism
GO:0018200,peptidyl-glutamic acid modification,HP:0005261,Joint hemorrhage
GO:0018200,peptidyl-glutamic acid modification,HP:0005305,Cerebral venous thrombosis
GO:0018200,peptidyl-glutamic acid modification,HP:0012233,Intramuscular hematoma
GO:0018200,peptidyl-glutamic acid modification,HP:0100724,Hypercoagulability
GO:0018200,peptidyl-glutamic acid modification,HP:0002638,Superficial thrombophlebitis
GO:0018212,peptidyl-tyrosine modification,HP:0000006,Autosomal dominant inheritance
GO:0018212,peptidyl-tyrosine modification,HP:0001894,Thrombocytosis
GO:0018212,peptidyl-tyrosine modification,HP:0002676,Cloverleaf skull
GO:0018212,peptidyl-tyrosine modification,HP:0002677,Small foramen magnum
GO:0018212,peptidyl-tyrosine modification,HP:0003095,Septic arthritis
GO:0018212,peptidyl-tyrosine modification,HP:0003319,Abnormality of the cervical spine
GO:0018212,peptidyl-tyrosine modification,HP:0005547,Myeloproliferative disorder
GO:0018214,protein carboxylation,HP:0002204,Pulmonary embolism
GO:0018214,protein carboxylation,HP:0002625,Deep venous thrombosis
GO:0018214,protein carboxylation,HP:0005261,Joint hemorrhage
GO:0018214,protein carboxylation,HP:0005305,Cerebral venous thrombosis
GO:0018214,protein carboxylation,HP:0012233,Intramuscular hematoma
GO:0018214,protein carboxylation,HP:0100724,Hypercoagulability
GO:0018214,protein carboxylation,HP:0002638,Superficial thrombophlebitis
GO:0018958,phenol-containing compound metabolic process,HP:0000853,Goiter
GO:0018958,phenol-containing compound metabolic process,HP:0008191,Thyroid agenesis
GO:0019216,regulation of lipid metabolic process,HP:0001528,Hemihypertrophy
GO:0019216,regulation of lipid metabolic process,HP:0002677,Small foramen magnum
GO:0019216,regulation of lipid metabolic process,HP:0003292,Decreased serum leptin
GO:0019216,regulation of lipid metabolic process,HP:0008668,"Gonadal dysgenesis, male"
GO:0019217,regulation of fatty acid metabolic process,HP:0001528,Hemihypertrophy
GO:0019218,regulation of steroid metabolic process,HP:0008668,"Gonadal dysgenesis, male"
GO:0019226,transmission of nerve impulse,HP:0000006,Autosomal dominant inheritance
GO:0019229,regulation of vasoconstriction,HP:0005465,Facial hyperostosis
GO:0019318,hexose metabolic process,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0019318,hexose metabolic process,HP:0000952,Jaundice
GO:0019318,hexose metabolic process,HP:0001082,Cholecystitis
GO:0019318,hexose metabolic process,HP:0001528,Hemihypertrophy
GO:0019318,hexose metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0019318,hexose metabolic process,HP:0005959,Impaired gluconeogenesis
GO:0019318,hexose metabolic process,HP:0012024,Hypergalactosemia
GO:0019319,hexose biosynthetic process,HP:0005959,Impaired gluconeogenesis
GO:0019320,hexose catabolic process,HP:0000952,Jaundice
GO:0019320,hexose catabolic process,HP:0001082,Cholecystitis
GO:0019320,hexose catabolic process,HP:0008166,Decreased beta-galactosidase activity
GO:0019320,hexose catabolic process,HP:0012024,Hypergalactosemia
GO:0019362,pyridine nucleotide metabolic process,HP:0000952,Jaundice
GO:0019362,pyridine nucleotide metabolic process,HP:0001082,Cholecystitis
GO:0019362,pyridine nucleotide metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0019395,fatty acid oxidation,HP:0001528,Hemihypertrophy
GO:0019627,urea metabolic process,HP:0001254,Lethargy
GO:0019627,urea metabolic process,HP:0001259,Coma
GO:0019627,urea metabolic process,HP:0001950,Respiratory alkalosis
GO:0019627,urea metabolic process,HP:0001951,Episodic ammonia intoxication
GO:0019627,urea metabolic process,HP:0001987,Hyperammonemia
GO:0019627,urea metabolic process,HP:0002013,Vomiting
GO:0019627,urea metabolic process,HP:0002038,Protein avoidance
GO:0019627,urea metabolic process,HP:0002181,Cerebral edema
GO:0019674,NAD metabolic process,HP:0000952,Jaundice
GO:0019674,NAD metabolic process,HP:0001082,Cholecystitis
GO:0019722,calcium-mediated signaling,HP:0003095,Septic arthritis
GO:0019724,B cell mediated immunity,HP:0001287,Meningitis
GO:0019724,B cell mediated immunity,HP:0002716,Lymphadenopathy
GO:0019724,B cell mediated immunity,HP:0002718,Recurrent bacterial infections
GO:0019724,B cell mediated immunity,HP:0002725,Systemic lupus erythematosus
GO:0019724,B cell mediated immunity,HP:0002849,Absence of lymph node germinal center
GO:0019724,B cell mediated immunity,HP:0003095,Septic arthritis
GO:0019724,B cell mediated immunity,HP:0004431,Complement deficiency
GO:0019724,B cell mediated immunity,HP:0005421,Decreased serum complement C3
GO:0019827,stem cell population maintenance,HP:0000006,Autosomal dominant inheritance
GO:0019915,lipid storage,HP:0003292,Decreased serum leptin
GO:0019932,second-messenger-mediated signaling,HP:0003095,Septic arthritis
GO:0021510,spinal cord development,HP:0000006,Autosomal dominant inheritance
GO:0021515,cell differentiation in spinal cord,HP:0000006,Autosomal dominant inheritance
GO:0021536,diencephalon development,HP:0000006,Autosomal dominant inheritance
GO:0021537,telencephalon development,HP:0000006,Autosomal dominant inheritance
GO:0021537,telencephalon development,HP:0000007,Autosomal recessive inheritance
GO:0021537,telencephalon development,HP:0000252,Microcephaly
GO:0021537,telencephalon development,HP:0001249,Intellectual disability
GO:0021537,telencephalon development,HP:0001250,Seizures
GO:0021537,telencephalon development,HP:0001263,Global developmental delay
GO:0021537,telencephalon development,HP:0001274,Agenesis of corpus callosum
GO:0021537,telencephalon development,HP:0001339,Lissencephaly
GO:0021700,developmental maturation,HP:0000006,Autosomal dominant inheritance
GO:0021700,developmental maturation,HP:0002677,Small foramen magnum
GO:0021700,developmental maturation,HP:0003095,Septic arthritis
GO:0021700,developmental maturation,HP:0004814,Fava bean-induced hemolytic anemia
GO:0021761,limbic system development,HP:0000243,Trigonocephaly
GO:0021782,glial cell development,HP:0001528,Hemihypertrophy
GO:0021872,forebrain generation of neurons,HP:0000243,Trigonocephaly
GO:0021904,dorsal/ventral neural tube patterning,HP:0000601,Hypotelorism
GO:0021915,neural tube development,HP:0000243,Trigonocephaly
GO:0021953,central nervous system neuron differentiation,HP:0000006,Autosomal dominant inheritance
GO:0022011,myelination in peripheral nervous system,HP:0001528,Hemihypertrophy
GO:0022400,regulation of rhodopsin mediated signaling pathway,HP:0000510,Rod-cone dystrophy
GO:0022400,regulation of rhodopsin mediated signaling pathway,HP:0007642,Congenital stationary night blindness
GO:0022404,molting cycle process,HP:0000535,Sparse and thin eyebrow
GO:0022404,molting cycle process,HP:0000668,Hypodontia
GO:0022404,molting cycle process,HP:0001006,Hypotrichosis
GO:0022404,molting cycle process,HP:0002561,Absent nipple
GO:0022405,hair cycle process,HP:0000535,Sparse and thin eyebrow
GO:0022405,hair cycle process,HP:0000668,Hypodontia
GO:0022405,hair cycle process,HP:0001006,Hypotrichosis
GO:0022405,hair cycle process,HP:0002561,Absent nipple
GO:0022407,regulation of cell-cell adhesion,HP:0001528,Hemihypertrophy
GO:0022407,regulation of cell-cell adhesion,HP:0001894,Thrombocytosis
GO:0022407,regulation of cell-cell adhesion,HP:0002716,Lymphadenopathy
GO:0022407,regulation of cell-cell adhesion,HP:0002721,Immunodeficiency
GO:0022409,positive regulation of cell-cell adhesion,HP:0001528,Hemihypertrophy
GO:0022409,positive regulation of cell-cell adhesion,HP:0002716,Lymphadenopathy
GO:0022409,positive regulation of cell-cell adhesion,HP:0002721,Immunodeficiency
GO:0022412,cellular process involved in reproduction in multicellular organism,HP:0000149,Ovarian gonadoblastoma
GO:0022412,cellular process involved in reproduction in multicellular organism,HP:0008668,"Gonadal dysgenesis, male"
GO:0022602,ovulation cycle process,HP:0001470,Sex-limited autosomal dominant
GO:0022604,regulation of cell morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0022604,regulation of cell morphogenesis,HP:0001054,Numerous nevi
GO:0022612,gland morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0022612,gland morphogenesis,HP:0000243,Trigonocephaly
GO:0022612,gland morphogenesis,HP:0000668,Hypodontia
GO:0022612,gland morphogenesis,HP:0002561,Absent nipple
GO:0022617,extracellular matrix disassembly,HP:0001083,Ectopia lentis
GO:0022898,regulation of transmembrane transporter activity,HP:0000006,Autosomal dominant inheritance
GO:0022898,regulation of transmembrane transporter activity,HP:0001279,Syncope
GO:0022898,regulation of transmembrane transporter activity,HP:0001657,Prolonged QT interval
GO:0023061,signal release,HP:0000006,Autosomal dominant inheritance
GO:0023061,signal release,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0023061,signal release,HP:0001894,Thrombocytosis
GO:0023061,signal release,HP:0003095,Septic arthritis
GO:0030002,cellular anion homeostasis,HP:0000117,Renal phosphate wasting
GO:0030031,cell projection assembly,HP:0000007,Autosomal recessive inheritance
GO:0030031,cell projection assembly,HP:0000090,Nephronophthisis
GO:0030031,cell projection assembly,HP:0000107,Renal cyst
GO:0030031,cell projection assembly,HP:0000246,Sinusitis
GO:0030031,cell projection assembly,HP:0000403,Recurrent otitis media
GO:0030031,cell projection assembly,HP:0000510,Rod-cone dystrophy
GO:0030031,cell projection assembly,HP:0001162,Postaxial hand polydactyly
GO:0030031,cell projection assembly,HP:0001696,Situs inversus totalis
GO:0030031,cell projection assembly,HP:0002110,Bronchiectasis
GO:0030031,cell projection assembly,HP:0002419,Molar tooth sign on MRI
GO:0030031,cell projection assembly,HP:0010442,Polydactyly
GO:0030031,cell projection assembly,HP:0011108,Recurrent sinusitis
GO:0030031,cell projection assembly,HP:0011109,Chronic sinusitis
GO:0030031,cell projection assembly,HP:0012263,Immotile cilia
GO:0030031,cell projection assembly,HP:0012265,Ciliary dyskinesia
GO:0030031,cell projection assembly,HP:0200073,Respiratory insufficiency due to defective ciliary clearance
GO:0030031,cell projection assembly,HP:0012384,Rhinitis
GO:0030048,actin filament-based movement,HP:0000006,Autosomal dominant inheritance
GO:0030048,actin filament-based movement,HP:0000408,Progressive sensorineural hearing impairment
GO:0030048,actin filament-based movement,HP:0001279,Syncope
GO:0030048,actin filament-based movement,HP:0001644,Dilated cardiomyopathy
GO:0030048,actin filament-based movement,HP:0001645,Sudden cardiac death
GO:0030048,actin filament-based movement,HP:0001657,Prolonged QT interval
GO:0030048,actin filament-based movement,HP:0001663,Ventricular fibrillation
GO:0030048,actin filament-based movement,HP:0001664,Torsade de pointes
GO:0030048,actin filament-based movement,HP:0003391,Gowers sign
GO:0030048,actin filament-based movement,HP:0003458,EMG: myopathic abnormalities
GO:0030048,actin filament-based movement,HP:0003803,Type 1 muscle fiber predominance
GO:0030048,actin filament-based movement,HP:0004749,Atrial flutter
GO:0030048,actin filament-based movement,HP:0005110,Atrial fibrillation
GO:0030048,actin filament-based movement,HP:0010445,Primum atrial septal defect
GO:0030048,actin filament-based movement,HP:0012232,Shortened QT interval
GO:0030049,muscle filament sliding,HP:0000006,Autosomal dominant inheritance
GO:0030049,muscle filament sliding,HP:0001639,Hypertrophic cardiomyopathy
GO:0030049,muscle filament sliding,HP:0001644,Dilated cardiomyopathy
GO:0030049,muscle filament sliding,HP:0003458,EMG: myopathic abnormalities
GO:0030049,muscle filament sliding,HP:0003803,Type 1 muscle fiber predominance
GO:0030072,peptide hormone secretion,HP:0000006,Autosomal dominant inheritance
GO:0030072,peptide hormone secretion,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0030072,peptide hormone secretion,HP:0001894,Thrombocytosis
GO:0030073,insulin secretion,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0030073,insulin secretion,HP:0001894,Thrombocytosis
GO:0030098,lymphocyte differentiation,HP:0001045,Vitiligo
GO:0030098,lymphocyte differentiation,HP:0002090,Pneumonia
GO:0030098,lymphocyte differentiation,HP:0002716,Lymphadenopathy
GO:0030098,lymphocyte differentiation,HP:0002718,Recurrent bacterial infections
GO:0030098,lymphocyte differentiation,HP:0002721,Immunodeficiency
GO:0030098,lymphocyte differentiation,HP:0003095,Septic arthritis
GO:0030099,myeloid cell differentiation,HP:0000006,Autosomal dominant inheritance
GO:0030099,myeloid cell differentiation,HP:0001083,Ectopia lentis
GO:0030099,myeloid cell differentiation,HP:0001894,Thrombocytosis
GO:0030099,myeloid cell differentiation,HP:0003010,Prolonged bleeding time
GO:0030099,myeloid cell differentiation,HP:0004814,Fava bean-induced hemolytic anemia
GO:0030099,myeloid cell differentiation,HP:0007807,Optic nerve compression
GO:0030104,water homeostasis,HP:0000668,Hypodontia
GO:0030104,water homeostasis,HP:0001955,Unexplained fevers
GO:0030111,regulation of Wnt signaling pathway,HP:0000006,Autosomal dominant inheritance
GO:0030111,regulation of Wnt signaling pathway,HP:0000074,Ureteropelvic junction obstruction
GO:0030149,sphingolipid catabolic process,HP:0001744,Splenomegaly
GO:0030166,proteoglycan biosynthetic process,HP:0004233,Advanced ossification of carpal bones
GO:0030166,proteoglycan biosynthetic process,HP:0006765,Chondrosarcoma
GO:0030168,platelet activation,HP:0000132,Menorrhagia
GO:0030168,platelet activation,HP:0000421,Epistaxis
GO:0030168,platelet activation,HP:0000978,Bruising susceptibility
GO:0030168,platelet activation,HP:0001528,Hemihypertrophy
GO:0030168,platelet activation,HP:0002849,Absence of lymph node germinal center
GO:0030168,platelet activation,HP:0003010,Prolonged bleeding time
GO:0030193,regulation of blood coagulation,HP:0002204,Pulmonary embolism
GO:0030193,regulation of blood coagulation,HP:0005305,Cerebral venous thrombosis
GO:0030193,regulation of blood coagulation,HP:0100724,Hypercoagulability
GO:0030195,negative regulation of blood coagulation,HP:0002204,Pulmonary embolism
GO:0030195,negative regulation of blood coagulation,HP:0100724,Hypercoagulability
GO:0030198,extracellular matrix organization,HP:0000006,Autosomal dominant inheritance
GO:0030198,extracellular matrix organization,HP:0000149,Ovarian gonadoblastoma
GO:0030198,extracellular matrix organization,HP:0000501,Glaucoma
GO:0030198,extracellular matrix organization,HP:0000703,Dentinogenesis imperfecta
GO:0030198,extracellular matrix organization,HP:0000926,Platyspondyly
GO:0030198,extracellular matrix organization,HP:0001083,Ectopia lentis
GO:0030198,extracellular matrix organization,HP:0001634,Mitral valve prolapse
GO:0030198,extracellular matrix organization,HP:0005116,Arterial tortuosity
GO:0030198,extracellular matrix organization,HP:0005731,Cortical irregularity
GO:0030198,extracellular matrix organization,HP:0030041,Schmorl's node
GO:0030199,collagen fibril organization,HP:0000272,Malar flattening
GO:0030199,collagen fibril organization,HP:0000501,Glaucoma
GO:0030199,collagen fibril organization,HP:0000926,Platyspondyly
GO:0030203,glycosaminoglycan metabolic process,HP:0000280,Coarse facial features
GO:0030203,glycosaminoglycan metabolic process,HP:0000365,Hearing impairment
GO:0030203,glycosaminoglycan metabolic process,HP:0000501,Glaucoma
GO:0030203,glycosaminoglycan metabolic process,HP:0000943,Dysostosis multiplex
GO:0030203,glycosaminoglycan metabolic process,HP:0001387,Joint stiffness
GO:0030203,glycosaminoglycan metabolic process,HP:0001654,Abnormality of the heart valves
GO:0030203,glycosaminoglycan metabolic process,HP:0002159,Heparan sulfate excretion in urine
GO:0030203,glycosaminoglycan metabolic process,HP:0002208,Coarse hair
GO:0030203,glycosaminoglycan metabolic process,HP:0002673,Coxa valga
GO:0030203,glycosaminoglycan metabolic process,HP:0002788,Recurrent upper respiratory tract infections
GO:0030203,glycosaminoglycan metabolic process,HP:0002857,Genu valgum
GO:0030203,glycosaminoglycan metabolic process,HP:0006765,Chondrosarcoma
GO:0030204,chondroitin sulfate metabolic process,HP:0004233,Advanced ossification of carpal bones
GO:0030217,T cell differentiation,HP:0002716,Lymphadenopathy
GO:0030239,myofibril assembly,HP:0000006,Autosomal dominant inheritance
GO:0030258,lipid modification,HP:0001528,Hemihypertrophy
GO:0030258,lipid modification,HP:0002676,Cloverleaf skull
GO:0030258,lipid modification,HP:0002677,Small foramen magnum
GO:0030258,lipid modification,HP:0003319,Abnormality of the cervical spine
GO:0030278,regulation of ossification,HP:0000006,Autosomal dominant inheritance
GO:0030278,regulation of ossification,HP:0005116,Arterial tortuosity
GO:0030278,regulation of ossification,HP:0005217,Duplication of internal organs
GO:0030278,regulation of ossification,HP:0008368,Tarsal synostosis
GO:0030279,negative regulation of ossification,HP:0008368,Tarsal synostosis
GO:0030282,bone mineralization,HP:0002677,Small foramen magnum
GO:0030282,bone mineralization,HP:0003015,Flared metaphysis
GO:0030282,bone mineralization,HP:0003319,Abnormality of the cervical spine
GO:0030301,cholesterol transport,HP:0012184,Hyperalphalipoproteinemia
GO:0030308,negative regulation of cell growth,HP:0000006,Autosomal dominant inheritance
GO:0030308,negative regulation of cell growth,HP:0000149,Ovarian gonadoblastoma
GO:0030308,negative regulation of cell growth,HP:0004814,Fava bean-induced hemolytic anemia
GO:0030308,negative regulation of cell growth,HP:0005116,Arterial tortuosity
GO:0030318,melanocyte differentiation,HP:0000635,Blue irides
GO:0030318,melanocyte differentiation,HP:0001008,Accumulation of melanosomes in melanocytes
GO:0030318,melanocyte differentiation,HP:0001022,Albinism
GO:0030318,melanocyte differentiation,HP:0001053,Hypopigmented skin patches
GO:0030318,melanocyte differentiation,HP:0001100,Heterochromia iridis
GO:0030318,melanocyte differentiation,HP:0002211,White forelock
GO:0030318,melanocyte differentiation,HP:0002226,White eyebrow
GO:0030318,melanocyte differentiation,HP:0002227,White eyelashes
GO:0030323,respiratory tube development,HP:0000006,Autosomal dominant inheritance
GO:0030323,respiratory tube development,HP:0000243,Trigonocephaly
GO:0030324,lung development,HP:0000006,Autosomal dominant inheritance
GO:0030324,lung development,HP:0000243,Trigonocephaly
GO:0030325,adrenal gland development,HP:0000149,Ovarian gonadoblastoma
GO:0030326,embryonic limb morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0030326,embryonic limb morphogenesis,HP:0000243,Trigonocephaly
GO:0030326,embryonic limb morphogenesis,HP:0000668,Hypodontia
GO:0030326,embryonic limb morphogenesis,HP:0001156,Brachydactyly syndrome
GO:0030326,embryonic limb morphogenesis,HP:0001199,Triphalangeal thumb
GO:0030326,embryonic limb morphogenesis,HP:0002984,Hypoplasia of the radius
GO:0030326,embryonic limb morphogenesis,HP:0005217,Duplication of internal organs
GO:0030326,embryonic limb morphogenesis,HP:0005736,Short tibia
GO:0030326,embryonic limb morphogenesis,HP:0009183,Joint contracture of the 5th finger
GO:0030335,positive regulation of cell migration,HP:0000006,Autosomal dominant inheritance
GO:0030335,positive regulation of cell migration,HP:0001528,Hemihypertrophy
GO:0030335,positive regulation of cell migration,HP:0001894,Thrombocytosis
GO:0030335,positive regulation of cell migration,HP:0005116,Arterial tortuosity
GO:0030335,positive regulation of cell migration,HP:0012233,Intramuscular hematoma
GO:0030449,regulation of complement activation,HP:0002725,Systemic lupus erythematosus
GO:0030449,regulation of complement activation,HP:0004431,Complement deficiency
GO:0030449,regulation of complement activation,HP:0005381,Recurrent meningococcal disease
GO:0030449,regulation of complement activation,HP:0005421,Decreased serum complement C3
GO:0030509,BMP signaling pathway,HP:0000006,Autosomal dominant inheritance
GO:0030509,BMP signaling pathway,HP:0001083,Ectopia lentis
GO:0030509,BMP signaling pathway,HP:0001684,Secundum atrial septal defect
GO:0030509,BMP signaling pathway,HP:0002408,Cerebral arteriovenous malformation
GO:0030509,BMP signaling pathway,HP:0008368,Tarsal synostosis
GO:0030510,regulation of BMP signaling pathway,HP:0000006,Autosomal dominant inheritance
GO:0030510,regulation of BMP signaling pathway,HP:0001083,Ectopia lentis
GO:0030510,regulation of BMP signaling pathway,HP:0002408,Cerebral arteriovenous malformation
GO:0030513,positive regulation of BMP signaling pathway,HP:0000006,Autosomal dominant inheritance
GO:0030513,positive regulation of BMP signaling pathway,HP:0002408,Cerebral arteriovenous malformation
GO:0030522,intracellular receptor signaling pathway,HP:0001894,Thrombocytosis
GO:0030534,adult behavior,HP:0001300,Parkinsonism
GO:0030534,adult behavior,HP:0002301,Hemiplegia
GO:0030539,male genitalia development,HP:0000149,Ovarian gonadoblastoma
GO:0030540,female genitalia development,HP:0000668,Hypodontia
GO:0030574,collagen catabolic process,HP:0000926,Platyspondyly
GO:0030641,regulation of cellular pH,HP:0002074,Increased neuronal autofluorescent lipopigment
GO:0030641,regulation of cellular pH,HP:0008341,Distal renal tubular acidosis
GO:0030705,cytoskeleton-dependent intracellular transport,HP:0000012,Urinary urgency
GO:0030850,prostate gland development,HP:0000006,Autosomal dominant inheritance
GO:0030856,regulation of epithelial cell differentiation,HP:0000006,Autosomal dominant inheritance
GO:0030856,regulation of epithelial cell differentiation,HP:0000668,Hypodontia
GO:0030857,negative regulation of epithelial cell differentiation,HP:0000668,Hypodontia
GO:0030878,thyroid gland development,HP:0000851,Congenital hypothyroidism
GO:0030878,thyroid gland development,HP:0008191,Thyroid agenesis
GO:0030879,mammary gland development,HP:0000006,Autosomal dominant inheritance
GO:0030879,mammary gland development,HP:0001528,Hemihypertrophy
GO:0030879,mammary gland development,HP:0001894,Thrombocytosis
GO:0030900,forebrain development,HP:0000006,Autosomal dominant inheritance
GO:0030900,forebrain development,HP:0000243,Trigonocephaly
GO:0030900,forebrain development,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0031023,microtubule organizing center organization,HP:0000007,Autosomal recessive inheritance
GO:0031023,microtubule organizing center organization,HP:0000252,Microcephaly
GO:0031023,microtubule organizing center organization,HP:0000340,Sloping forehead
GO:0031032,actomyosin structure organization,HP:0000006,Autosomal dominant inheritance
GO:0031032,actomyosin structure organization,HP:0000408,Progressive sensorineural hearing impairment
GO:0031056,regulation of histone modification,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0031069,hair follicle morphogenesis,HP:0000668,Hypodontia
GO:0031099,regeneration,HP:0001054,Numerous nevi
GO:0031099,regeneration,HP:0001894,Thrombocytosis
GO:0031102,neuron projection regeneration,HP:0001054,Numerous nevi
GO:0031102,neuron projection regeneration,HP:0001894,Thrombocytosis
GO:0031214,biomineral tissue development,HP:0000703,Dentinogenesis imperfecta
GO:0031214,biomineral tissue development,HP:0000705,Amelogenesis imperfecta
GO:0031214,biomineral tissue development,HP:0002677,Small foramen magnum
GO:0031214,biomineral tissue development,HP:0003319,Abnormality of the cervical spine
GO:0031297,replication fork processing,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0031348,negative regulation of defense response,HP:0001894,Thrombocytosis
GO:0031348,negative regulation of defense response,HP:0002716,Lymphadenopathy
GO:0031348,negative regulation of defense response,HP:0002829,Arthralgia
GO:0031581,hemidesmosome assembly,HP:0000006,Autosomal dominant inheritance
GO:0031581,hemidesmosome assembly,HP:0008404,Nail dystrophy
GO:0031589,cell-substrate adhesion,HP:0000243,Trigonocephaly
GO:0031589,cell-substrate adhesion,HP:0001054,Numerous nevi
GO:0031589,cell-substrate adhesion,HP:0001894,Thrombocytosis
GO:0031647,regulation of protein stability,HP:0000012,Urinary urgency
GO:0031667,response to nutrient levels,HP:0004814,Fava bean-induced hemolytic anemia
GO:0032042,mitochondrial DNA metabolic process,HP:0000006,Autosomal dominant inheritance
GO:0032042,mitochondrial DNA metabolic process,HP:0000007,Autosomal recessive inheritance
GO:0032042,mitochondrial DNA metabolic process,HP:0000508,Ptosis
GO:0032042,mitochondrial DNA metabolic process,HP:0000590,Progressive external ophthalmoplegia
GO:0032042,mitochondrial DNA metabolic process,HP:0003546,Exercise intolerance
GO:0032042,mitochondrial DNA metabolic process,HP:0003689,Multiple mitochondrial DNA deletions
GO:0032094,response to food,HP:0004814,Fava bean-induced hemolytic anemia
GO:0032102,negative regulation of response to external stimulus,HP:0001894,Thrombocytosis
GO:0032102,negative regulation of response to external stimulus,HP:0002716,Lymphadenopathy
GO:0032102,negative regulation of response to external stimulus,HP:0100724,Hypercoagulability
GO:0032147,activation of protein kinase activity,HP:0001894,Thrombocytosis
GO:0032204,regulation of telomere maintenance,HP:0000252,Microcephaly
GO:0032204,regulation of telomere maintenance,HP:0005528,Bone marrow hypocellularity
GO:0032204,regulation of telomere maintenance,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0032206,positive regulation of telomere maintenance,HP:0005528,Bone marrow hypocellularity
GO:0032206,positive regulation of telomere maintenance,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0032292,peripheral nervous system axon ensheathment,HP:0001528,Hemihypertrophy
GO:0032330,regulation of chondrocyte differentiation,HP:0005736,Short tibia
GO:0032332,positive regulation of chondrocyte differentiation,HP:0003038,Fibular hypoplasia
GO:0032332,positive regulation of chondrocyte differentiation,HP:0005736,Short tibia
GO:0032355,response to estradiol,HP:0008668,"Gonadal dysgenesis, male"
GO:0032368,regulation of lipid transport,HP:0001528,Hemihypertrophy
GO:0032368,regulation of lipid transport,HP:0012184,Hyperalphalipoproteinemia
GO:0032371,regulation of sterol transport,HP:0012184,Hyperalphalipoproteinemia
GO:0032374,regulation of cholesterol transport,HP:0012184,Hyperalphalipoproteinemia
GO:0032386,regulation of intracellular transport,HP:0001894,Thrombocytosis
GO:0032392,DNA geometric change,HP:0000007,Autosomal recessive inheritance
GO:0032392,DNA geometric change,HP:0000252,Microcephaly
GO:0032392,DNA geometric change,HP:0000992,Cutaneous photosensitivity
GO:0032392,DNA geometric change,HP:0001029,Poikiloderma
GO:0032392,DNA geometric change,HP:0001249,Intellectual disability
GO:0032392,DNA geometric change,HP:0004322,Short stature
GO:0032392,DNA geometric change,HP:0004334,Dermal atrophy
GO:0032392,DNA geometric change,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0032400,melanosome localization,HP:0000510,Rod-cone dystrophy
GO:0032400,melanosome localization,HP:0001008,Accumulation of melanosomes in melanocytes
GO:0032400,melanosome localization,HP:0003241,External genital hypoplasia
GO:0032401,establishment of melanosome localization,HP:0000510,Rod-cone dystrophy
GO:0032401,establishment of melanosome localization,HP:0001008,Accumulation of melanosomes in melanocytes
GO:0032401,establishment of melanosome localization,HP:0003241,External genital hypoplasia
GO:0032402,melanosome transport,HP:0000510,Rod-cone dystrophy
GO:0032402,melanosome transport,HP:0001008,Accumulation of melanosomes in melanocytes
GO:0032402,melanosome transport,HP:0003241,External genital hypoplasia
GO:0032409,regulation of transporter activity,HP:0000006,Autosomal dominant inheritance
GO:0032409,regulation of transporter activity,HP:0001279,Syncope
GO:0032409,regulation of transporter activity,HP:0001657,Prolonged QT interval
GO:0032410,negative regulation of transporter activity,HP:0001279,Syncope
GO:0032412,regulation of ion transmembrane transporter activity,HP:0001279,Syncope
GO:0032412,regulation of ion transmembrane transporter activity,HP:0001657,Prolonged QT interval
GO:0032413,negative regulation of ion transmembrane transporter activity,HP:0001279,Syncope
GO:0032413,negative regulation of ion transmembrane transporter activity,HP:0001657,Prolonged QT interval
GO:0032414,positive regulation of ion transmembrane transporter activity,HP:0000006,Autosomal dominant inheritance
GO:0032496,response to lipopolysaccharide,HP:0001045,Vitiligo
GO:0032496,response to lipopolysaccharide,HP:0001894,Thrombocytosis
GO:0032496,response to lipopolysaccharide,HP:0002716,Lymphadenopathy
GO:0032496,response to lipopolysaccharide,HP:0005959,Impaired gluconeogenesis
GO:0032508,DNA duplex unwinding,HP:0000992,Cutaneous photosensitivity
GO:0032508,DNA duplex unwinding,HP:0001029,Poikiloderma
GO:0032508,DNA duplex unwinding,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0032835,glomerulus development,HP:0000093,Proteinuria
GO:0032835,glomerulus development,HP:0000100,Nephrotic syndrome
GO:0032835,glomerulus development,HP:0000149,Ovarian gonadoblastoma
GO:0032836,glomerular basement membrane development,HP:0000100,Nephrotic syndrome
GO:0032836,glomerular basement membrane development,HP:0000149,Ovarian gonadoblastoma
GO:0032836,glomerular basement membrane development,HP:0001967,Diffuse mesangial sclerosis
GO:0032844,regulation of homeostatic process,HP:0000006,Autosomal dominant inheritance
GO:0032844,regulation of homeostatic process,HP:0000012,Urinary urgency
GO:0032844,regulation of homeostatic process,HP:0001279,Syncope
GO:0032844,regulation of homeostatic process,HP:0003391,Gowers sign
GO:0032844,regulation of homeostatic process,HP:0004749,Atrial flutter
GO:0032844,regulation of homeostatic process,HP:0007807,Optic nerve compression
GO:0032844,regulation of homeostatic process,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0032846,positive regulation of homeostatic process,HP:0007807,Optic nerve compression
GO:0032846,positive regulation of homeostatic process,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0032881,regulation of polysaccharide metabolic process,HP:0001528,Hemihypertrophy
GO:0032886,regulation of microtubule-based process,HP:0000012,Urinary urgency
GO:0032890,regulation of organic acid transport,HP:0001528,Hemihypertrophy
GO:0032924,activin receptor signaling pathway,HP:0000006,Autosomal dominant inheritance
GO:0032924,activin receptor signaling pathway,HP:0001719,Double outlet right ventricle
GO:0032943,mononuclear cell proliferation,HP:0002716,Lymphadenopathy
GO:0032943,mononuclear cell proliferation,HP:0002718,Recurrent bacterial infections
GO:0032943,mononuclear cell proliferation,HP:0002721,Immunodeficiency
GO:0032943,mononuclear cell proliferation,HP:0002849,Absence of lymph node germinal center
GO:0032944,regulation of mononuclear cell proliferation,HP:0002721,Immunodeficiency
GO:0032944,regulation of mononuclear cell proliferation,HP:0002849,Absence of lymph node germinal center
GO:0032963,collagen metabolic process,HP:0000006,Autosomal dominant inheritance
GO:0032963,collagen metabolic process,HP:0000926,Platyspondyly
GO:0032970,regulation of actin filament-based process,HP:0000006,Autosomal dominant inheritance
GO:0032970,regulation of actin filament-based process,HP:0001279,Syncope
GO:0032970,regulation of actin filament-based process,HP:0004308,Ventricular arrhythmia
GO:0032970,regulation of actin filament-based process,HP:0005116,Arterial tortuosity
GO:0032970,regulation of actin filament-based process,HP:0011663,Right ventricular cardiomyopathy
GO:0033002,muscle cell proliferation,HP:0000006,Autosomal dominant inheritance
GO:0033002,muscle cell proliferation,HP:0001894,Thrombocytosis
GO:0033002,muscle cell proliferation,HP:0005465,Facial hyperostosis
GO:0033013,tetrapyrrole metabolic process,HP:0001254,Lethargy
GO:0033013,tetrapyrrole metabolic process,HP:0001889,Megaloblastic anemia
GO:0033013,tetrapyrrole metabolic process,HP:0002156,Homocystinuria
GO:0033013,tetrapyrrole metabolic process,HP:0002160,Hyperhomocystinemia
GO:0033013,tetrapyrrole metabolic process,HP:0002912,Methylmalonic acidemia
GO:0033013,tetrapyrrole metabolic process,HP:0003145,Decreased adenosylcobalamin
GO:0033013,tetrapyrrole metabolic process,HP:0003223,Decreased methylcobalamin
GO:0033013,tetrapyrrole metabolic process,HP:0003524,Decreased methionine synthase activity
GO:0033013,tetrapyrrole metabolic process,HP:0003658,Hypomethioninemia
GO:0033013,tetrapyrrole metabolic process,HP:0005518,Increased mean corpuscular volume
GO:0033013,tetrapyrrole metabolic process,HP:0012120,Methylmalonic aciduria
GO:0033059,cellular pigmentation,HP:0000510,Rod-cone dystrophy
GO:0033059,cellular pigmentation,HP:0001008,Accumulation of melanosomes in melanocytes
GO:0033059,cellular pigmentation,HP:0001022,Albinism
GO:0033059,cellular pigmentation,HP:0001107,Ocular albinism
GO:0033059,cellular pigmentation,HP:0003241,External genital hypoplasia
GO:0033275,actin-myosin filament sliding,HP:0001639,Hypertrophic cardiomyopathy
GO:0033275,actin-myosin filament sliding,HP:0001644,Dilated cardiomyopathy
GO:0033275,actin-myosin filament sliding,HP:0003458,EMG: myopathic abnormalities
GO:0033275,actin-myosin filament sliding,HP:0003803,Type 1 muscle fiber predominance
GO:0033500,carbohydrate homeostasis,HP:0000006,Autosomal dominant inheritance
GO:0033500,carbohydrate homeostasis,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0033500,carbohydrate homeostasis,HP:0001528,Hemihypertrophy
GO:0033500,carbohydrate homeostasis,HP:0004904,Maturity-onset diabetes of the young
GO:0033500,carbohydrate homeostasis,HP:0005959,Impaired gluconeogenesis
GO:0033561,regulation of water loss via skin,HP:0000668,Hypodontia
GO:0033627,cell adhesion mediated by integrin,HP:0001083,Ectopia lentis
GO:0033674,positive regulation of kinase activity,HP:0000006,Autosomal dominant inheritance
GO:0033674,positive regulation of kinase activity,HP:0001528,Hemihypertrophy
GO:0033674,positive regulation of kinase activity,HP:0001894,Thrombocytosis
GO:0033674,positive regulation of kinase activity,HP:0002677,Small foramen magnum
GO:0033674,positive regulation of kinase activity,HP:0002849,Absence of lymph node germinal center
GO:0033674,positive regulation of kinase activity,HP:0003764,Nevus
GO:0033692,cellular polysaccharide biosynthetic process,HP:0001528,Hemihypertrophy
GO:0033692,cellular polysaccharide biosynthetic process,HP:0006765,Chondrosarcoma
GO:0034101,erythrocyte homeostasis,HP:0001894,Thrombocytosis
GO:0034101,erythrocyte homeostasis,HP:0004814,Fava bean-induced hemolytic anemia
GO:0034109,homotypic cell-cell adhesion,HP:0003010,Prolonged bleeding time
GO:0034284,response to monosaccharide,HP:0005959,Impaired gluconeogenesis
GO:0034284,response to monosaccharide,HP:0010445,Primum atrial septal defect
GO:0034330,cell junction organization,HP:0000006,Autosomal dominant inheritance
GO:0034330,cell junction organization,HP:0005116,Arterial tortuosity
GO:0034330,cell junction organization,HP:0100792,Acantholysis
GO:0034367,macromolecular complex remodeling,HP:0012184,Hyperalphalipoproteinemia
GO:0034368,protein-lipid complex remodeling,HP:0012184,Hyperalphalipoproteinemia
GO:0034369,plasma lipoprotein particle remodeling,HP:0012184,Hyperalphalipoproteinemia
GO:0034370,triglyceride-rich lipoprotein particle remodeling,HP:0012184,Hyperalphalipoproteinemia
GO:0034372,very-low-density lipoprotein particle remodeling,HP:0012184,Hyperalphalipoproteinemia
GO:0034389,lipid particle organization,HP:0000007,Autosomal recessive inheritance
GO:0034405,response to fluid shear stress,HP:0005465,Facial hyperostosis
GO:0034440,lipid oxidation,HP:0000007,Autosomal recessive inheritance
GO:0034440,lipid oxidation,HP:0001250,Seizures
GO:0034440,lipid oxidation,HP:0001252,Muscular hypotonia
GO:0034440,lipid oxidation,HP:0001254,Lethargy
GO:0034440,lipid oxidation,HP:0001528,Hemihypertrophy
GO:0034440,lipid oxidation,HP:0002240,Hepatomegaly
GO:0034440,lipid oxidation,HP:0002910,Elevated hepatic transaminases
GO:0034504,protein localization to nucleus,HP:0000006,Autosomal dominant inheritance
GO:0034504,protein localization to nucleus,HP:0000316,Hypertelorism
GO:0034504,protein localization to nucleus,HP:0000668,Hypodontia
GO:0034504,protein localization to nucleus,HP:0001894,Thrombocytosis
GO:0034504,protein localization to nucleus,HP:0004749,Atrial flutter
GO:0034504,protein localization to nucleus,HP:0005116,Arterial tortuosity
GO:0034505,tooth mineralization,HP:0000705,Amelogenesis imperfecta
GO:0034599,cellular response to oxidative stress,HP:0001894,Thrombocytosis
GO:0034599,cellular response to oxidative stress,HP:0003095,Septic arthritis
GO:0034599,cellular response to oxidative stress,HP:0004814,Fava bean-induced hemolytic anemia
GO:0034614,cellular response to reactive oxygen species,HP:0003095,Septic arthritis
GO:0034637,cellular carbohydrate biosynthetic process,HP:0001528,Hemihypertrophy
GO:0034637,cellular carbohydrate biosynthetic process,HP:0006765,Chondrosarcoma
GO:0034698,response to gonadotropin,HP:0000149,Ovarian gonadoblastoma
GO:0034754,cellular hormone metabolic process,HP:0000840,Adrenogenital syndrome
GO:0034762,regulation of transmembrane transport,HP:0000006,Autosomal dominant inheritance
GO:0034762,regulation of transmembrane transport,HP:0001279,Syncope
GO:0034762,regulation of transmembrane transport,HP:0001528,Hemihypertrophy
GO:0034762,regulation of transmembrane transport,HP:0001657,Prolonged QT interval
GO:0034762,regulation of transmembrane transport,HP:0001663,Ventricular fibrillation
GO:0034762,regulation of transmembrane transport,HP:0002069,Generalized tonic-clonic seizures
GO:0034762,regulation of transmembrane transport,HP:0004749,Atrial flutter
GO:0034762,regulation of transmembrane transport,HP:0004814,Fava bean-induced hemolytic anemia
GO:0034762,regulation of transmembrane transport,HP:0005110,Atrial fibrillation
GO:0034762,regulation of transmembrane transport,HP:0005465,Facial hyperostosis
GO:0034762,regulation of transmembrane transport,HP:0012232,Shortened QT interval
GO:0034763,negative regulation of transmembrane transport,HP:0001279,Syncope
GO:0034763,negative regulation of transmembrane transport,HP:0001528,Hemihypertrophy
GO:0034763,negative regulation of transmembrane transport,HP:0001657,Prolonged QT interval
GO:0034764,positive regulation of transmembrane transport,HP:0001279,Syncope
GO:0034764,positive regulation of transmembrane transport,HP:0001657,Prolonged QT interval
GO:0034764,positive regulation of transmembrane transport,HP:0004814,Fava bean-induced hemolytic anemia
GO:0034765,regulation of ion transmembrane transport,HP:0000006,Autosomal dominant inheritance
GO:0034765,regulation of ion transmembrane transport,HP:0001279,Syncope
GO:0034765,regulation of ion transmembrane transport,HP:0001528,Hemihypertrophy
GO:0034765,regulation of ion transmembrane transport,HP:0001657,Prolonged QT interval
GO:0034765,regulation of ion transmembrane transport,HP:0001663,Ventricular fibrillation
GO:0034765,regulation of ion transmembrane transport,HP:0002069,Generalized tonic-clonic seizures
GO:0034765,regulation of ion transmembrane transport,HP:0004749,Atrial flutter
GO:0034765,regulation of ion transmembrane transport,HP:0004814,Fava bean-induced hemolytic anemia
GO:0034765,regulation of ion transmembrane transport,HP:0005110,Atrial fibrillation
GO:0034765,regulation of ion transmembrane transport,HP:0005465,Facial hyperostosis
GO:0034765,regulation of ion transmembrane transport,HP:0012232,Shortened QT interval
GO:0034766,negative regulation of ion transmembrane transport,HP:0001279,Syncope
GO:0034766,negative regulation of ion transmembrane transport,HP:0001528,Hemihypertrophy
GO:0034766,negative regulation of ion transmembrane transport,HP:0001657,Prolonged QT interval
GO:0034767,positive regulation of ion transmembrane transport,HP:0001279,Syncope
GO:0034767,positive regulation of ion transmembrane transport,HP:0001657,Prolonged QT interval
GO:0034767,positive regulation of ion transmembrane transport,HP:0004814,Fava bean-induced hemolytic anemia
GO:0035019,somatic stem cell population maintenance,HP:0000006,Autosomal dominant inheritance
GO:0035050,embryonic heart tube development,HP:0010445,Primum atrial septal defect
GO:0035051,cardiocyte differentiation,HP:0000006,Autosomal dominant inheritance
GO:0035051,cardiocyte differentiation,HP:0000149,Ovarian gonadoblastoma
GO:0035051,cardiocyte differentiation,HP:0001644,Dilated cardiomyopathy
GO:0035051,cardiocyte differentiation,HP:0001684,Secundum atrial septal defect
GO:0035051,cardiocyte differentiation,HP:0004814,Fava bean-induced hemolytic anemia
GO:0035058,,HP:0000510,Rod-cone dystrophy
GO:0035058,,HP:0003241,External genital hypoplasia
GO:0035082,axoneme assembly,HP:0000246,Sinusitis
GO:0035082,axoneme assembly,HP:0000403,Recurrent otitis media
GO:0035082,axoneme assembly,HP:0000789,Infertility
GO:0035082,axoneme assembly,HP:0001696,Situs inversus totalis
GO:0035082,axoneme assembly,HP:0002110,Bronchiectasis
GO:0035082,axoneme assembly,HP:0002257,Chronic rhinitis
GO:0035082,axoneme assembly,HP:0004469,Chronic bronchitis
GO:0035082,axoneme assembly,HP:0011108,Recurrent sinusitis
GO:0035082,axoneme assembly,HP:0011109,Chronic sinusitis
GO:0035082,axoneme assembly,HP:0012263,Immotile cilia
GO:0035082,axoneme assembly,HP:0012265,Ciliary dyskinesia
GO:0035082,axoneme assembly,HP:0100582,Nasal polyposis
GO:0035082,axoneme assembly,HP:0200073,Respiratory insufficiency due to defective ciliary clearance
GO:0035082,axoneme assembly,HP:0012384,Rhinitis
GO:0035107,appendage morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0035107,appendage morphogenesis,HP:0000175,Cleft palate
GO:0035107,appendage morphogenesis,HP:0000243,Trigonocephaly
GO:0035107,appendage morphogenesis,HP:0000668,Hypodontia
GO:0035107,appendage morphogenesis,HP:0001156,Brachydactyly syndrome
GO:0035107,appendage morphogenesis,HP:0001199,Triphalangeal thumb
GO:0035107,appendage morphogenesis,HP:0005217,Duplication of internal organs
GO:0035107,appendage morphogenesis,HP:0005736,Short tibia
GO:0035107,appendage morphogenesis,HP:0009183,Joint contracture of the 5th finger
GO:0035107,appendage morphogenesis,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0035108,limb morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0035108,limb morphogenesis,HP:0000175,Cleft palate
GO:0035108,limb morphogenesis,HP:0000204,Cleft upper lip
GO:0035108,limb morphogenesis,HP:0000243,Trigonocephaly
GO:0035108,limb morphogenesis,HP:0000272,Malar flattening
GO:0035108,limb morphogenesis,HP:0000405,Conductive hearing impairment
GO:0035108,limb morphogenesis,HP:0000668,Hypodontia
GO:0035108,limb morphogenesis,HP:0001156,Brachydactyly syndrome
GO:0035108,limb morphogenesis,HP:0001159,Syndactyly
GO:0035108,limb morphogenesis,HP:0001162,Postaxial hand polydactyly
GO:0035108,limb morphogenesis,HP:0001199,Triphalangeal thumb
GO:0035108,limb morphogenesis,HP:0002984,Hypoplasia of the radius
GO:0035108,limb morphogenesis,HP:0005217,Duplication of internal organs
GO:0035108,limb morphogenesis,HP:0005736,Short tibia
GO:0035108,limb morphogenesis,HP:0005914,Aplasia/Hypoplasia involving the metacarpal bones
GO:0035108,limb morphogenesis,HP:0008368,Tarsal synostosis
GO:0035108,limb morphogenesis,HP:0009183,Joint contracture of the 5th finger
GO:0035108,limb morphogenesis,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0035112,genitalia morphogenesis,HP:0000668,Hypodontia
GO:0035113,embryonic appendage morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0035113,embryonic appendage morphogenesis,HP:0000243,Trigonocephaly
GO:0035113,embryonic appendage morphogenesis,HP:0000668,Hypodontia
GO:0035113,embryonic appendage morphogenesis,HP:0001156,Brachydactyly syndrome
GO:0035113,embryonic appendage morphogenesis,HP:0001199,Triphalangeal thumb
GO:0035113,embryonic appendage morphogenesis,HP:0002984,Hypoplasia of the radius
GO:0035113,embryonic appendage morphogenesis,HP:0005217,Duplication of internal organs
GO:0035113,embryonic appendage morphogenesis,HP:0005736,Short tibia
GO:0035113,embryonic appendage morphogenesis,HP:0009183,Joint contracture of the 5th finger
GO:0035115,embryonic forelimb morphogenesis,HP:0005217,Duplication of internal organs
GO:0035136,forelimb morphogenesis,HP:0005217,Duplication of internal organs
GO:0035136,forelimb morphogenesis,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0035137,hindlimb morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0035150,regulation of tube size,HP:0005465,Facial hyperostosis
GO:0035150,regulation of tube size,HP:0012727,Thoracic aortic aneurysm
GO:0035239,tube morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0035239,tube morphogenesis,HP:0000074,Ureteropelvic junction obstruction
GO:0035239,tube morphogenesis,HP:0000149,Ovarian gonadoblastoma
GO:0035239,tube morphogenesis,HP:0000243,Trigonocephaly
GO:0035239,tube morphogenesis,HP:0000668,Hypodontia
GO:0035239,tube morphogenesis,HP:0002408,Cerebral arteriovenous malformation
GO:0035239,tube morphogenesis,HP:0002561,Absent nipple
GO:0035239,tube morphogenesis,HP:0005116,Arterial tortuosity
GO:0035239,tube morphogenesis,HP:0010445,Primum atrial septal defect
GO:0035264,multicellular organism growth,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0035265,organ growth,HP:0000006,Autosomal dominant inheritance
GO:0035265,organ growth,HP:0000149,Ovarian gonadoblastoma
GO:0035265,organ growth,HP:0001684,Secundum atrial septal defect
GO:0035265,organ growth,HP:0002676,Cloverleaf skull
GO:0035265,organ growth,HP:0002677,Small foramen magnum
GO:0035265,organ growth,HP:0003319,Abnormality of the cervical spine
GO:0035265,organ growth,HP:0004814,Fava bean-induced hemolytic anemia
GO:0035265,organ growth,HP:0010445,Primum atrial septal defect
GO:0035268,protein mannosylation,HP:0000158,Macroglossia
GO:0035268,protein mannosylation,HP:0001321,Cerebellar hypoplasia
GO:0035268,protein mannosylation,HP:0003236,Elevated serum creatine phosphokinase
GO:0035268,protein mannosylation,HP:0003560,Muscular dystrophy
GO:0035268,protein mannosylation,HP:0003741,Congenital muscular dystrophy
GO:0035268,protein mannosylation,HP:0007260,Type II lissencephaly
GO:0035268,protein mannosylation,HP:0007973,Retinal dysplasia
GO:0035269,protein O-linked mannosylation,HP:0000158,Macroglossia
GO:0035269,protein O-linked mannosylation,HP:0001321,Cerebellar hypoplasia
GO:0035269,protein O-linked mannosylation,HP:0003236,Elevated serum creatine phosphokinase
GO:0035269,protein O-linked mannosylation,HP:0003560,Muscular dystrophy
GO:0035269,protein O-linked mannosylation,HP:0003741,Congenital muscular dystrophy
GO:0035269,protein O-linked mannosylation,HP:0007260,Type II lissencephaly
GO:0035269,protein O-linked mannosylation,HP:0007973,Retinal dysplasia
GO:0035270,endocrine system development,HP:0000006,Autosomal dominant inheritance
GO:0035270,endocrine system development,HP:0000149,Ovarian gonadoblastoma
GO:0035270,endocrine system development,HP:0001684,Secundum atrial septal defect
GO:0035270,endocrine system development,HP:0008191,Thyroid agenesis
GO:0035282,segmentation,HP:0000149,Ovarian gonadoblastoma
GO:0035383,thioester metabolic process,HP:0003128,Lactic acidosis
GO:0035383,thioester metabolic process,HP:0200044,Porokeratosis
GO:0035637,multicellular organismal signaling,HP:0000006,Autosomal dominant inheritance
GO:0035637,multicellular organismal signaling,HP:0001279,Syncope
GO:0035637,multicellular organismal signaling,HP:0001645,Sudden cardiac death
GO:0035637,multicellular organismal signaling,HP:0001657,Prolonged QT interval
GO:0035637,multicellular organismal signaling,HP:0001663,Ventricular fibrillation
GO:0035637,multicellular organismal signaling,HP:0001962,Palpitations
GO:0035637,multicellular organismal signaling,HP:0002301,Hemiplegia
GO:0035637,multicellular organismal signaling,HP:0004749,Atrial flutter
GO:0035637,multicellular organismal signaling,HP:0005110,Atrial fibrillation
GO:0035637,multicellular organismal signaling,HP:0012232,Shortened QT interval
GO:0035690,cellular response to drug,HP:0001279,Syncope
GO:0035725,sodium ion transmembrane transport,HP:0000006,Autosomal dominant inheritance
GO:0035725,sodium ion transmembrane transport,HP:0001279,Syncope
GO:0035725,sodium ion transmembrane transport,HP:0001663,Ventricular fibrillation
GO:0035725,sodium ion transmembrane transport,HP:0004749,Atrial flutter
GO:0035850,epithelial cell differentiation involved in kidney development,HP:0000100,Nephrotic syndrome
GO:0035850,epithelial cell differentiation involved in kidney development,HP:0000149,Ovarian gonadoblastoma
GO:0035904,aorta development,HP:0000006,Autosomal dominant inheritance
GO:0035904,aorta development,HP:0002408,Cerebral arteriovenous malformation
GO:0035909,aorta morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0035909,aorta morphogenesis,HP:0002408,Cerebral arteriovenous malformation
GO:0036075,replacement ossification,HP:0000926,Platyspondyly
GO:0036075,replacement ossification,HP:0001156,Brachydactyly syndrome
GO:0036075,replacement ossification,HP:0002677,Small foramen magnum
GO:0036075,replacement ossification,HP:0003015,Flared metaphysis
GO:0036092,phosphatidylinositol-3-phosphate biosynthetic process,HP:0002676,Cloverleaf skull
GO:0036092,phosphatidylinositol-3-phosphate biosynthetic process,HP:0002677,Small foramen magnum
GO:0036092,phosphatidylinositol-3-phosphate biosynthetic process,HP:0003319,Abnormality of the cervical spine
GO:0036158,outer dynein arm assembly,HP:0000246,Sinusitis
GO:0036158,outer dynein arm assembly,HP:0000403,Recurrent otitis media
GO:0036158,outer dynein arm assembly,HP:0001696,Situs inversus totalis
GO:0036158,outer dynein arm assembly,HP:0002110,Bronchiectasis
GO:0036158,outer dynein arm assembly,HP:0004469,Chronic bronchitis
GO:0036158,outer dynein arm assembly,HP:0011108,Recurrent sinusitis
GO:0036158,outer dynein arm assembly,HP:0012265,Ciliary dyskinesia
GO:0036158,outer dynein arm assembly,HP:0200073,Respiratory insufficiency due to defective ciliary clearance
GO:0036158,outer dynein arm assembly,HP:0012384,Rhinitis
GO:0036159,inner dynein arm assembly,HP:0000007,Autosomal recessive inheritance
GO:0036159,inner dynein arm assembly,HP:0000246,Sinusitis
GO:0036159,inner dynein arm assembly,HP:0000403,Recurrent otitis media
GO:0036159,inner dynein arm assembly,HP:0000789,Infertility
GO:0036159,inner dynein arm assembly,HP:0001696,Situs inversus totalis
GO:0036159,inner dynein arm assembly,HP:0002110,Bronchiectasis
GO:0036159,inner dynein arm assembly,HP:0002205,Recurrent respiratory infections
GO:0036159,inner dynein arm assembly,HP:0011108,Recurrent sinusitis
GO:0036159,inner dynein arm assembly,HP:0012265,Ciliary dyskinesia
GO:0036159,inner dynein arm assembly,HP:0012384,Rhinitis
GO:0036293,response to decreased oxygen levels,HP:0000006,Autosomal dominant inheritance
GO:0036293,response to decreased oxygen levels,HP:0005116,Arterial tortuosity
GO:0036297,interstrand cross-link repair,HP:0000104,Renal agenesis
GO:0036297,interstrand cross-link repair,HP:0000957,Cafe-au-lait spot
GO:0036297,interstrand cross-link repair,HP:0001017,Anemic pallor
GO:0036297,interstrand cross-link repair,HP:0001876,Pancytopenia
GO:0036297,interstrand cross-link repair,HP:0001903,Anemia
GO:0036297,interstrand cross-link repair,HP:0001909,Leukemia
GO:0036297,interstrand cross-link repair,HP:0003213,Deficient excision of UV-induced pyrimidine dimers in DNA
GO:0036297,interstrand cross-link repair,HP:0003214,Prolonged G2 phase of cell cycle
GO:0036297,interstrand cross-link repair,HP:0003220,Abnormality of chromosome stability
GO:0036297,interstrand cross-link repair,HP:0003221,Chromosomal breakage induced by crosslinking agents
GO:0036297,interstrand cross-link repair,HP:0003974,Absent radius
GO:0036297,interstrand cross-link repair,HP:0009777,Absent thumb
GO:0036297,interstrand cross-link repair,HP:0009943,Complete duplication of thumb phalanx
GO:0036303,lymph vessel morphogenesis,HP:0001004,Lymphedema
GO:0036342,post-anal tail morphogenesis,HP:0000668,Hypodontia
GO:0036473,cell death in response to oxidative stress,HP:0001894,Thrombocytosis
GO:0038128,ERBB2 signaling pathway,HP:0001528,Hemihypertrophy
GO:0040017,positive regulation of locomotion,HP:0000006,Autosomal dominant inheritance
GO:0040017,positive regulation of locomotion,HP:0001528,Hemihypertrophy
GO:0040017,positive regulation of locomotion,HP:0001894,Thrombocytosis
GO:0040017,positive regulation of locomotion,HP:0005116,Arterial tortuosity
GO:0040017,positive regulation of locomotion,HP:0012233,Intramuscular hematoma
GO:0042063,gliogenesis,HP:0000006,Autosomal dominant inheritance
GO:0042063,gliogenesis,HP:0001528,Hemihypertrophy
GO:0042073,intraciliary transport,HP:0000510,Rod-cone dystrophy
GO:0042073,intraciliary transport,HP:0000774,Narrow chest
GO:0042098,T cell proliferation,HP:0002721,Immunodeficiency
GO:0042110,T cell activation,HP:0001047,Atopic dermatitis
GO:0042110,T cell activation,HP:0001528,Hemihypertrophy
GO:0042110,T cell activation,HP:0002716,Lymphadenopathy
GO:0042110,T cell activation,HP:0002721,Immunodeficiency
GO:0042113,B cell activation,HP:0002014,Diarrhea
GO:0042113,B cell activation,HP:0002090,Pneumonia
GO:0042113,B cell activation,HP:0002716,Lymphadenopathy
GO:0042113,B cell activation,HP:0002718,Recurrent bacterial infections
GO:0042113,B cell activation,HP:0002720,IgA deficiency
GO:0042113,B cell activation,HP:0002721,Immunodeficiency
GO:0042113,B cell activation,HP:0002849,Absence of lymph node germinal center
GO:0042113,B cell activation,HP:0003095,Septic arthritis
GO:0042113,B cell activation,HP:0004313,Decreased antibody level in blood
GO:0042113,B cell activation,HP:0004432,Agammaglobulinemia
GO:0042157,lipoprotein metabolic process,HP:0012184,Hyperalphalipoproteinemia
GO:0042180,cellular ketone metabolic process,HP:0001528,Hemihypertrophy
GO:0042278,purine nucleoside metabolic process,HP:0000952,Jaundice
GO:0042278,purine nucleoside metabolic process,HP:0001082,Cholecystitis
GO:0042303,molting cycle,HP:0000006,Autosomal dominant inheritance
GO:0042303,molting cycle,HP:0000535,Sparse and thin eyebrow
GO:0042303,molting cycle,HP:0000668,Hypodontia
GO:0042303,molting cycle,HP:0001006,Hypotrichosis
GO:0042303,molting cycle,HP:0002561,Absent nipple
GO:0042306,regulation of protein import into nucleus,HP:0001894,Thrombocytosis
GO:0042307,positive regulation of protein import into nucleus,HP:0001894,Thrombocytosis
GO:0042310,vasoconstriction,HP:0005465,Facial hyperostosis
GO:0042340,keratan sulfate catabolic process,HP:0000007,Autosomal recessive inheritance
GO:0042340,keratan sulfate catabolic process,HP:0008166,Decreased beta-galactosidase activity
GO:0042384,,HP:0000007,Autosomal recessive inheritance
GO:0042384,,HP:0000090,Nephronophthisis
GO:0042384,,HP:0000107,Renal cyst
GO:0042384,,HP:0000246,Sinusitis
GO:0042384,,HP:0000403,Recurrent otitis media
GO:0042384,,HP:0000510,Rod-cone dystrophy
GO:0042384,,HP:0000657,Oculomotor apraxia
GO:0042384,,HP:0000774,Narrow chest
GO:0042384,,HP:0001162,Postaxial hand polydactyly
GO:0042384,,HP:0001408,Bile duct proliferation
GO:0042384,,HP:0001513,Obesity
GO:0042384,,HP:0001696,Situs inversus totalis
GO:0042384,,HP:0002084,Encephalocele
GO:0042384,,HP:0002110,Bronchiectasis
GO:0042384,,HP:0002419,Molar tooth sign on MRI
GO:0042384,,HP:0003241,External genital hypoplasia
GO:0042384,,HP:0003774,Stage 5 chronic kidney disease
GO:0042384,,HP:0010442,Polydactyly
GO:0042384,,HP:0011108,Recurrent sinusitis
GO:0042384,,HP:0011109,Chronic sinusitis
GO:0042384,,HP:0012263,Immotile cilia
GO:0042384,,HP:0012265,Ciliary dyskinesia
GO:0042384,,HP:0100259,Postaxial polydactyly
GO:0042384,,HP:0100582,Nasal polyposis
GO:0042384,,HP:0200073,Respiratory insufficiency due to defective ciliary clearance
GO:0042384,,HP:0012384,Rhinitis
GO:0042391,regulation of membrane potential,HP:0000006,Autosomal dominant inheritance
GO:0042391,regulation of membrane potential,HP:0001279,Syncope
GO:0042391,regulation of membrane potential,HP:0001300,Parkinsonism
GO:0042391,regulation of membrane potential,HP:0001425,Heterogeneous
GO:0042391,regulation of membrane potential,HP:0001645,Sudden cardiac death
GO:0042391,regulation of membrane potential,HP:0001657,Prolonged QT interval
GO:0042391,regulation of membrane potential,HP:0001663,Ventricular fibrillation
GO:0042391,regulation of membrane potential,HP:0001664,Torsade de pointes
GO:0042391,regulation of membrane potential,HP:0001962,Palpitations
GO:0042391,regulation of membrane potential,HP:0002015,Dysphagia
GO:0042391,regulation of membrane potential,HP:0002069,Generalized tonic-clonic seizures
GO:0042391,regulation of membrane potential,HP:0002301,Hemiplegia
GO:0042391,regulation of membrane potential,HP:0003391,Gowers sign
GO:0042391,regulation of membrane potential,HP:0004749,Atrial flutter
GO:0042391,regulation of membrane potential,HP:0005110,Atrial fibrillation
GO:0042391,regulation of membrane potential,HP:0012232,Shortened QT interval
GO:0042403,thyroid hormone metabolic process,HP:0000853,Goiter
GO:0042403,thyroid hormone metabolic process,HP:0008191,Thyroid agenesis
GO:0042416,dopamine biosynthetic process,HP:0001300,Parkinsonism
GO:0042417,dopamine metabolic process,HP:0001300,Parkinsonism
GO:0042423,catecholamine biosynthetic process,HP:0001300,Parkinsonism
GO:0042438,melanin biosynthetic process,HP:0001022,Albinism
GO:0042445,hormone metabolic process,HP:0000007,Autosomal recessive inheritance
GO:0042445,hormone metabolic process,HP:0000840,Adrenogenital syndrome
GO:0042445,hormone metabolic process,HP:0000853,Goiter
GO:0042445,hormone metabolic process,HP:0008191,Thyroid agenesis
GO:0042445,hormone metabolic process,HP:0008258,Congenital adrenal hyperplasia
GO:0042446,hormone biosynthetic process,HP:0000840,Adrenogenital syndrome
GO:0042446,hormone biosynthetic process,HP:0008258,Congenital adrenal hyperplasia
GO:0042461,photoreceptor cell development,HP:0000505,Visual impairment
GO:0042461,photoreceptor cell development,HP:0000510,Rod-cone dystrophy
GO:0042461,photoreceptor cell development,HP:0000662,Nyctalopia
GO:0042461,photoreceptor cell development,HP:0008499,High-grade hypermetropia
GO:0042462,eye photoreceptor cell development,HP:0000505,Visual impairment
GO:0042462,eye photoreceptor cell development,HP:0000510,Rod-cone dystrophy
GO:0042462,eye photoreceptor cell development,HP:0000662,Nyctalopia
GO:0042462,eye photoreceptor cell development,HP:0008499,High-grade hypermetropia
GO:0042471,ear morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0042471,ear morphogenesis,HP:0000175,Cleft palate
GO:0042471,ear morphogenesis,HP:0000405,Conductive hearing impairment
GO:0042471,ear morphogenesis,HP:0005217,Duplication of internal organs
GO:0042472,inner ear morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0042475,odontogenesis of dentin-containing tooth,HP:0000006,Autosomal dominant inheritance
GO:0042475,odontogenesis of dentin-containing tooth,HP:0000668,Hypodontia
GO:0042475,odontogenesis of dentin-containing tooth,HP:0000691,Microdontia
GO:0042475,odontogenesis of dentin-containing tooth,HP:0000705,Amelogenesis imperfecta
GO:0042475,odontogenesis of dentin-containing tooth,HP:0002561,Absent nipple
GO:0042476,odontogenesis,HP:0000006,Autosomal dominant inheritance
GO:0042476,odontogenesis,HP:0000668,Hypodontia
GO:0042476,odontogenesis,HP:0000705,Amelogenesis imperfecta
GO:0042476,odontogenesis,HP:0002561,Absent nipple
GO:0042493,response to drug,HP:0000006,Autosomal dominant inheritance
GO:0042493,response to drug,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0042493,response to drug,HP:0000952,Jaundice
GO:0042493,response to drug,HP:0001054,Numerous nevi
GO:0042503,,HP:0001894,Thrombocytosis
GO:0042503,,HP:0002677,Small foramen magnum
GO:0042506,,HP:0001894,Thrombocytosis
GO:0042509,regulation of tyrosine phosphorylation of STAT protein,HP:0001894,Thrombocytosis
GO:0042509,regulation of tyrosine phosphorylation of STAT protein,HP:0002677,Small foramen magnum
GO:0042516,,HP:0001894,Thrombocytosis
GO:0042516,,HP:0002677,Small foramen magnum
GO:0042517,,HP:0001894,Thrombocytosis
GO:0042517,,HP:0002677,Small foramen magnum
GO:0042522,,HP:0001894,Thrombocytosis
GO:0042523,,HP:0001894,Thrombocytosis
GO:0042552,myelination,HP:0001528,Hemihypertrophy
GO:0042552,myelination,HP:0008668,"Gonadal dysgenesis, male"
GO:0042554,superoxide anion generation,HP:0000976,Eczematoid dermatitis
GO:0042554,superoxide anion generation,HP:0001400,Hepatic abscesses due to immunodeficiency
GO:0042554,superoxide anion generation,HP:0002716,Lymphadenopathy
GO:0042554,superoxide anion generation,HP:0002723,Absence of bactericidal oxidative 'respiratory burst' in phagocytes
GO:0042554,superoxide anion generation,HP:0002724,Recurrent Aspergillus infections
GO:0042554,superoxide anion generation,HP:0002726,Recurrent Staphylococcus aureus infections
GO:0042554,superoxide anion generation,HP:0002740,Recurrent E. coli infections
GO:0042554,superoxide anion generation,HP:0002741,Recurrent Serratia marcescens infections
GO:0042554,superoxide anion generation,HP:0002742,Recurrent Klebsiella infections
GO:0042554,superoxide anion generation,HP:0002755,Osteomyelitis due to immunodeficiency
GO:0042554,superoxide anion generation,HP:0002840,Lymphadenitis
GO:0042554,superoxide anion generation,HP:0002842,Recurrent Burkholderia cepacia infections
GO:0042554,superoxide anion generation,HP:0002955,Granulomatosis
GO:0042554,superoxide anion generation,HP:0003203,Negative nitroblue tetrazolium reduction test
GO:0042554,superoxide anion generation,HP:0003206,Decreased activity of NADPH oxidase
GO:0042554,superoxide anion generation,HP:0003553,Cellulitis due to immunodeficiency
GO:0042554,superoxide anion generation,HP:0005224,Rectal abscess
GO:0042554,superoxide anion generation,HP:0005406,Recurrent bacterial skin infections
GO:0042554,superoxide anion generation,HP:0006532,Recurrent pneumonia
GO:0042554,superoxide anion generation,HP:0007417,Discoid lupus rash
GO:0042558,pteridine-containing compound metabolic process,HP:0004923,Hyperphenylalaninemia
GO:0042558,pteridine-containing compound metabolic process,HP:0008297,Transient hyperphenylalaninemia
GO:0042593,glucose homeostasis,HP:0000006,Autosomal dominant inheritance
GO:0042593,glucose homeostasis,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0042593,glucose homeostasis,HP:0001528,Hemihypertrophy
GO:0042593,glucose homeostasis,HP:0004904,Maturity-onset diabetes of the young
GO:0042593,glucose homeostasis,HP:0005959,Impaired gluconeogenesis
GO:0042632,cholesterol homeostasis,HP:0003124,Hypercholesterolemia
GO:0042632,cholesterol homeostasis,HP:0012184,Hyperalphalipoproteinemia
GO:0042633,hair cycle,HP:0000006,Autosomal dominant inheritance
GO:0042633,hair cycle,HP:0000535,Sparse and thin eyebrow
GO:0042633,hair cycle,HP:0000668,Hypodontia
GO:0042633,hair cycle,HP:0001006,Hypotrichosis
GO:0042633,hair cycle,HP:0002561,Absent nipple
GO:0042692,muscle cell differentiation,HP:0000006,Autosomal dominant inheritance
GO:0042692,muscle cell differentiation,HP:0000149,Ovarian gonadoblastoma
GO:0042692,muscle cell differentiation,HP:0000408,Progressive sensorineural hearing impairment
GO:0042692,muscle cell differentiation,HP:0001644,Dilated cardiomyopathy
GO:0042692,muscle cell differentiation,HP:0001684,Secundum atrial septal defect
GO:0042692,muscle cell differentiation,HP:0002197,Generalized seizures
GO:0042692,muscle cell differentiation,HP:0003391,Gowers sign
GO:0042692,muscle cell differentiation,HP:0003560,Muscular dystrophy
GO:0042692,muscle cell differentiation,HP:0004635,Cervical C5/C6 vertebrae fusion
GO:0042692,muscle cell differentiation,HP:0004814,Fava bean-induced hemolytic anemia
GO:0042693,muscle cell fate commitment,HP:0000149,Ovarian gonadoblastoma
GO:0042698,ovulation cycle,HP:0001470,Sex-limited autosomal dominant
GO:0042730,fibrinolysis,HP:0100724,Hypercoagulability
GO:0042733,embryonic digit morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0042733,embryonic digit morphogenesis,HP:0000243,Trigonocephaly
GO:0042886,amide transport,HP:0000006,Autosomal dominant inheritance
GO:0042886,amide transport,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0042886,amide transport,HP:0001894,Thrombocytosis
GO:0043010,camera-type eye development,HP:0000006,Autosomal dominant inheritance
GO:0043010,camera-type eye development,HP:0000149,Ovarian gonadoblastoma
GO:0043010,camera-type eye development,HP:0000501,Glaucoma
GO:0043010,camera-type eye development,HP:0000510,Rod-cone dystrophy
GO:0043010,camera-type eye development,HP:0000568,Microphthalmia
GO:0043010,camera-type eye development,HP:0001083,Ectopia lentis
GO:0043010,camera-type eye development,HP:0005116,Arterial tortuosity
GO:0043010,camera-type eye development,HP:0007780,Cortical pulverulent cataract
GO:0043010,camera-type eye development,HP:0007971,Lamellar cataract
GO:0043010,camera-type eye development,HP:0008031,Posterior Y-sutural cataract
GO:0043010,camera-type eye development,HP:0010695,Sutural cataract
GO:0043010,camera-type eye development,HP:0012038,Corneal guttata
GO:0043039,tRNA aminoacylation,HP:0002151,Increased serum lactate
GO:0043062,extracellular structure organization,HP:0000006,Autosomal dominant inheritance
GO:0043062,extracellular structure organization,HP:0000149,Ovarian gonadoblastoma
GO:0043062,extracellular structure organization,HP:0000501,Glaucoma
GO:0043062,extracellular structure organization,HP:0000703,Dentinogenesis imperfecta
GO:0043062,extracellular structure organization,HP:0000926,Platyspondyly
GO:0043062,extracellular structure organization,HP:0001083,Ectopia lentis
GO:0043062,extracellular structure organization,HP:0001634,Mitral valve prolapse
GO:0043062,extracellular structure organization,HP:0005116,Arterial tortuosity
GO:0043062,extracellular structure organization,HP:0005731,Cortical irregularity
GO:0043062,extracellular structure organization,HP:0030041,Schmorl's node
GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,HP:0002721,Immunodeficiency
GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,HP:0002721,Immunodeficiency
GO:0043217,myelin maintenance,HP:0001528,Hemihypertrophy
GO:0043266,regulation of potassium ion transport,HP:0000006,Autosomal dominant inheritance
GO:0043266,regulation of potassium ion transport,HP:0001279,Syncope
GO:0043266,regulation of potassium ion transport,HP:0001657,Prolonged QT interval
GO:0043267,negative regulation of potassium ion transport,HP:0001279,Syncope
GO:0043268,positive regulation of potassium ion transport,HP:0001279,Syncope
GO:0043268,positive regulation of potassium ion transport,HP:0001657,Prolonged QT interval
GO:0043270,positive regulation of ion transport,HP:0000006,Autosomal dominant inheritance
GO:0043270,positive regulation of ion transport,HP:0001279,Syncope
GO:0043270,positive regulation of ion transport,HP:0001645,Sudden cardiac death
GO:0043270,positive regulation of ion transport,HP:0001657,Prolonged QT interval
GO:0043270,positive regulation of ion transport,HP:0001663,Ventricular fibrillation
GO:0043270,positive regulation of ion transport,HP:0004749,Atrial flutter
GO:0043270,positive regulation of ion transport,HP:0004814,Fava bean-induced hemolytic anemia
GO:0043271,negative regulation of ion transport,HP:0001279,Syncope
GO:0043271,negative regulation of ion transport,HP:0001528,Hemihypertrophy
GO:0043271,negative regulation of ion transport,HP:0001657,Prolonged QT interval
GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,HP:0000668,Hypodontia
GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,HP:0001894,Thrombocytosis
GO:0043388,positive regulation of DNA binding,HP:0001894,Thrombocytosis
GO:0043405,regulation of MAP kinase activity,HP:0001894,Thrombocytosis
GO:0043405,regulation of MAP kinase activity,HP:0002849,Absence of lymph node germinal center
GO:0043406,positive regulation of MAP kinase activity,HP:0002849,Absence of lymph node germinal center
GO:0043410,positive regulation of MAPK cascade,HP:0000006,Autosomal dominant inheritance
GO:0043410,positive regulation of MAPK cascade,HP:0001054,Numerous nevi
GO:0043410,positive regulation of MAPK cascade,HP:0001894,Thrombocytosis
GO:0043410,positive regulation of MAPK cascade,HP:0002676,Cloverleaf skull
GO:0043410,positive regulation of MAPK cascade,HP:0002677,Small foramen magnum
GO:0043410,positive regulation of MAPK cascade,HP:0002849,Absence of lymph node germinal center
GO:0043410,positive regulation of MAPK cascade,HP:0003319,Abnormality of the cervical spine
GO:0043413,macromolecule glycosylation,HP:0000007,Autosomal recessive inheritance
GO:0043413,macromolecule glycosylation,HP:0000158,Macroglossia
GO:0043413,macromolecule glycosylation,HP:0001083,Ectopia lentis
GO:0043413,macromolecule glycosylation,HP:0001321,Cerebellar hypoplasia
GO:0043413,macromolecule glycosylation,HP:0002350,Cerebellar cyst
GO:0043413,macromolecule glycosylation,HP:0003236,Elevated serum creatine phosphokinase
GO:0043413,macromolecule glycosylation,HP:0003391,Gowers sign
GO:0043413,macromolecule glycosylation,HP:0003560,Muscular dystrophy
GO:0043413,macromolecule glycosylation,HP:0003642,Type I transferrin isoform profile
GO:0043413,macromolecule glycosylation,HP:0003741,Congenital muscular dystrophy
GO:0043413,macromolecule glycosylation,HP:0006765,Chondrosarcoma
GO:0043413,macromolecule glycosylation,HP:0007033,Cerebellar dysplasia
GO:0043413,macromolecule glycosylation,HP:0007260,Type II lissencephaly
GO:0043413,macromolecule glycosylation,HP:0007973,Retinal dysplasia
GO:0043413,macromolecule glycosylation,HP:0010970,Blood group antigen abnormality
GO:0043434,response to peptide hormone,HP:0000006,Autosomal dominant inheritance
GO:0043434,response to peptide hormone,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0043434,response to peptide hormone,HP:0001083,Ectopia lentis
GO:0043434,response to peptide hormone,HP:0001528,Hemihypertrophy
GO:0043434,response to peptide hormone,HP:0001894,Thrombocytosis
GO:0043434,response to peptide hormone,HP:0005465,Facial hyperostosis
GO:0043434,response to peptide hormone,HP:0008258,Congenital adrenal hyperplasia
GO:0043467,regulation of generation of precursor metabolites and energy,HP:0000012,Urinary urgency
GO:0043467,regulation of generation of precursor metabolites and energy,HP:0001528,Hemihypertrophy
GO:0043473,pigmentation,HP:0000635,Blue irides
GO:0043473,pigmentation,HP:0001008,Accumulation of melanosomes in melanocytes
GO:0043473,pigmentation,HP:0001022,Albinism
GO:0043473,pigmentation,HP:0001053,Hypopigmented skin patches
GO:0043473,pigmentation,HP:0001100,Heterochromia iridis
GO:0043473,pigmentation,HP:0001107,Ocular albinism
GO:0043473,pigmentation,HP:0002211,White forelock
GO:0043473,pigmentation,HP:0002226,White eyebrow
GO:0043473,pigmentation,HP:0002227,White eyelashes
GO:0043473,pigmentation,HP:0002561,Absent nipple
GO:0043473,pigmentation,HP:0007894,Hypopigmentation of the fundus
GO:0043491,protein kinase B signaling,HP:0001528,Hemihypertrophy
GO:0043491,protein kinase B signaling,HP:0012233,Intramuscular hematoma
GO:0043500,muscle adaptation,HP:0004814,Fava bean-induced hemolytic anemia
GO:0043523,regulation of neuron apoptotic process,HP:0000012,Urinary urgency
GO:0043523,regulation of neuron apoptotic process,HP:0001894,Thrombocytosis
GO:0043523,regulation of neuron apoptotic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0043524,negative regulation of neuron apoptotic process,HP:0000012,Urinary urgency
GO:0043524,negative regulation of neuron apoptotic process,HP:0001894,Thrombocytosis
GO:0043542,endothelial cell migration,HP:0000006,Autosomal dominant inheritance
GO:0043542,endothelial cell migration,HP:0000034,Hydrocele testis
GO:0043542,endothelial cell migration,HP:0001528,Hemihypertrophy
GO:0043574,peroxisomal transport,HP:0001250,Seizures
GO:0043574,peroxisomal transport,HP:0003455,Elevated long chain fatty acids
GO:0043574,peroxisomal transport,HP:0008935,Generalized neonatal hypotonia
GO:0043574,peroxisomal transport,HP:0010655,Epiphyseal stippling
GO:0043583,ear development,HP:0000006,Autosomal dominant inheritance
GO:0043583,ear development,HP:0000243,Trigonocephaly
GO:0043583,ear development,HP:0000407,Sensorineural hearing impairment
GO:0043583,ear development,HP:0005217,Duplication of internal organs
GO:0043588,skin development,HP:0000006,Autosomal dominant inheritance
GO:0043588,skin development,HP:0000535,Sparse and thin eyebrow
GO:0043588,skin development,HP:0000668,Hypodontia
GO:0043588,skin development,HP:0001006,Hypotrichosis
GO:0043588,skin development,HP:0002561,Absent nipple
GO:0043627,response to estrogen,HP:0008668,"Gonadal dysgenesis, male"
GO:0043648,dicarboxylic acid metabolic process,HP:0000007,Autosomal recessive inheritance
GO:0043648,dicarboxylic acid metabolic process,HP:0001263,Global developmental delay
GO:0043648,dicarboxylic acid metabolic process,HP:0005959,Impaired gluconeogenesis
GO:0044042,glucan metabolic process,HP:0001528,Hemihypertrophy
GO:0044042,glucan metabolic process,HP:0006568,Increased hepatic glycogen content
GO:0044057,regulation of system process,HP:0000006,Autosomal dominant inheritance
GO:0044057,regulation of system process,HP:0001279,Syncope
GO:0044057,regulation of system process,HP:0001644,Dilated cardiomyopathy
GO:0044057,regulation of system process,HP:0001645,Sudden cardiac death
GO:0044057,regulation of system process,HP:0001657,Prolonged QT interval
GO:0044057,regulation of system process,HP:0001663,Ventricular fibrillation
GO:0044057,regulation of system process,HP:0001894,Thrombocytosis
GO:0044057,regulation of system process,HP:0004749,Atrial flutter
GO:0044057,regulation of system process,HP:0004756,Ventricular tachycardia
GO:0044057,regulation of system process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0044057,regulation of system process,HP:0005110,Atrial fibrillation
GO:0044057,regulation of system process,HP:0005465,Facial hyperostosis
GO:0044057,regulation of system process,HP:0010445,Primum atrial septal defect
GO:0044057,regulation of system process,HP:0012232,Shortened QT interval
GO:0044070,regulation of anion transport,HP:0001528,Hemihypertrophy
GO:0044070,regulation of anion transport,HP:0002150,Hypercalciuria
GO:0044089,positive regulation of cellular component biogenesis,HP:0006744,Adrenocortical carcinoma
GO:0044236,multicellular organism metabolic process,HP:0000006,Autosomal dominant inheritance
GO:0044236,multicellular organism metabolic process,HP:0000926,Platyspondyly
GO:0044242,cellular lipid catabolic process,HP:0001528,Hemihypertrophy
GO:0044242,cellular lipid catabolic process,HP:0002240,Hepatomegaly
GO:0044242,cellular lipid catabolic process,HP:0009058,Increased muscle lipid content
GO:0044243,multicellular organismal catabolic process,HP:0000926,Platyspondyly
GO:0044247,cellular polysaccharide catabolic process,HP:0006568,Increased hepatic glycogen content
GO:0044259,multicellular organismal macromolecule metabolic process,HP:0000006,Autosomal dominant inheritance
GO:0044259,multicellular organismal macromolecule metabolic process,HP:0000926,Platyspondyly
GO:0044262,cellular carbohydrate metabolic process,HP:0001528,Hemihypertrophy
GO:0044262,cellular carbohydrate metabolic process,HP:0006568,Increased hepatic glycogen content
GO:0044262,cellular carbohydrate metabolic process,HP:0006765,Chondrosarcoma
GO:0044264,cellular polysaccharide metabolic process,HP:0001528,Hemihypertrophy
GO:0044264,cellular polysaccharide metabolic process,HP:0006568,Increased hepatic glycogen content
GO:0044264,cellular polysaccharide metabolic process,HP:0006765,Chondrosarcoma
GO:0044272,sulfur compound biosynthetic process,HP:0006765,Chondrosarcoma
GO:0044273,sulfur compound catabolic process,HP:0000280,Coarse facial features
GO:0044273,sulfur compound catabolic process,HP:0000943,Dysostosis multiplex
GO:0044275,cellular carbohydrate catabolic process,HP:0006568,Increased hepatic glycogen content
GO:0044282,small molecule catabolic process,HP:0000007,Autosomal recessive inheritance
GO:0044282,small molecule catabolic process,HP:0000952,Jaundice
GO:0044282,small molecule catabolic process,HP:0001254,Lethargy
GO:0044282,small molecule catabolic process,HP:0001259,Coma
GO:0044282,small molecule catabolic process,HP:0001528,Hemihypertrophy
GO:0044282,small molecule catabolic process,HP:0001942,Metabolic acidosis
GO:0044282,small molecule catabolic process,HP:0002013,Vomiting
GO:0044282,small molecule catabolic process,HP:0003231,Hypertyrosinemia
GO:0044282,small molecule catabolic process,HP:0003607,4-Hydroxyphenylacetic aciduria
GO:0044282,small molecule catabolic process,HP:0004911,Episodic metabolic acidosis
GO:0044282,small molecule catabolic process,HP:0012024,Hypergalactosemia
GO:0044283,small molecule biosynthetic process,HP:0000007,Autosomal recessive inheritance
GO:0044283,small molecule biosynthetic process,HP:0000952,Jaundice
GO:0044283,small molecule biosynthetic process,HP:0001508,Failure to thrive
GO:0044283,small molecule biosynthetic process,HP:0001951,Episodic ammonia intoxication
GO:0044283,small molecule biosynthetic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0044283,small molecule biosynthetic process,HP:0005959,Impaired gluconeogenesis
GO:0044283,small molecule biosynthetic process,HP:0008258,Congenital adrenal hyperplasia
GO:0044283,small molecule biosynthetic process,HP:0200044,Porokeratosis
GO:0044344,cellular response to fibroblast growth factor stimulus,HP:0000006,Autosomal dominant inheritance
GO:0044344,cellular response to fibroblast growth factor stimulus,HP:0002676,Cloverleaf skull
GO:0044344,cellular response to fibroblast growth factor stimulus,HP:0002677,Small foramen magnum
GO:0044344,cellular response to fibroblast growth factor stimulus,HP:0003319,Abnormality of the cervical spine
GO:0044458,motile cilium assembly,HP:0000789,Infertility
GO:0044458,motile cilium assembly,HP:0002110,Bronchiectasis
GO:0044458,motile cilium assembly,HP:0012265,Ciliary dyskinesia
GO:0044708,single-organism behavior,HP:0000408,Progressive sensorineural hearing impairment
GO:0044708,single-organism behavior,HP:0000726,Dementia
GO:0044708,single-organism behavior,HP:0001054,Numerous nevi
GO:0044708,single-organism behavior,HP:0001260,Dysarthria
GO:0044708,single-organism behavior,HP:0001300,Parkinsonism
GO:0044708,single-organism behavior,HP:0002080,Intention tremor
GO:0044708,single-organism behavior,HP:0002301,Hemiplegia
GO:0044723,single-organism carbohydrate metabolic process,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0044723,single-organism carbohydrate metabolic process,HP:0000952,Jaundice
GO:0044723,single-organism carbohydrate metabolic process,HP:0001082,Cholecystitis
GO:0044723,single-organism carbohydrate metabolic process,HP:0001528,Hemihypertrophy
GO:0044723,single-organism carbohydrate metabolic process,HP:0001943,Hypoglycemia
GO:0044723,single-organism carbohydrate metabolic process,HP:0002240,Hepatomegaly
GO:0044723,single-organism carbohydrate metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0044723,single-organism carbohydrate metabolic process,HP:0005959,Impaired gluconeogenesis
GO:0044723,single-organism carbohydrate metabolic process,HP:0006568,Increased hepatic glycogen content
GO:0044723,single-organism carbohydrate metabolic process,HP:0006765,Chondrosarcoma
GO:0044723,single-organism carbohydrate metabolic process,HP:0009051,Increased muscle glycogen content
GO:0044723,single-organism carbohydrate metabolic process,HP:0012024,Hypergalactosemia
GO:0044724,single-organism carbohydrate catabolic process,HP:0000952,Jaundice
GO:0044724,single-organism carbohydrate catabolic process,HP:0001082,Cholecystitis
GO:0044724,single-organism carbohydrate catabolic process,HP:0006568,Increased hepatic glycogen content
GO:0044724,single-organism carbohydrate catabolic process,HP:0009051,Increased muscle glycogen content
GO:0044724,single-organism carbohydrate catabolic process,HP:0012024,Hypergalactosemia
GO:0044743,protein transmembrane import into intracellular organelle,HP:0008935,Generalized neonatal hypotonia
GO:0044743,protein transmembrane import into intracellular organelle,HP:0010655,Epiphyseal stippling
GO:0044744,protein targeting to nucleus,HP:0000006,Autosomal dominant inheritance
GO:0044744,protein targeting to nucleus,HP:0001894,Thrombocytosis
GO:0044744,protein targeting to nucleus,HP:0004749,Atrial flutter
GO:0044744,protein targeting to nucleus,HP:0005116,Arterial tortuosity
GO:0044770,cell cycle phase transition,HP:0000252,Microcephaly
GO:0044770,cell cycle phase transition,HP:0006498,Aplasia/Hypoplasia of the patella
GO:0044770,cell cycle phase transition,HP:0006744,Adrenocortical carcinoma
GO:0044772,mitotic cell cycle phase transition,HP:0000252,Microcephaly
GO:0044772,mitotic cell cycle phase transition,HP:0006498,Aplasia/Hypoplasia of the patella
GO:0044772,mitotic cell cycle phase transition,HP:0006744,Adrenocortical carcinoma
GO:0044782,cilium organization,HP:0000007,Autosomal recessive inheritance
GO:0044782,cilium organization,HP:0000090,Nephronophthisis
GO:0044782,cilium organization,HP:0000107,Renal cyst
GO:0044782,cilium organization,HP:0000246,Sinusitis
GO:0044782,cilium organization,HP:0000403,Recurrent otitis media
GO:0044782,cilium organization,HP:0000510,Rod-cone dystrophy
GO:0044782,cilium organization,HP:0000774,Narrow chest
GO:0044782,cilium organization,HP:0001162,Postaxial hand polydactyly
GO:0044782,cilium organization,HP:0001273,Abnormality of the corpus callosum
GO:0044782,cilium organization,HP:0001408,Bile duct proliferation
GO:0044782,cilium organization,HP:0001513,Obesity
GO:0044782,cilium organization,HP:0001696,Situs inversus totalis
GO:0044782,cilium organization,HP:0002110,Bronchiectasis
GO:0044782,cilium organization,HP:0002419,Molar tooth sign on MRI
GO:0044782,cilium organization,HP:0003241,External genital hypoplasia
GO:0044782,cilium organization,HP:0003774,Stage 5 chronic kidney disease
GO:0044782,cilium organization,HP:0010442,Polydactyly
GO:0044782,cilium organization,HP:0011108,Recurrent sinusitis
GO:0044782,cilium organization,HP:0011109,Chronic sinusitis
GO:0044782,cilium organization,HP:0012263,Immotile cilia
GO:0044782,cilium organization,HP:0012265,Ciliary dyskinesia
GO:0044782,cilium organization,HP:0100259,Postaxial polydactyly
GO:0044782,cilium organization,HP:0200073,Respiratory insufficiency due to defective ciliary clearance
GO:0044782,cilium organization,HP:0012384,Rhinitis
GO:0044839,cell cycle G2/M phase transition,HP:0000252,Microcephaly
GO:0045005,DNA-dependent DNA replication maintenance of fidelity,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0045017,glycerolipid biosynthetic process,HP:0002676,Cloverleaf skull
GO:0045017,glycerolipid biosynthetic process,HP:0002677,Small foramen magnum
GO:0045017,glycerolipid biosynthetic process,HP:0003319,Abnormality of the cervical spine
GO:0045055,regulated exocytosis,HP:0003095,Septic arthritis
GO:0045103,intermediate filament-based process,HP:0000006,Autosomal dominant inheritance
GO:0045104,intermediate filament cytoskeleton organization,HP:0000006,Autosomal dominant inheritance
GO:0045104,intermediate filament cytoskeleton organization,HP:0000982,Palmoplantar keratoderma
GO:0045104,intermediate filament cytoskeleton organization,HP:0002224,Woolly hair
GO:0045109,intermediate filament organization,HP:0000006,Autosomal dominant inheritance
GO:0045137,development of primary sexual characteristics,HP:0000133,Gonadal dysgenesis
GO:0045137,development of primary sexual characteristics,HP:0000149,Ovarian gonadoblastoma
GO:0045137,development of primary sexual characteristics,HP:0000150,Gonadoblastoma
GO:0045137,development of primary sexual characteristics,HP:0000786,Primary amenorrhea
GO:0045137,development of primary sexual characteristics,HP:0001470,Sex-limited autosomal dominant
GO:0045137,development of primary sexual characteristics,HP:0008668,"Gonadal dysgenesis, male"
GO:0045137,development of primary sexual characteristics,HP:0011682,Perimembranous ventricular septal defect
GO:0045137,development of primary sexual characteristics,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0045137,development of primary sexual characteristics,HP:0012245,Sex reversal
GO:0045165,cell fate commitment,HP:0000006,Autosomal dominant inheritance
GO:0045165,cell fate commitment,HP:0000149,Ovarian gonadoblastoma
GO:0045165,cell fate commitment,HP:0000243,Trigonocephaly
GO:0045165,cell fate commitment,HP:0004635,Cervical C5/C6 vertebrae fusion
GO:0045190,isotype switching,HP:0002849,Absence of lymph node germinal center
GO:0045190,isotype switching,HP:0002959,Impaired Ig class switch recombination
GO:0045190,isotype switching,HP:0004315,IgG deficiency
GO:0045216,cell-cell junction organization,HP:0000006,Autosomal dominant inheritance
GO:0045216,cell-cell junction organization,HP:0005116,Arterial tortuosity
GO:0045216,cell-cell junction organization,HP:0100792,Acantholysis
GO:0045333,cellular respiration,HP:0000131,Uterine leiomyoma
GO:0045444,fat cell differentiation,HP:0001528,Hemihypertrophy
GO:0045444,fat cell differentiation,HP:0003292,Decreased serum leptin
GO:0045446,endothelial cell differentiation,HP:0002408,Cerebral arteriovenous malformation
GO:0045471,response to ethanol,HP:0004814,Fava bean-induced hemolytic anemia
GO:0045494,photoreceptor cell maintenance,HP:0000510,Rod-cone dystrophy
GO:0045494,photoreceptor cell maintenance,HP:0000662,Nyctalopia
GO:0045667,regulation of osteoblast differentiation,HP:0000006,Autosomal dominant inheritance
GO:0045668,negative regulation of osteoblast differentiation,HP:0000006,Autosomal dominant inheritance
GO:0045669,positive regulation of osteoblast differentiation,HP:0000006,Autosomal dominant inheritance
GO:0045683,negative regulation of epidermis development,HP:0000668,Hypodontia
GO:0045740,positive regulation of DNA replication,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0045765,regulation of angiogenesis,HP:0000006,Autosomal dominant inheritance
GO:0045765,regulation of angiogenesis,HP:0002408,Cerebral arteriovenous malformation
GO:0045778,positive regulation of ossification,HP:0000006,Autosomal dominant inheritance
GO:0045778,positive regulation of ossification,HP:0005116,Arterial tortuosity
GO:0045778,positive regulation of ossification,HP:0005217,Duplication of internal organs
GO:0045785,positive regulation of cell adhesion,HP:0001528,Hemihypertrophy
GO:0045785,positive regulation of cell adhesion,HP:0001894,Thrombocytosis
GO:0045785,positive regulation of cell adhesion,HP:0002716,Lymphadenopathy
GO:0045785,positive regulation of cell adhesion,HP:0002721,Immunodeficiency
GO:0045785,positive regulation of cell adhesion,HP:0005116,Arterial tortuosity
GO:0045787,positive regulation of cell cycle,HP:0011682,Perimembranous ventricular septal defect
GO:0045787,positive regulation of cell cycle,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0045834,positive regulation of lipid metabolic process,HP:0001528,Hemihypertrophy
GO:0045834,positive regulation of lipid metabolic process,HP:0002677,Small foramen magnum
GO:0045843,negative regulation of striated muscle tissue development,HP:0004814,Fava bean-induced hemolytic anemia
GO:0045860,positive regulation of protein kinase activity,HP:0000006,Autosomal dominant inheritance
GO:0045860,positive regulation of protein kinase activity,HP:0001528,Hemihypertrophy
GO:0045860,positive regulation of protein kinase activity,HP:0001894,Thrombocytosis
GO:0045860,positive regulation of protein kinase activity,HP:0002849,Absence of lymph node germinal center
GO:0045860,positive regulation of protein kinase activity,HP:0003764,Nevus
GO:0045861,negative regulation of proteolysis,HP:0011999,Paranoia
GO:0045926,negative regulation of growth,HP:0000006,Autosomal dominant inheritance
GO:0045926,negative regulation of growth,HP:0000149,Ovarian gonadoblastoma
GO:0045926,negative regulation of growth,HP:0002677,Small foramen magnum
GO:0045926,negative regulation of growth,HP:0004814,Fava bean-induced hemolytic anemia
GO:0045926,negative regulation of growth,HP:0005116,Arterial tortuosity
GO:0045927,positive regulation of growth,HP:0000148,Vaginal atresia
GO:0045927,positive regulation of growth,HP:0000149,Ovarian gonadoblastoma
GO:0045995,regulation of embryonic development,HP:0000074,Ureteropelvic junction obstruction
GO:0045995,regulation of embryonic development,HP:0001674,Complete atrioventricular canal defect
GO:0046031,ADP metabolic process,HP:0000952,Jaundice
GO:0046031,ADP metabolic process,HP:0001081,Cholelithiasis
GO:0046031,ADP metabolic process,HP:0001082,Cholecystitis
GO:0046031,ADP metabolic process,HP:0001897,Normocytic anemia
GO:0046031,ADP metabolic process,HP:0001930,Nonspherocytic hemolytic anemia
GO:0046034,ATP metabolic process,HP:0000952,Jaundice
GO:0046034,ATP metabolic process,HP:0001082,Cholecystitis
GO:0046128,purine ribonucleoside metabolic process,HP:0000952,Jaundice
GO:0046128,purine ribonucleoside metabolic process,HP:0001082,Cholecystitis
GO:0046165,alcohol biosynthetic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0046165,alcohol biosynthetic process,HP:0200044,Porokeratosis
GO:0046209,nitric oxide metabolic process,HP:0001894,Thrombocytosis
GO:0046364,monosaccharide biosynthetic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0046364,monosaccharide biosynthetic process,HP:0005959,Impaired gluconeogenesis
GO:0046390,ribose phosphate biosynthetic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0046394,carboxylic acid biosynthetic process,HP:0000007,Autosomal recessive inheritance
GO:0046394,carboxylic acid biosynthetic process,HP:0001951,Episodic ammonia intoxication
GO:0046395,carboxylic acid catabolic process,HP:0000007,Autosomal recessive inheritance
GO:0046395,carboxylic acid catabolic process,HP:0001250,Seizures
GO:0046395,carboxylic acid catabolic process,HP:0001254,Lethargy
GO:0046395,carboxylic acid catabolic process,HP:0001528,Hemihypertrophy
GO:0046395,carboxylic acid catabolic process,HP:0001942,Metabolic acidosis
GO:0046395,carboxylic acid catabolic process,HP:0001987,Hyperammonemia
GO:0046395,carboxylic acid catabolic process,HP:0003231,Hypertyrosinemia
GO:0046395,carboxylic acid catabolic process,HP:0003607,4-Hydroxyphenylacetic aciduria
GO:0046395,carboxylic acid catabolic process,HP:0004911,Episodic metabolic acidosis
GO:0046474,glycerophospholipid biosynthetic process,HP:0002676,Cloverleaf skull
GO:0046474,glycerophospholipid biosynthetic process,HP:0002677,Small foramen magnum
GO:0046474,glycerophospholipid biosynthetic process,HP:0003319,Abnormality of the cervical spine
GO:0046486,glycerolipid metabolic process,HP:0002676,Cloverleaf skull
GO:0046486,glycerolipid metabolic process,HP:0002677,Small foramen magnum
GO:0046486,glycerolipid metabolic process,HP:0003319,Abnormality of the cervical spine
GO:0046486,glycerolipid metabolic process,HP:0003391,Gowers sign
GO:0046486,glycerolipid metabolic process,HP:0012184,Hyperalphalipoproteinemia
GO:0046488,phosphatidylinositol metabolic process,HP:0002676,Cloverleaf skull
GO:0046488,phosphatidylinositol metabolic process,HP:0002677,Small foramen magnum
GO:0046488,phosphatidylinositol metabolic process,HP:0003319,Abnormality of the cervical spine
GO:0046496,nicotinamide nucleotide metabolic process,HP:0000952,Jaundice
GO:0046496,nicotinamide nucleotide metabolic process,HP:0001082,Cholecystitis
GO:0046496,nicotinamide nucleotide metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0046530,photoreceptor cell differentiation,HP:0000505,Visual impairment
GO:0046530,photoreceptor cell differentiation,HP:0000510,Rod-cone dystrophy
GO:0046530,photoreceptor cell differentiation,HP:0000662,Nyctalopia
GO:0046530,photoreceptor cell differentiation,HP:0008499,High-grade hypermetropia
GO:0046545,development of primary female sexual characteristics,HP:0000149,Ovarian gonadoblastoma
GO:0046546,development of primary male sexual characteristics,HP:0000133,Gonadal dysgenesis
GO:0046546,development of primary male sexual characteristics,HP:0000149,Ovarian gonadoblastoma
GO:0046546,development of primary male sexual characteristics,HP:0000150,Gonadoblastoma
GO:0046546,development of primary male sexual characteristics,HP:0001470,Sex-limited autosomal dominant
GO:0046546,development of primary male sexual characteristics,HP:0008668,"Gonadal dysgenesis, male"
GO:0046546,development of primary male sexual characteristics,HP:0011682,Perimembranous ventricular septal defect
GO:0046546,development of primary male sexual characteristics,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0046546,development of primary male sexual characteristics,HP:0012245,Sex reversal
GO:0046620,regulation of organ growth,HP:0000006,Autosomal dominant inheritance
GO:0046620,regulation of organ growth,HP:0000149,Ovarian gonadoblastoma
GO:0046620,regulation of organ growth,HP:0001684,Secundum atrial septal defect
GO:0046620,regulation of organ growth,HP:0004814,Fava bean-induced hemolytic anemia
GO:0046621,negative regulation of organ growth,HP:0004814,Fava bean-induced hemolytic anemia
GO:0046622,positive regulation of organ growth,HP:0000149,Ovarian gonadoblastoma
GO:0046651,lymphocyte proliferation,HP:0002716,Lymphadenopathy
GO:0046651,lymphocyte proliferation,HP:0002718,Recurrent bacterial infections
GO:0046651,lymphocyte proliferation,HP:0002721,Immunodeficiency
GO:0046651,lymphocyte proliferation,HP:0002849,Absence of lymph node germinal center
GO:0046660,female sex differentiation,HP:0000149,Ovarian gonadoblastoma
GO:0046660,female sex differentiation,HP:0000668,Hypodontia
GO:0046661,male sex differentiation,HP:0000133,Gonadal dysgenesis
GO:0046661,male sex differentiation,HP:0000149,Ovarian gonadoblastoma
GO:0046661,male sex differentiation,HP:0000150,Gonadoblastoma
GO:0046661,male sex differentiation,HP:0001470,Sex-limited autosomal dominant
GO:0046661,male sex differentiation,HP:0008668,"Gonadal dysgenesis, male"
GO:0046661,male sex differentiation,HP:0011682,Perimembranous ventricular septal defect
GO:0046661,male sex differentiation,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0046661,male sex differentiation,HP:0012245,Sex reversal
GO:0046683,response to organophosphorus,HP:0000149,Ovarian gonadoblastoma
GO:0046683,response to organophosphorus,HP:0001054,Numerous nevi
GO:0046716,muscle cell cellular homeostasis,HP:0003236,Elevated serum creatine phosphokinase
GO:0046716,muscle cell cellular homeostasis,HP:0003391,Gowers sign
GO:0046777,protein autophosphorylation,HP:0001894,Thrombocytosis
GO:0046777,protein autophosphorylation,HP:0002676,Cloverleaf skull
GO:0046777,protein autophosphorylation,HP:0002677,Small foramen magnum
GO:0046777,protein autophosphorylation,HP:0003095,Septic arthritis
GO:0046777,protein autophosphorylation,HP:0003319,Abnormality of the cervical spine
GO:0046822,regulation of nucleocytoplasmic transport,HP:0001894,Thrombocytosis
GO:0046824,positive regulation of nucleocytoplasmic transport,HP:0001894,Thrombocytosis
GO:0046834,lipid phosphorylation,HP:0002676,Cloverleaf skull
GO:0046834,lipid phosphorylation,HP:0002677,Small foramen magnum
GO:0046834,lipid phosphorylation,HP:0003319,Abnormality of the cervical spine
GO:0046854,phosphatidylinositol phosphorylation,HP:0000006,Autosomal dominant inheritance
GO:0046854,phosphatidylinositol phosphorylation,HP:0002676,Cloverleaf skull
GO:0046854,phosphatidylinositol phosphorylation,HP:0002677,Small foramen magnum
GO:0046854,phosphatidylinositol phosphorylation,HP:0003319,Abnormality of the cervical spine
GO:0046879,hormone secretion,HP:0000006,Autosomal dominant inheritance
GO:0046879,hormone secretion,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0046879,hormone secretion,HP:0001894,Thrombocytosis
GO:0046879,hormone secretion,HP:0002173,Hypoglycemic seizures
GO:0046879,hormone secretion,HP:0003095,Septic arthritis
GO:0046883,regulation of hormone secretion,HP:0000006,Autosomal dominant inheritance
GO:0046883,regulation of hormone secretion,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0046883,regulation of hormone secretion,HP:0001894,Thrombocytosis
GO:0046883,regulation of hormone secretion,HP:0002173,Hypoglycemic seizures
GO:0046887,positive regulation of hormone secretion,HP:0001894,Thrombocytosis
GO:0046890,regulation of lipid biosynthetic process,HP:0008668,"Gonadal dysgenesis, male"
GO:0046916,cellular transition metal ion homeostasis,HP:0000726,Dementia
GO:0046916,cellular transition metal ion homeostasis,HP:0006999,Basal ganglia gliosis
GO:0046939,nucleotide phosphorylation,HP:0000952,Jaundice
GO:0046939,nucleotide phosphorylation,HP:0001082,Cholecystitis
GO:0046942,carboxylic acid transport,HP:0001528,Hemihypertrophy
GO:0046942,carboxylic acid transport,HP:0002908,Conjugated hyperbilirubinemia
GO:0048015,phosphatidylinositol-mediated signaling,HP:0000006,Autosomal dominant inheritance
GO:0048015,phosphatidylinositol-mediated signaling,HP:0001528,Hemihypertrophy
GO:0048015,phosphatidylinositol-mediated signaling,HP:0001894,Thrombocytosis
GO:0048015,phosphatidylinositol-mediated signaling,HP:0002676,Cloverleaf skull
GO:0048015,phosphatidylinositol-mediated signaling,HP:0002677,Small foramen magnum
GO:0048015,phosphatidylinositol-mediated signaling,HP:0003319,Abnormality of the cervical spine
GO:0048017,inositol lipid-mediated signaling,HP:0000006,Autosomal dominant inheritance
GO:0048017,inositol lipid-mediated signaling,HP:0001528,Hemihypertrophy
GO:0048017,inositol lipid-mediated signaling,HP:0001894,Thrombocytosis
GO:0048017,inositol lipid-mediated signaling,HP:0002676,Cloverleaf skull
GO:0048017,inositol lipid-mediated signaling,HP:0002677,Small foramen magnum
GO:0048017,inositol lipid-mediated signaling,HP:0003319,Abnormality of the cervical spine
GO:0048048,embryonic eye morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0048048,embryonic eye morphogenesis,HP:0001083,Ectopia lentis
GO:0048066,developmental pigmentation,HP:0000635,Blue irides
GO:0048066,developmental pigmentation,HP:0001008,Accumulation of melanosomes in melanocytes
GO:0048066,developmental pigmentation,HP:0001022,Albinism
GO:0048066,developmental pigmentation,HP:0001053,Hypopigmented skin patches
GO:0048066,developmental pigmentation,HP:0001100,Heterochromia iridis
GO:0048066,developmental pigmentation,HP:0002211,White forelock
GO:0048066,developmental pigmentation,HP:0002226,White eyebrow
GO:0048066,developmental pigmentation,HP:0002227,White eyelashes
GO:0048066,developmental pigmentation,HP:0007894,Hypopigmentation of the fundus
GO:0048167,regulation of synaptic plasticity,HP:0001054,Numerous nevi
GO:0048193,Golgi vesicle transport,HP:0012233,Intramuscular hematoma
GO:0048208,COPII vesicle coating,HP:0000006,Autosomal dominant inheritance
GO:0048208,COPII vesicle coating,HP:0000007,Autosomal recessive inheritance
GO:0048208,COPII vesicle coating,HP:0000166,Severe periodontitis
GO:0048208,COPII vesicle coating,HP:0001030,Fragile skin
GO:0048208,COPII vesicle coating,HP:0001056,Milia
GO:0048208,COPII vesicle coating,HP:0003125,Reduced factor VIII activity
GO:0048208,COPII vesicle coating,HP:0003225,Reduced factor V activity
GO:0048208,COPII vesicle coating,HP:0008404,Nail dystrophy
GO:0048332,mesoderm morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0048469,cell maturation,HP:0003095,Septic arthritis
GO:0048469,cell maturation,HP:0004814,Fava bean-induced hemolytic anemia
GO:0048483,autonomic nervous system development,HP:0000006,Autosomal dominant inheritance
GO:0048483,autonomic nervous system development,HP:0002211,White forelock
GO:0048489,synaptic vesicle transport,HP:0000012,Urinary urgency
GO:0048511,rhythmic process,HP:0001470,Sex-limited autosomal dominant
GO:0048514,blood vessel morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0048514,blood vessel morphogenesis,HP:0000149,Ovarian gonadoblastoma
GO:0048514,blood vessel morphogenesis,HP:0000501,Glaucoma
GO:0048514,blood vessel morphogenesis,HP:0001684,Secundum atrial septal defect
GO:0048514,blood vessel morphogenesis,HP:0002408,Cerebral arteriovenous malformation
GO:0048514,blood vessel morphogenesis,HP:0004383,Hypoplastic left heart
GO:0048514,blood vessel morphogenesis,HP:0010445,Primum atrial septal defect
GO:0048545,response to steroid hormone,HP:0001894,Thrombocytosis
GO:0048546,digestive tract morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0048546,digestive tract morphogenesis,HP:0000074,Ureteropelvic junction obstruction
GO:0048546,digestive tract morphogenesis,HP:0000668,Hypodontia
GO:0048562,embryonic organ morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0048562,embryonic organ morphogenesis,HP:0000175,Cleft palate
GO:0048562,embryonic organ morphogenesis,HP:0000243,Trigonocephaly
GO:0048562,embryonic organ morphogenesis,HP:0000405,Conductive hearing impairment
GO:0048562,embryonic organ morphogenesis,HP:0000501,Glaucoma
GO:0048562,embryonic organ morphogenesis,HP:0001083,Ectopia lentis
GO:0048562,embryonic organ morphogenesis,HP:0001156,Brachydactyly syndrome
GO:0048562,embryonic organ morphogenesis,HP:0005217,Duplication of internal organs
GO:0048562,embryonic organ morphogenesis,HP:0008191,Thyroid agenesis
GO:0048562,embryonic organ morphogenesis,HP:0010445,Primum atrial septal defect
GO:0048565,digestive tract development,HP:0000006,Autosomal dominant inheritance
GO:0048565,digestive tract development,HP:0000074,Ureteropelvic junction obstruction
GO:0048565,digestive tract development,HP:0005116,Arterial tortuosity
GO:0048566,embryonic digestive tract development,HP:0000006,Autosomal dominant inheritance
GO:0048568,embryonic organ development,HP:0000006,Autosomal dominant inheritance
GO:0048568,embryonic organ development,HP:0000243,Trigonocephaly
GO:0048568,embryonic organ development,HP:0000501,Glaucoma
GO:0048568,embryonic organ development,HP:0000668,Hypodontia
GO:0048568,embryonic organ development,HP:0001083,Ectopia lentis
GO:0048568,embryonic organ development,HP:0001674,Complete atrioventricular canal defect
GO:0048568,embryonic organ development,HP:0004635,Cervical C5/C6 vertebrae fusion
GO:0048568,embryonic organ development,HP:0005116,Arterial tortuosity
GO:0048568,embryonic organ development,HP:0005217,Duplication of internal organs
GO:0048568,embryonic organ development,HP:0005465,Facial hyperostosis
GO:0048568,embryonic organ development,HP:0008191,Thyroid agenesis
GO:0048568,embryonic organ development,HP:0010445,Primum atrial septal defect
GO:0048570,notochord morphogenesis,HP:0008368,Tarsal synostosis
GO:0048592,eye morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0048592,eye morphogenesis,HP:0000505,Visual impairment
GO:0048592,eye morphogenesis,HP:0000510,Rod-cone dystrophy
GO:0048592,eye morphogenesis,HP:0001083,Ectopia lentis
GO:0048592,eye morphogenesis,HP:0005217,Duplication of internal organs
GO:0048592,eye morphogenesis,HP:0008499,High-grade hypermetropia
GO:0048592,eye morphogenesis,HP:0012038,Corneal guttata
GO:0048593,camera-type eye morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0048593,camera-type eye morphogenesis,HP:0012038,Corneal guttata
GO:0048608,reproductive structure development,HP:0000006,Autosomal dominant inheritance
GO:0048608,reproductive structure development,HP:0000013,Hypoplasia of the uterus
GO:0048608,reproductive structure development,HP:0000149,Ovarian gonadoblastoma
GO:0048608,reproductive structure development,HP:0000150,Gonadoblastoma
GO:0048608,reproductive structure development,HP:0000668,Hypodontia
GO:0048608,reproductive structure development,HP:0001470,Sex-limited autosomal dominant
GO:0048608,reproductive structure development,HP:0008668,"Gonadal dysgenesis, male"
GO:0048608,reproductive structure development,HP:0011682,Perimembranous ventricular septal defect
GO:0048608,reproductive structure development,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0048608,reproductive structure development,HP:0012245,Sex reversal
GO:0048634,regulation of muscle organ development,HP:0000006,Autosomal dominant inheritance
GO:0048634,regulation of muscle organ development,HP:0004814,Fava bean-induced hemolytic anemia
GO:0048635,negative regulation of muscle organ development,HP:0004814,Fava bean-induced hemolytic anemia
GO:0048638,regulation of developmental growth,HP:0000006,Autosomal dominant inheritance
GO:0048638,regulation of developmental growth,HP:0000148,Vaginal atresia
GO:0048638,regulation of developmental growth,HP:0000149,Ovarian gonadoblastoma
GO:0048638,regulation of developmental growth,HP:0001684,Secundum atrial septal defect
GO:0048638,regulation of developmental growth,HP:0002676,Cloverleaf skull
GO:0048638,regulation of developmental growth,HP:0002677,Small foramen magnum
GO:0048638,regulation of developmental growth,HP:0003319,Abnormality of the cervical spine
GO:0048638,regulation of developmental growth,HP:0004814,Fava bean-induced hemolytic anemia
GO:0048639,positive regulation of developmental growth,HP:0000006,Autosomal dominant inheritance
GO:0048639,positive regulation of developmental growth,HP:0000148,Vaginal atresia
GO:0048639,positive regulation of developmental growth,HP:0000149,Ovarian gonadoblastoma
GO:0048644,muscle organ morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0048644,muscle organ morphogenesis,HP:0000501,Glaucoma
GO:0048644,muscle organ morphogenesis,HP:0001644,Dilated cardiomyopathy
GO:0048645,animal organ formation,HP:0000006,Autosomal dominant inheritance
GO:0048645,animal organ formation,HP:0000149,Ovarian gonadoblastoma
GO:0048645,animal organ formation,HP:0000243,Trigonocephaly
GO:0048659,smooth muscle cell proliferation,HP:0001894,Thrombocytosis
GO:0048660,regulation of smooth muscle cell proliferation,HP:0000006,Autosomal dominant inheritance
GO:0048660,regulation of smooth muscle cell proliferation,HP:0001894,Thrombocytosis
GO:0048661,positive regulation of smooth muscle cell proliferation,HP:0001894,Thrombocytosis
GO:0048663,neuron fate commitment,HP:0000006,Autosomal dominant inheritance
GO:0048667,cell morphogenesis involved in neuron differentiation,HP:0000006,Autosomal dominant inheritance
GO:0048667,cell morphogenesis involved in neuron differentiation,HP:0000012,Urinary urgency
GO:0048667,cell morphogenesis involved in neuron differentiation,HP:0001054,Numerous nevi
GO:0048667,cell morphogenesis involved in neuron differentiation,HP:0002300,Mutism
GO:0048701,embryonic cranial skeleton morphogenesis,HP:0005217,Duplication of internal organs
GO:0048704,embryonic skeletal system morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0048704,embryonic skeletal system morphogenesis,HP:0000175,Cleft palate
GO:0048704,embryonic skeletal system morphogenesis,HP:0000272,Malar flattening
GO:0048704,embryonic skeletal system morphogenesis,HP:0000405,Conductive hearing impairment
GO:0048704,embryonic skeletal system morphogenesis,HP:0005217,Duplication of internal organs
GO:0048704,embryonic skeletal system morphogenesis,HP:0005280,Depressed nasal bridge
GO:0048705,skeletal system morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0048705,skeletal system morphogenesis,HP:0000175,Cleft palate
GO:0048705,skeletal system morphogenesis,HP:0000243,Trigonocephaly
GO:0048705,skeletal system morphogenesis,HP:0000272,Malar flattening
GO:0048705,skeletal system morphogenesis,HP:0000316,Hypertelorism
GO:0048705,skeletal system morphogenesis,HP:0000405,Conductive hearing impairment
GO:0048705,skeletal system morphogenesis,HP:0000926,Platyspondyly
GO:0048705,skeletal system morphogenesis,HP:0001156,Brachydactyly syndrome
GO:0048705,skeletal system morphogenesis,HP:0001166,Arachnodactyly
GO:0048705,skeletal system morphogenesis,HP:0001363,Craniosynostosis
GO:0048705,skeletal system morphogenesis,HP:0002676,Cloverleaf skull
GO:0048705,skeletal system morphogenesis,HP:0002677,Small foramen magnum
GO:0048705,skeletal system morphogenesis,HP:0003319,Abnormality of the cervical spine
GO:0048705,skeletal system morphogenesis,HP:0005116,Arterial tortuosity
GO:0048705,skeletal system morphogenesis,HP:0005217,Duplication of internal organs
GO:0048705,skeletal system morphogenesis,HP:0005280,Depressed nasal bridge
GO:0048705,skeletal system morphogenesis,HP:0005474,Decreased calvarial ossification
GO:0048705,skeletal system morphogenesis,HP:0008368,Tarsal synostosis
GO:0048705,skeletal system morphogenesis,HP:0011800,Midface retrusion
GO:0048705,skeletal system morphogenesis,HP:0012385,Camptodactyly
GO:0048706,embryonic skeletal system development,HP:0000006,Autosomal dominant inheritance
GO:0048706,embryonic skeletal system development,HP:0000175,Cleft palate
GO:0048706,embryonic skeletal system development,HP:0000272,Malar flattening
GO:0048706,embryonic skeletal system development,HP:0005217,Duplication of internal organs
GO:0048730,epidermis morphogenesis,HP:0000668,Hypodontia
GO:0048732,gland development,HP:0000006,Autosomal dominant inheritance
GO:0048732,gland development,HP:0000074,Ureteropelvic junction obstruction
GO:0048732,gland development,HP:0000149,Ovarian gonadoblastoma
GO:0048732,gland development,HP:0000243,Trigonocephaly
GO:0048732,gland development,HP:0000668,Hypodontia
GO:0048732,gland development,HP:0001054,Numerous nevi
GO:0048732,gland development,HP:0001528,Hemihypertrophy
GO:0048732,gland development,HP:0001684,Secundum atrial septal defect
GO:0048732,gland development,HP:0001894,Thrombocytosis
GO:0048732,gland development,HP:0002561,Absent nipple
GO:0048732,gland development,HP:0005116,Arterial tortuosity
GO:0048732,gland development,HP:0008191,Thyroid agenesis
GO:0048736,appendage development,HP:0000006,Autosomal dominant inheritance
GO:0048736,appendage development,HP:0000175,Cleft palate
GO:0048736,appendage development,HP:0000243,Trigonocephaly
GO:0048736,appendage development,HP:0000668,Hypodontia
GO:0048736,appendage development,HP:0001156,Brachydactyly syndrome
GO:0048736,appendage development,HP:0001162,Postaxial hand polydactyly
GO:0048736,appendage development,HP:0001199,Triphalangeal thumb
GO:0048736,appendage development,HP:0005217,Duplication of internal organs
GO:0048736,appendage development,HP:0005736,Short tibia
GO:0048736,appendage development,HP:0009183,Joint contracture of the 5th finger
GO:0048736,appendage development,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0048738,cardiac muscle tissue development,HP:0000006,Autosomal dominant inheritance
GO:0048738,cardiac muscle tissue development,HP:0000149,Ovarian gonadoblastoma
GO:0048738,cardiac muscle tissue development,HP:0000501,Glaucoma
GO:0048738,cardiac muscle tissue development,HP:0001644,Dilated cardiomyopathy
GO:0048738,cardiac muscle tissue development,HP:0001684,Secundum atrial septal defect
GO:0048738,cardiac muscle tissue development,HP:0001723,Restrictive cardiomyopathy
GO:0048738,cardiac muscle tissue development,HP:0004814,Fava bean-induced hemolytic anemia
GO:0048738,cardiac muscle tissue development,HP:0010445,Primum atrial septal defect
GO:0048745,smooth muscle tissue development,HP:0000006,Autosomal dominant inheritance
GO:0048754,branching morphogenesis of an epithelial tube,HP:0000006,Autosomal dominant inheritance
GO:0048754,branching morphogenesis of an epithelial tube,HP:0000149,Ovarian gonadoblastoma
GO:0048762,mesenchymal cell differentiation,HP:0000006,Autosomal dominant inheritance
GO:0048762,mesenchymal cell differentiation,HP:0001053,Hypopigmented skin patches
GO:0048762,mesenchymal cell differentiation,HP:0001100,Heterochromia iridis
GO:0048762,mesenchymal cell differentiation,HP:0002211,White forelock
GO:0048762,mesenchymal cell differentiation,HP:0002226,White eyebrow
GO:0048762,mesenchymal cell differentiation,HP:0003250,Aplasia of the vagina
GO:0048762,mesenchymal cell differentiation,HP:0005116,Arterial tortuosity
GO:0048799,animal organ maturation,HP:0002677,Small foramen magnum
GO:0048806,genitalia development,HP:0000149,Ovarian gonadoblastoma
GO:0048806,genitalia development,HP:0000668,Hypodontia
GO:0048839,inner ear development,HP:0000006,Autosomal dominant inheritance
GO:0048839,inner ear development,HP:0000243,Trigonocephaly
GO:0048839,inner ear development,HP:0000407,Sensorineural hearing impairment
GO:0048844,artery morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0048844,artery morphogenesis,HP:0002408,Cerebral arteriovenous malformation
GO:0048857,neural nucleus development,HP:0004814,Fava bean-induced hemolytic anemia
GO:0048863,stem cell differentiation,HP:0000006,Autosomal dominant inheritance
GO:0048863,stem cell differentiation,HP:0000668,Hypodontia
GO:0048864,stem cell development,HP:0001053,Hypopigmented skin patches
GO:0048864,stem cell development,HP:0001100,Heterochromia iridis
GO:0048864,stem cell development,HP:0002226,White eyebrow
GO:0048871,multicellular organismal homeostasis,HP:0000006,Autosomal dominant inheritance
GO:0048871,multicellular organismal homeostasis,HP:0000510,Rod-cone dystrophy
GO:0048871,multicellular organismal homeostasis,HP:0000668,Hypodontia
GO:0048871,multicellular organismal homeostasis,HP:0001955,Unexplained fevers
GO:0048872,homeostasis of number of cells,HP:0001894,Thrombocytosis
GO:0048872,homeostasis of number of cells,HP:0004814,Fava bean-induced hemolytic anemia
GO:0050654,chondroitin sulfate proteoglycan metabolic process,HP:0004233,Advanced ossification of carpal bones
GO:0050670,regulation of lymphocyte proliferation,HP:0002721,Immunodeficiency
GO:0050670,regulation of lymphocyte proliferation,HP:0002849,Absence of lymph node germinal center
GO:0050671,positive regulation of lymphocyte proliferation,HP:0002721,Immunodeficiency
GO:0050671,positive regulation of lymphocyte proliferation,HP:0002849,Absence of lymph node germinal center
GO:0050673,epithelial cell proliferation,HP:0000006,Autosomal dominant inheritance
GO:0050673,epithelial cell proliferation,HP:0000668,Hypodontia
GO:0050673,epithelial cell proliferation,HP:0005116,Arterial tortuosity
GO:0050673,epithelial cell proliferation,HP:0005465,Facial hyperostosis
GO:0050678,regulation of epithelial cell proliferation,HP:0000006,Autosomal dominant inheritance
GO:0050678,regulation of epithelial cell proliferation,HP:0005116,Arterial tortuosity
GO:0050678,regulation of epithelial cell proliferation,HP:0005465,Facial hyperostosis
GO:0050679,positive regulation of epithelial cell proliferation,HP:0000006,Autosomal dominant inheritance
GO:0050708,regulation of protein secretion,HP:0000006,Autosomal dominant inheritance
GO:0050708,regulation of protein secretion,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0050708,regulation of protein secretion,HP:0001894,Thrombocytosis
GO:0050708,regulation of protein secretion,HP:0002849,Absence of lymph node germinal center
GO:0050727,regulation of inflammatory response,HP:0001291,Abnormality of the cranial nerves
GO:0050727,regulation of inflammatory response,HP:0001894,Thrombocytosis
GO:0050727,regulation of inflammatory response,HP:0002586,Peritonitis
GO:0050727,regulation of inflammatory response,HP:0002716,Lymphadenopathy
GO:0050727,regulation of inflammatory response,HP:0002725,Systemic lupus erythematosus
GO:0050727,regulation of inflammatory response,HP:0003095,Septic arthritis
GO:0050727,regulation of inflammatory response,HP:0004431,Complement deficiency
GO:0050727,regulation of inflammatory response,HP:0005421,Decreased serum complement C3
GO:0050728,negative regulation of inflammatory response,HP:0001894,Thrombocytosis
GO:0050728,negative regulation of inflammatory response,HP:0002716,Lymphadenopathy
GO:0050728,negative regulation of inflammatory response,HP:0002829,Arthralgia
GO:0050730,regulation of peptidyl-tyrosine phosphorylation,HP:0001894,Thrombocytosis
GO:0050730,regulation of peptidyl-tyrosine phosphorylation,HP:0002677,Small foramen magnum
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,HP:0001894,Thrombocytosis
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,HP:0002677,Small foramen magnum
GO:0050768,negative regulation of neurogenesis,HP:0000006,Autosomal dominant inheritance
GO:0050769,positive regulation of neurogenesis,HP:0000006,Autosomal dominant inheritance
GO:0050769,positive regulation of neurogenesis,HP:0000243,Trigonocephaly
GO:0050769,positive regulation of neurogenesis,HP:0001472,Familial predisposition
GO:0050796,regulation of insulin secretion,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0050796,regulation of insulin secretion,HP:0001325,Hypoglycemic coma
GO:0050796,regulation of insulin secretion,HP:0001894,Thrombocytosis
GO:0050804,modulation of synaptic transmission,HP:0000006,Autosomal dominant inheritance
GO:0050804,modulation of synaptic transmission,HP:0001054,Numerous nevi
GO:0050804,modulation of synaptic transmission,HP:0001300,Parkinsonism
GO:0050805,negative regulation of synaptic transmission,HP:0001054,Numerous nevi
GO:0050806,positive regulation of synaptic transmission,HP:0001054,Numerous nevi
GO:0050808,synapse organization,HP:0003391,Gowers sign
GO:0050810,regulation of steroid biosynthetic process,HP:0008668,"Gonadal dysgenesis, male"
GO:0050817,coagulation,HP:0000006,Autosomal dominant inheritance
GO:0050817,coagulation,HP:0000132,Menorrhagia
GO:0050817,coagulation,HP:0000408,Progressive sensorineural hearing impairment
GO:0050817,coagulation,HP:0000421,Epistaxis
GO:0050817,coagulation,HP:0000978,Bruising susceptibility
GO:0050817,coagulation,HP:0001528,Hemihypertrophy
GO:0050817,coagulation,HP:0001894,Thrombocytosis
GO:0050817,coagulation,HP:0002625,Deep venous thrombosis
GO:0050817,coagulation,HP:0002849,Absence of lymph node germinal center
GO:0050817,coagulation,HP:0003010,Prolonged bleeding time
GO:0050817,coagulation,HP:0003645,Prolonged partial thromboplastin time
GO:0050817,coagulation,HP:0005261,Joint hemorrhage
GO:0050817,coagulation,HP:0012233,Intramuscular hematoma
GO:0050817,coagulation,HP:0100724,Hypercoagulability
GO:0050818,regulation of coagulation,HP:0002204,Pulmonary embolism
GO:0050818,regulation of coagulation,HP:0005305,Cerebral venous thrombosis
GO:0050818,regulation of coagulation,HP:0100724,Hypercoagulability
GO:0050819,negative regulation of coagulation,HP:0002204,Pulmonary embolism
GO:0050819,negative regulation of coagulation,HP:0100724,Hypercoagulability
GO:0050863,regulation of T cell activation,HP:0001528,Hemihypertrophy
GO:0050863,regulation of T cell activation,HP:0002716,Lymphadenopathy
GO:0050863,regulation of T cell activation,HP:0002721,Immunodeficiency
GO:0050865,regulation of cell activation,HP:0001528,Hemihypertrophy
GO:0050865,regulation of cell activation,HP:0001894,Thrombocytosis
GO:0050865,regulation of cell activation,HP:0002716,Lymphadenopathy
GO:0050865,regulation of cell activation,HP:0002718,Recurrent bacterial infections
GO:0050865,regulation of cell activation,HP:0002721,Immunodeficiency
GO:0050865,regulation of cell activation,HP:0002849,Absence of lymph node germinal center
GO:0050865,regulation of cell activation,HP:0003095,Septic arthritis
GO:0050867,positive regulation of cell activation,HP:0001528,Hemihypertrophy
GO:0050867,positive regulation of cell activation,HP:0001894,Thrombocytosis
GO:0050867,positive regulation of cell activation,HP:0002716,Lymphadenopathy
GO:0050867,positive regulation of cell activation,HP:0002718,Recurrent bacterial infections
GO:0050867,positive regulation of cell activation,HP:0002721,Immunodeficiency
GO:0050867,positive regulation of cell activation,HP:0002849,Absence of lymph node germinal center
GO:0050867,positive regulation of cell activation,HP:0003095,Septic arthritis
GO:0050870,positive regulation of T cell activation,HP:0001528,Hemihypertrophy
GO:0050870,positive regulation of T cell activation,HP:0002716,Lymphadenopathy
GO:0050870,positive regulation of T cell activation,HP:0002721,Immunodeficiency
GO:0050878,regulation of body fluid levels,HP:0000006,Autosomal dominant inheritance
GO:0050878,regulation of body fluid levels,HP:0000132,Menorrhagia
GO:0050878,regulation of body fluid levels,HP:0000408,Progressive sensorineural hearing impairment
GO:0050878,regulation of body fluid levels,HP:0000421,Epistaxis
GO:0050878,regulation of body fluid levels,HP:0000668,Hypodontia
GO:0050878,regulation of body fluid levels,HP:0000978,Bruising susceptibility
GO:0050878,regulation of body fluid levels,HP:0001528,Hemihypertrophy
GO:0050878,regulation of body fluid levels,HP:0001894,Thrombocytosis
GO:0050878,regulation of body fluid levels,HP:0001955,Unexplained fevers
GO:0050878,regulation of body fluid levels,HP:0001981,Schistocytosis
GO:0050878,regulation of body fluid levels,HP:0002625,Deep venous thrombosis
GO:0050878,regulation of body fluid levels,HP:0002849,Absence of lymph node germinal center
GO:0050878,regulation of body fluid levels,HP:0003010,Prolonged bleeding time
GO:0050878,regulation of body fluid levels,HP:0003645,Prolonged partial thromboplastin time
GO:0050878,regulation of body fluid levels,HP:0005261,Joint hemorrhage
GO:0050878,regulation of body fluid levels,HP:0005465,Facial hyperostosis
GO:0050878,regulation of body fluid levels,HP:0010445,Primum atrial septal defect
GO:0050878,regulation of body fluid levels,HP:0012233,Intramuscular hematoma
GO:0050878,regulation of body fluid levels,HP:0100724,Hypercoagulability
GO:0050879,multicellular organismal movement,HP:0003391,Gowers sign
GO:0050880,regulation of blood vessel size,HP:0005465,Facial hyperostosis
GO:0050880,regulation of blood vessel size,HP:0012727,Thoracic aortic aneurysm
GO:0050881,musculoskeletal movement,HP:0003391,Gowers sign
GO:0050890,cognition,HP:0000751,Personality changes
GO:0050890,cognition,HP:0001054,Numerous nevi
GO:0050890,cognition,HP:0001300,Parkinsonism
GO:0050891,multicellular organismal water homeostasis,HP:0000668,Hypodontia
GO:0050891,multicellular organismal water homeostasis,HP:0001955,Unexplained fevers
GO:0050900,leukocyte migration,HP:0001894,Thrombocytosis
GO:0050931,pigment cell differentiation,HP:0000635,Blue irides
GO:0050931,pigment cell differentiation,HP:0001008,Accumulation of melanosomes in melanocytes
GO:0050931,pigment cell differentiation,HP:0001022,Albinism
GO:0050931,pigment cell differentiation,HP:0001053,Hypopigmented skin patches
GO:0050931,pigment cell differentiation,HP:0001100,Heterochromia iridis
GO:0050931,pigment cell differentiation,HP:0002211,White forelock
GO:0050931,pigment cell differentiation,HP:0002226,White eyebrow
GO:0050931,pigment cell differentiation,HP:0002227,White eyelashes
GO:0050953,sensory perception of light stimulus,HP:0000408,Progressive sensorineural hearing impairment
GO:0050953,sensory perception of light stimulus,HP:0000505,Visual impairment
GO:0050953,sensory perception of light stimulus,HP:0000510,Rod-cone dystrophy
GO:0050953,sensory perception of light stimulus,HP:0000512,Abnormal electroretinogram
GO:0050953,sensory perception of light stimulus,HP:0000533,Chorioretinal atrophy
GO:0050953,sensory perception of light stimulus,HP:0000545,Myopia
GO:0050953,sensory perception of light stimulus,HP:0000548,Cone/cone-rod dystrophy
GO:0050953,sensory perception of light stimulus,HP:0000613,Photophobia
GO:0050953,sensory perception of light stimulus,HP:0000662,Nyctalopia
GO:0050953,sensory perception of light stimulus,HP:0001099,Fundus atrophy
GO:0050953,sensory perception of light stimulus,HP:0001133,Constriction of peripheral visual field
GO:0050953,sensory perception of light stimulus,HP:0007642,Congenital stationary night blindness
GO:0050953,sensory perception of light stimulus,HP:0007663,Reduced visual acuity
GO:0050953,sensory perception of light stimulus,HP:0007677,Vitelliform-like macular lesions
GO:0050953,sensory perception of light stimulus,HP:0007737,Bone spicule pigmentation of the retina
GO:0050953,sensory perception of light stimulus,HP:0007754,Macular dystrophy
GO:0050953,sensory perception of light stimulus,HP:0007843,Attenuation of retinal blood vessels
GO:0050953,sensory perception of light stimulus,HP:0007971,Lamellar cataract
GO:0050953,sensory perception of light stimulus,HP:0007984,Electronegative electroretinogram
GO:0050953,sensory perception of light stimulus,HP:0010920,Zonular cataract
GO:0050953,sensory perception of light stimulus,HP:0030515,Moderate visual impairment
GO:0050954,sensory perception of mechanical stimulus,HP:0000006,Autosomal dominant inheritance
GO:0050954,sensory perception of mechanical stimulus,HP:0000407,Sensorineural hearing impairment
GO:0050954,sensory perception of mechanical stimulus,HP:0000408,Progressive sensorineural hearing impairment
GO:0050954,sensory perception of mechanical stimulus,HP:0005217,Duplication of internal organs
GO:0050962,detection of light stimulus involved in sensory perception,HP:0000007,Autosomal recessive inheritance
GO:0050962,detection of light stimulus involved in sensory perception,HP:0000505,Visual impairment
GO:0050962,detection of light stimulus involved in sensory perception,HP:0000510,Rod-cone dystrophy
GO:0050962,detection of light stimulus involved in sensory perception,HP:0000662,Nyctalopia
GO:0050962,detection of light stimulus involved in sensory perception,HP:0007642,Congenital stationary night blindness
GO:0050962,detection of light stimulus involved in sensory perception,HP:0007663,Reduced visual acuity
GO:0051047,positive regulation of secretion,HP:0000006,Autosomal dominant inheritance
GO:0051047,positive regulation of secretion,HP:0000012,Urinary urgency
GO:0051047,positive regulation of secretion,HP:0001894,Thrombocytosis
GO:0051051,negative regulation of transport,HP:0000006,Autosomal dominant inheritance
GO:0051051,negative regulation of transport,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0051051,negative regulation of transport,HP:0001054,Numerous nevi
GO:0051051,negative regulation of transport,HP:0001279,Syncope
GO:0051051,negative regulation of transport,HP:0001528,Hemihypertrophy
GO:0051052,regulation of DNA metabolic process,HP:0001528,Hemihypertrophy
GO:0051052,regulation of DNA metabolic process,HP:0002716,Lymphadenopathy
GO:0051052,regulation of DNA metabolic process,HP:0005465,Facial hyperostosis
GO:0051052,regulation of DNA metabolic process,HP:0010982,Polygenic inheritance
GO:0051052,regulation of DNA metabolic process,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0051054,positive regulation of DNA metabolic process,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0051090,regulation of sequence-specific DNA binding transcription factor activity,HP:0000668,Hypodontia
GO:0051090,regulation of sequence-specific DNA binding transcription factor activity,HP:0001419,X-linked recessive inheritance
GO:0051090,regulation of sequence-specific DNA binding transcription factor activity,HP:0001894,Thrombocytosis
GO:0051090,regulation of sequence-specific DNA binding transcription factor activity,HP:0002849,Absence of lymph node germinal center
GO:0051090,regulation of sequence-specific DNA binding transcription factor activity,HP:0003095,Septic arthritis
GO:0051091,positive regulation of sequence-specific DNA binding transcription factor activity,HP:0000668,Hypodontia
GO:0051091,positive regulation of sequence-specific DNA binding transcription factor activity,HP:0001419,X-linked recessive inheritance
GO:0051091,positive regulation of sequence-specific DNA binding transcription factor activity,HP:0001894,Thrombocytosis
GO:0051091,positive regulation of sequence-specific DNA binding transcription factor activity,HP:0002849,Absence of lymph node germinal center
GO:0051091,positive regulation of sequence-specific DNA binding transcription factor activity,HP:0003095,Septic arthritis
GO:0051092,positive regulation of NF-kappaB transcription factor activity,HP:0000668,Hypodontia
GO:0051092,positive regulation of NF-kappaB transcription factor activity,HP:0001419,X-linked recessive inheritance
GO:0051092,positive regulation of NF-kappaB transcription factor activity,HP:0002721,Immunodeficiency
GO:0051092,positive regulation of NF-kappaB transcription factor activity,HP:0002849,Absence of lymph node germinal center
GO:0051092,positive regulation of NF-kappaB transcription factor activity,HP:0003095,Septic arthritis
GO:0051098,regulation of binding,HP:0000006,Autosomal dominant inheritance
GO:0051098,regulation of binding,HP:0001894,Thrombocytosis
GO:0051098,regulation of binding,HP:0005116,Arterial tortuosity
GO:0051099,positive regulation of binding,HP:0001894,Thrombocytosis
GO:0051101,regulation of DNA binding,HP:0001894,Thrombocytosis
GO:0051145,smooth muscle cell differentiation,HP:0000006,Autosomal dominant inheritance
GO:0051146,striated muscle cell differentiation,HP:0000006,Autosomal dominant inheritance
GO:0051146,striated muscle cell differentiation,HP:0000149,Ovarian gonadoblastoma
GO:0051146,striated muscle cell differentiation,HP:0000408,Progressive sensorineural hearing impairment
GO:0051146,striated muscle cell differentiation,HP:0001644,Dilated cardiomyopathy
GO:0051146,striated muscle cell differentiation,HP:0001684,Secundum atrial septal defect
GO:0051146,striated muscle cell differentiation,HP:0003391,Gowers sign
GO:0051146,striated muscle cell differentiation,HP:0004814,Fava bean-induced hemolytic anemia
GO:0051147,regulation of muscle cell differentiation,HP:0000006,Autosomal dominant inheritance
GO:0051147,regulation of muscle cell differentiation,HP:0004635,Cervical C5/C6 vertebrae fusion
GO:0051147,regulation of muscle cell differentiation,HP:0004814,Fava bean-induced hemolytic anemia
GO:0051148,negative regulation of muscle cell differentiation,HP:0000006,Autosomal dominant inheritance
GO:0051148,negative regulation of muscle cell differentiation,HP:0004814,Fava bean-induced hemolytic anemia
GO:0051156,glucose 6-phosphate metabolic process,HP:0001082,Cholecystitis
GO:0051156,glucose 6-phosphate metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0051170,nuclear import,HP:0000006,Autosomal dominant inheritance
GO:0051170,nuclear import,HP:0001894,Thrombocytosis
GO:0051170,nuclear import,HP:0004749,Atrial flutter
GO:0051170,nuclear import,HP:0005116,Arterial tortuosity
GO:0051181,cofactor transport,HP:0000007,Autosomal recessive inheritance
GO:0051186,cofactor metabolic process,HP:0000007,Autosomal recessive inheritance
GO:0051186,cofactor metabolic process,HP:0000952,Jaundice
GO:0051186,cofactor metabolic process,HP:0001081,Cholelithiasis
GO:0051186,cofactor metabolic process,HP:0001082,Cholecystitis
GO:0051186,cofactor metabolic process,HP:0001083,Ectopia lentis
GO:0051186,cofactor metabolic process,HP:0001332,Dystonia
GO:0051186,cofactor metabolic process,HP:0001942,Metabolic acidosis
GO:0051186,cofactor metabolic process,HP:0001943,Hypoglycemia
GO:0051186,cofactor metabolic process,HP:0001992,Organic aciduria
GO:0051186,cofactor metabolic process,HP:0003128,Lactic acidosis
GO:0051186,cofactor metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0051186,cofactor metabolic process,HP:0004923,Hyperphenylalaninemia
GO:0051186,cofactor metabolic process,HP:0008297,Transient hyperphenylalaninemia
GO:0051186,cofactor metabolic process,HP:0011999,Paranoia
GO:0051186,cofactor metabolic process,HP:0200044,Porokeratosis
GO:0051188,cofactor biosynthetic process,HP:0001332,Dystonia
GO:0051188,cofactor biosynthetic process,HP:0003128,Lactic acidosis
GO:0051188,cofactor biosynthetic process,HP:0004923,Hyperphenylalaninemia
GO:0051188,cofactor biosynthetic process,HP:0008297,Transient hyperphenylalaninemia
GO:0051188,cofactor biosynthetic process,HP:0011999,Paranoia
GO:0051216,cartilage development,HP:0000006,Autosomal dominant inheritance
GO:0051216,cartilage development,HP:0000243,Trigonocephaly
GO:0051216,cartilage development,HP:0000272,Malar flattening
GO:0051216,cartilage development,HP:0000773,Short ribs
GO:0051216,cartilage development,HP:0000926,Platyspondyly
GO:0051216,cartilage development,HP:0001156,Brachydactyly syndrome
GO:0051216,cartilage development,HP:0002676,Cloverleaf skull
GO:0051216,cartilage development,HP:0002677,Small foramen magnum
GO:0051216,cartilage development,HP:0005116,Arterial tortuosity
GO:0051216,cartilage development,HP:0005736,Short tibia
GO:0051216,cartilage development,HP:0008368,Tarsal synostosis
GO:0051216,cartilage development,HP:0010049,Short metacarpal
GO:0051216,cartilage development,HP:0011800,Midface retrusion
GO:0051235,maintenance of location,HP:0001083,Ectopia lentis
GO:0051235,maintenance of location,HP:0003292,Decreased serum leptin
GO:0051235,maintenance of location,HP:0003391,Gowers sign
GO:0051249,regulation of lymphocyte activation,HP:0001528,Hemihypertrophy
GO:0051249,regulation of lymphocyte activation,HP:0002716,Lymphadenopathy
GO:0051249,regulation of lymphocyte activation,HP:0002718,Recurrent bacterial infections
GO:0051249,regulation of lymphocyte activation,HP:0002721,Immunodeficiency
GO:0051249,regulation of lymphocyte activation,HP:0002849,Absence of lymph node germinal center
GO:0051249,regulation of lymphocyte activation,HP:0003095,Septic arthritis
GO:0051251,positive regulation of lymphocyte activation,HP:0001528,Hemihypertrophy
GO:0051251,positive regulation of lymphocyte activation,HP:0002090,Pneumonia
GO:0051251,positive regulation of lymphocyte activation,HP:0002716,Lymphadenopathy
GO:0051251,positive regulation of lymphocyte activation,HP:0002718,Recurrent bacterial infections
GO:0051251,positive regulation of lymphocyte activation,HP:0002721,Immunodeficiency
GO:0051251,positive regulation of lymphocyte activation,HP:0002849,Absence of lymph node germinal center
GO:0051251,positive regulation of lymphocyte activation,HP:0003095,Septic arthritis
GO:0051259,protein oligomerization,HP:0000006,Autosomal dominant inheritance
GO:0051259,protein oligomerization,HP:0000012,Urinary urgency
GO:0051260,protein homooligomerization,HP:0000012,Urinary urgency
GO:0051272,positive regulation of cellular component movement,HP:0000006,Autosomal dominant inheritance
GO:0051272,positive regulation of cellular component movement,HP:0001528,Hemihypertrophy
GO:0051272,positive regulation of cellular component movement,HP:0001894,Thrombocytosis
GO:0051272,positive regulation of cellular component movement,HP:0005116,Arterial tortuosity
GO:0051272,positive regulation of cellular component movement,HP:0012233,Intramuscular hematoma
GO:0051297,,HP:0000252,Microcephaly
GO:0051297,,HP:0000340,Sloping forehead
GO:0051298,centrosome duplication,HP:0000252,Microcephaly
GO:0051298,centrosome duplication,HP:0000340,Sloping forehead
GO:0051384,response to glucocorticoid,HP:0000007,Autosomal recessive inheritance
GO:0051402,neuron apoptotic process,HP:0000006,Autosomal dominant inheritance
GO:0051402,neuron apoptotic process,HP:0000012,Urinary urgency
GO:0051402,neuron apoptotic process,HP:0001894,Thrombocytosis
GO:0051402,neuron apoptotic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0051453,regulation of intracellular pH,HP:0002074,Increased neuronal autofluorescent lipopigment
GO:0051453,regulation of intracellular pH,HP:0008341,Distal renal tubular acidosis
GO:0051480,regulation of cytosolic calcium ion concentration,HP:0000006,Autosomal dominant inheritance
GO:0051480,regulation of cytosolic calcium ion concentration,HP:0001894,Thrombocytosis
GO:0051480,regulation of cytosolic calcium ion concentration,HP:0003391,Gowers sign
GO:0051591,response to cAMP,HP:0000149,Ovarian gonadoblastoma
GO:0051604,protein maturation,HP:0000243,Trigonocephaly
GO:0051604,protein maturation,HP:0002725,Systemic lupus erythematosus
GO:0051604,protein maturation,HP:0004431,Complement deficiency
GO:0051604,protein maturation,HP:0005421,Decreased serum complement C3
GO:0051604,protein maturation,HP:0012233,Intramuscular hematoma
GO:0051604,protein maturation,HP:0040154,Acne inversa
GO:0051640,organelle localization,HP:0000012,Urinary urgency
GO:0051640,organelle localization,HP:0001008,Accumulation of melanosomes in melanocytes
GO:0051640,organelle localization,HP:0001054,Numerous nevi
GO:0051640,organelle localization,HP:0001300,Parkinsonism
GO:0051640,organelle localization,HP:0003095,Septic arthritis
GO:0051640,organelle localization,HP:0003391,Gowers sign
GO:0051648,vesicle localization,HP:0000012,Urinary urgency
GO:0051648,vesicle localization,HP:0001008,Accumulation of melanosomes in melanocytes
GO:0051648,vesicle localization,HP:0001054,Numerous nevi
GO:0051650,establishment of vesicle localization,HP:0000012,Urinary urgency
GO:0051650,establishment of vesicle localization,HP:0001008,Accumulation of melanosomes in melanocytes
GO:0051656,establishment of organelle localization,HP:0000012,Urinary urgency
GO:0051656,establishment of organelle localization,HP:0001008,Accumulation of melanosomes in melanocytes
GO:0051656,establishment of organelle localization,HP:0001300,Parkinsonism
GO:0051656,establishment of organelle localization,HP:0003095,Septic arthritis
GO:0051875,pigment granule localization,HP:0000510,Rod-cone dystrophy
GO:0051875,pigment granule localization,HP:0001008,Accumulation of melanosomes in melanocytes
GO:0051875,pigment granule localization,HP:0003241,External genital hypoplasia
GO:0051896,regulation of protein kinase B signaling,HP:0012233,Intramuscular hematoma
GO:0051899,membrane depolarization,HP:0000006,Autosomal dominant inheritance
GO:0051899,membrane depolarization,HP:0001279,Syncope
GO:0051899,membrane depolarization,HP:0001657,Prolonged QT interval
GO:0051899,membrane depolarization,HP:0002069,Generalized tonic-clonic seizures
GO:0051899,membrane depolarization,HP:0004749,Atrial flutter
GO:0051904,pigment granule transport,HP:0000510,Rod-cone dystrophy
GO:0051904,pigment granule transport,HP:0001008,Accumulation of melanosomes in melanocytes
GO:0051904,pigment granule transport,HP:0003241,External genital hypoplasia
GO:0051905,establishment of pigment granule localization,HP:0000510,Rod-cone dystrophy
GO:0051905,establishment of pigment granule localization,HP:0001008,Accumulation of melanosomes in melanocytes
GO:0051905,establishment of pigment granule localization,HP:0003241,External genital hypoplasia
GO:0051924,regulation of calcium ion transport,HP:0000006,Autosomal dominant inheritance
GO:0051924,regulation of calcium ion transport,HP:0003391,Gowers sign
GO:0051924,regulation of calcium ion transport,HP:0004814,Fava bean-induced hemolytic anemia
GO:0051928,positive regulation of calcium ion transport,HP:0000006,Autosomal dominant inheritance
GO:0051928,positive regulation of calcium ion transport,HP:0004814,Fava bean-induced hemolytic anemia
GO:0051961,negative regulation of nervous system development,HP:0000006,Autosomal dominant inheritance
GO:0051961,negative regulation of nervous system development,HP:0008386,Aplasia/Hypoplasia of the nails
GO:0051962,positive regulation of nervous system development,HP:0000006,Autosomal dominant inheritance
GO:0051962,positive regulation of nervous system development,HP:0000243,Trigonocephaly
GO:0051962,positive regulation of nervous system development,HP:0001472,Familial predisposition
GO:0052547,regulation of peptidase activity,HP:0000006,Autosomal dominant inheritance
GO:0052547,regulation of peptidase activity,HP:0000012,Urinary urgency
GO:0052547,regulation of peptidase activity,HP:0001894,Thrombocytosis
GO:0052547,regulation of peptidase activity,HP:0011999,Paranoia
GO:0052548,regulation of endopeptidase activity,HP:0001894,Thrombocytosis
GO:0055001,muscle cell development,HP:0000006,Autosomal dominant inheritance
GO:0055001,muscle cell development,HP:0001644,Dilated cardiomyopathy
GO:0055001,muscle cell development,HP:0003236,Elevated serum creatine phosphokinase
GO:0055001,muscle cell development,HP:0003391,Gowers sign
GO:0055001,muscle cell development,HP:0003560,Muscular dystrophy
GO:0055001,muscle cell development,HP:0004814,Fava bean-induced hemolytic anemia
GO:0055002,striated muscle cell development,HP:0000006,Autosomal dominant inheritance
GO:0055002,striated muscle cell development,HP:0001644,Dilated cardiomyopathy
GO:0055002,striated muscle cell development,HP:0003236,Elevated serum creatine phosphokinase
GO:0055002,striated muscle cell development,HP:0003391,Gowers sign
GO:0055002,striated muscle cell development,HP:0003560,Muscular dystrophy
GO:0055002,striated muscle cell development,HP:0004814,Fava bean-induced hemolytic anemia
GO:0055006,cardiac cell development,HP:0000006,Autosomal dominant inheritance
GO:0055006,cardiac cell development,HP:0001644,Dilated cardiomyopathy
GO:0055006,cardiac cell development,HP:0004814,Fava bean-induced hemolytic anemia
GO:0055007,cardiac muscle cell differentiation,HP:0000006,Autosomal dominant inheritance
GO:0055007,cardiac muscle cell differentiation,HP:0000149,Ovarian gonadoblastoma
GO:0055007,cardiac muscle cell differentiation,HP:0001644,Dilated cardiomyopathy
GO:0055007,cardiac muscle cell differentiation,HP:0001684,Secundum atrial septal defect
GO:0055007,cardiac muscle cell differentiation,HP:0004814,Fava bean-induced hemolytic anemia
GO:0055008,cardiac muscle tissue morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0055008,cardiac muscle tissue morphogenesis,HP:0000501,Glaucoma
GO:0055008,cardiac muscle tissue morphogenesis,HP:0001644,Dilated cardiomyopathy
GO:0055010,ventricular cardiac muscle tissue morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0055010,ventricular cardiac muscle tissue morphogenesis,HP:0001644,Dilated cardiomyopathy
GO:0055013,cardiac muscle cell development,HP:0000006,Autosomal dominant inheritance
GO:0055013,cardiac muscle cell development,HP:0001644,Dilated cardiomyopathy
GO:0055013,cardiac muscle cell development,HP:0004814,Fava bean-induced hemolytic anemia
GO:0055017,cardiac muscle tissue growth,HP:0000006,Autosomal dominant inheritance
GO:0055017,cardiac muscle tissue growth,HP:0004814,Fava bean-induced hemolytic anemia
GO:0055017,cardiac muscle tissue growth,HP:0010445,Primum atrial septal defect
GO:0055021,regulation of cardiac muscle tissue growth,HP:0000006,Autosomal dominant inheritance
GO:0055021,regulation of cardiac muscle tissue growth,HP:0004814,Fava bean-induced hemolytic anemia
GO:0055022,negative regulation of cardiac muscle tissue growth,HP:0004814,Fava bean-induced hemolytic anemia
GO:0055024,regulation of cardiac muscle tissue development,HP:0000006,Autosomal dominant inheritance
GO:0055024,regulation of cardiac muscle tissue development,HP:0004814,Fava bean-induced hemolytic anemia
GO:0055026,negative regulation of cardiac muscle tissue development,HP:0004814,Fava bean-induced hemolytic anemia
GO:0055062,phosphate ion homeostasis,HP:0000117,Renal phosphate wasting
GO:0055067,monovalent inorganic cation homeostasis,HP:0008341,Distal renal tubular acidosis
GO:0055072,iron ion homeostasis,HP:0003281,Increased serum ferritin
GO:0055074,calcium ion homeostasis,HP:0000006,Autosomal dominant inheritance
GO:0055074,calcium ion homeostasis,HP:0001894,Thrombocytosis
GO:0055074,calcium ion homeostasis,HP:0003391,Gowers sign
GO:0055076,transition metal ion homeostasis,HP:0000726,Dementia
GO:0055076,transition metal ion homeostasis,HP:0003281,Increased serum ferritin
GO:0055076,transition metal ion homeostasis,HP:0006999,Basal ganglia gliosis
GO:0055081,anion homeostasis,HP:0000117,Renal phosphate wasting
GO:0055088,lipid homeostasis,HP:0003124,Hypercholesterolemia
GO:0055088,lipid homeostasis,HP:0012184,Hyperalphalipoproteinemia
GO:0055092,sterol homeostasis,HP:0003124,Hypercholesterolemia
GO:0055092,sterol homeostasis,HP:0012184,Hyperalphalipoproteinemia
GO:0055117,regulation of cardiac muscle contraction,HP:0000006,Autosomal dominant inheritance
GO:0055117,regulation of cardiac muscle contraction,HP:0001279,Syncope
GO:0055117,regulation of cardiac muscle contraction,HP:0001645,Sudden cardiac death
GO:0055117,regulation of cardiac muscle contraction,HP:0001657,Prolonged QT interval
GO:0055117,regulation of cardiac muscle contraction,HP:0001699,Sudden death
GO:0055117,regulation of cardiac muscle contraction,HP:0004308,Ventricular arrhythmia
GO:0055117,regulation of cardiac muscle contraction,HP:0004749,Atrial flutter
GO:0055117,regulation of cardiac muscle contraction,HP:0004756,Ventricular tachycardia
GO:0055117,regulation of cardiac muscle contraction,HP:0005110,Atrial fibrillation
GO:0055117,regulation of cardiac muscle contraction,HP:0011663,Right ventricular cardiomyopathy
GO:0055123,digestive system development,HP:0000006,Autosomal dominant inheritance
GO:0055123,digestive system development,HP:0000074,Ureteropelvic junction obstruction
GO:0055123,digestive system development,HP:0001674,Complete atrioventricular canal defect
GO:0055123,digestive system development,HP:0005116,Arterial tortuosity
GO:0060021,palate development,HP:0000006,Autosomal dominant inheritance
GO:0060021,palate development,HP:0000175,Cleft palate
GO:0060037,pharyngeal system development,HP:0000006,Autosomal dominant inheritance
GO:0060038,cardiac muscle cell proliferation,HP:0000006,Autosomal dominant inheritance
GO:0060039,pericardium development,HP:0000149,Ovarian gonadoblastoma
GO:0060041,retina development in camera-type eye,HP:0000510,Rod-cone dystrophy
GO:0060043,regulation of cardiac muscle cell proliferation,HP:0000006,Autosomal dominant inheritance
GO:0060047,heart contraction,HP:0000006,Autosomal dominant inheritance
GO:0060047,heart contraction,HP:0001279,Syncope
GO:0060047,heart contraction,HP:0001644,Dilated cardiomyopathy
GO:0060047,heart contraction,HP:0001645,Sudden cardiac death
GO:0060047,heart contraction,HP:0001657,Prolonged QT interval
GO:0060047,heart contraction,HP:0001663,Ventricular fibrillation
GO:0060047,heart contraction,HP:0001699,Sudden death
GO:0060047,heart contraction,HP:0001894,Thrombocytosis
GO:0060047,heart contraction,HP:0003391,Gowers sign
GO:0060047,heart contraction,HP:0004749,Atrial flutter
GO:0060047,heart contraction,HP:0004756,Ventricular tachycardia
GO:0060047,heart contraction,HP:0005110,Atrial fibrillation
GO:0060047,heart contraction,HP:0006673,Reduced systolic function
GO:0060047,heart contraction,HP:0010445,Primum atrial septal defect
GO:0060047,heart contraction,HP:0012232,Shortened QT interval
GO:0060048,cardiac muscle contraction,HP:0000006,Autosomal dominant inheritance
GO:0060048,cardiac muscle contraction,HP:0001279,Syncope
GO:0060048,cardiac muscle contraction,HP:0001644,Dilated cardiomyopathy
GO:0060048,cardiac muscle contraction,HP:0001645,Sudden cardiac death
GO:0060048,cardiac muscle contraction,HP:0001657,Prolonged QT interval
GO:0060048,cardiac muscle contraction,HP:0001663,Ventricular fibrillation
GO:0060048,cardiac muscle contraction,HP:0001664,Torsade de pointes
GO:0060048,cardiac muscle contraction,HP:0001699,Sudden death
GO:0060048,cardiac muscle contraction,HP:0004749,Atrial flutter
GO:0060048,cardiac muscle contraction,HP:0004756,Ventricular tachycardia
GO:0060048,cardiac muscle contraction,HP:0005110,Atrial fibrillation
GO:0060048,cardiac muscle contraction,HP:0010445,Primum atrial septal defect
GO:0060048,cardiac muscle contraction,HP:0012232,Shortened QT interval
GO:0060070,canonical Wnt signaling pathway,HP:0000006,Autosomal dominant inheritance
GO:0060078,regulation of postsynaptic membrane potential,HP:0000006,Autosomal dominant inheritance
GO:0060078,regulation of postsynaptic membrane potential,HP:0004749,Atrial flutter
GO:0060173,limb development,HP:0000006,Autosomal dominant inheritance
GO:0060173,limb development,HP:0000175,Cleft palate
GO:0060173,limb development,HP:0000243,Trigonocephaly
GO:0060173,limb development,HP:0000668,Hypodontia
GO:0060173,limb development,HP:0001156,Brachydactyly syndrome
GO:0060173,limb development,HP:0001162,Postaxial hand polydactyly
GO:0060173,limb development,HP:0001199,Triphalangeal thumb
GO:0060173,limb development,HP:0005217,Duplication of internal organs
GO:0060173,limb development,HP:0005736,Short tibia
GO:0060173,limb development,HP:0009183,Joint contracture of the 5th finger
GO:0060173,limb development,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0060174,limb bud formation,HP:0000006,Autosomal dominant inheritance
GO:0060191,regulation of lipase activity,HP:0002676,Cloverleaf skull
GO:0060191,regulation of lipase activity,HP:0002677,Small foramen magnum
GO:0060191,regulation of lipase activity,HP:0003319,Abnormality of the cervical spine
GO:0060193,positive regulation of lipase activity,HP:0002676,Cloverleaf skull
GO:0060193,positive regulation of lipase activity,HP:0002677,Small foramen magnum
GO:0060193,positive regulation of lipase activity,HP:0003319,Abnormality of the cervical spine
GO:0060231,mesenchymal to epithelial transition,HP:0000149,Ovarian gonadoblastoma
GO:0060249,anatomical structure homeostasis,HP:0000510,Rod-cone dystrophy
GO:0060249,anatomical structure homeostasis,HP:0003391,Gowers sign
GO:0060249,anatomical structure homeostasis,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0060271,cilium assembly,HP:0000007,Autosomal recessive inheritance
GO:0060271,cilium assembly,HP:0000090,Nephronophthisis
GO:0060271,cilium assembly,HP:0000107,Renal cyst
GO:0060271,cilium assembly,HP:0000246,Sinusitis
GO:0060271,cilium assembly,HP:0000403,Recurrent otitis media
GO:0060271,cilium assembly,HP:0000510,Rod-cone dystrophy
GO:0060271,cilium assembly,HP:0000774,Narrow chest
GO:0060271,cilium assembly,HP:0001162,Postaxial hand polydactyly
GO:0060271,cilium assembly,HP:0001395,Hepatic fibrosis
GO:0060271,cilium assembly,HP:0001408,Bile duct proliferation
GO:0060271,cilium assembly,HP:0001513,Obesity
GO:0060271,cilium assembly,HP:0001696,Situs inversus totalis
GO:0060271,cilium assembly,HP:0002110,Bronchiectasis
GO:0060271,cilium assembly,HP:0002419,Molar tooth sign on MRI
GO:0060271,cilium assembly,HP:0010442,Polydactyly
GO:0060271,cilium assembly,HP:0011108,Recurrent sinusitis
GO:0060271,cilium assembly,HP:0011109,Chronic sinusitis
GO:0060271,cilium assembly,HP:0012263,Immotile cilia
GO:0060271,cilium assembly,HP:0012265,Ciliary dyskinesia
GO:0060271,cilium assembly,HP:0100259,Postaxial polydactyly
GO:0060271,cilium assembly,HP:0200073,Respiratory insufficiency due to defective ciliary clearance
GO:0060271,cilium assembly,HP:0012384,Rhinitis
GO:0060306,regulation of membrane repolarization,HP:0000006,Autosomal dominant inheritance
GO:0060306,regulation of membrane repolarization,HP:0001279,Syncope
GO:0060306,regulation of membrane repolarization,HP:0001645,Sudden cardiac death
GO:0060306,regulation of membrane repolarization,HP:0001657,Prolonged QT interval
GO:0060306,regulation of membrane repolarization,HP:0001663,Ventricular fibrillation
GO:0060306,regulation of membrane repolarization,HP:0001664,Torsade de pointes
GO:0060306,regulation of membrane repolarization,HP:0005110,Atrial fibrillation
GO:0060307,regulation of ventricular cardiac muscle cell membrane repolarization,HP:0000006,Autosomal dominant inheritance
GO:0060307,regulation of ventricular cardiac muscle cell membrane repolarization,HP:0001279,Syncope
GO:0060307,regulation of ventricular cardiac muscle cell membrane repolarization,HP:0001645,Sudden cardiac death
GO:0060307,regulation of ventricular cardiac muscle cell membrane repolarization,HP:0001657,Prolonged QT interval
GO:0060307,regulation of ventricular cardiac muscle cell membrane repolarization,HP:0001663,Ventricular fibrillation
GO:0060307,regulation of ventricular cardiac muscle cell membrane repolarization,HP:0001664,Torsade de pointes
GO:0060317,cardiac epithelial to mesenchymal transition,HP:0000006,Autosomal dominant inheritance
GO:0060323,head morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0060348,bone development,HP:0000006,Autosomal dominant inheritance
GO:0060348,bone development,HP:0000243,Trigonocephaly
GO:0060348,bone development,HP:0000272,Malar flattening
GO:0060348,bone development,HP:0000501,Glaucoma
GO:0060348,bone development,HP:0000926,Platyspondyly
GO:0060348,bone development,HP:0001083,Ectopia lentis
GO:0060348,bone development,HP:0001156,Brachydactyly syndrome
GO:0060348,bone development,HP:0002676,Cloverleaf skull
GO:0060348,bone development,HP:0002677,Small foramen magnum
GO:0060348,bone development,HP:0002681,Deformed sella turcica
GO:0060348,bone development,HP:0003015,Flared metaphysis
GO:0060348,bone development,HP:0003319,Abnormality of the cervical spine
GO:0060348,bone development,HP:0005731,Cortical irregularity
GO:0060348,bone development,HP:0010049,Short metacarpal
GO:0060348,bone development,HP:0011800,Midface retrusion
GO:0060349,bone morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0060349,bone morphogenesis,HP:0000243,Trigonocephaly
GO:0060349,bone morphogenesis,HP:0000272,Malar flattening
GO:0060349,bone morphogenesis,HP:0000926,Platyspondyly
GO:0060349,bone morphogenesis,HP:0001156,Brachydactyly syndrome
GO:0060349,bone morphogenesis,HP:0001363,Craniosynostosis
GO:0060349,bone morphogenesis,HP:0002676,Cloverleaf skull
GO:0060349,bone morphogenesis,HP:0002677,Small foramen magnum
GO:0060349,bone morphogenesis,HP:0003319,Abnormality of the cervical spine
GO:0060349,bone morphogenesis,HP:0011800,Midface retrusion
GO:0060350,endochondral bone morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0060350,endochondral bone morphogenesis,HP:0000272,Malar flattening
GO:0060350,endochondral bone morphogenesis,HP:0000926,Platyspondyly
GO:0060350,endochondral bone morphogenesis,HP:0001156,Brachydactyly syndrome
GO:0060350,endochondral bone morphogenesis,HP:0002677,Small foramen magnum
GO:0060350,endochondral bone morphogenesis,HP:0003015,Flared metaphysis
GO:0060350,endochondral bone morphogenesis,HP:0005280,Depressed nasal bridge
GO:0060350,endochondral bone morphogenesis,HP:0008873,Disproportionate short-limb short stature
GO:0060350,endochondral bone morphogenesis,HP:0011800,Midface retrusion
GO:0060351,cartilage development involved in endochondral bone morphogenesis,HP:0000926,Platyspondyly
GO:0060389,pathway-restricted SMAD protein phosphorylation,HP:0002408,Cerebral arteriovenous malformation
GO:0060389,pathway-restricted SMAD protein phosphorylation,HP:0008368,Tarsal synostosis
GO:0060393,regulation of pathway-restricted SMAD protein phosphorylation,HP:0002408,Cerebral arteriovenous malformation
GO:0060393,regulation of pathway-restricted SMAD protein phosphorylation,HP:0008368,Tarsal synostosis
GO:0060395,SMAD protein signal transduction,HP:0005116,Arterial tortuosity
GO:0060411,cardiac septum morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0060412,ventricular septum morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0060415,muscle tissue morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0060415,muscle tissue morphogenesis,HP:0000501,Glaucoma
GO:0060415,muscle tissue morphogenesis,HP:0001644,Dilated cardiomyopathy
GO:0060416,response to growth hormone,HP:0001894,Thrombocytosis
GO:0060419,heart growth,HP:0000006,Autosomal dominant inheritance
GO:0060419,heart growth,HP:0000149,Ovarian gonadoblastoma
GO:0060419,heart growth,HP:0001684,Secundum atrial septal defect
GO:0060419,heart growth,HP:0004814,Fava bean-induced hemolytic anemia
GO:0060419,heart growth,HP:0010445,Primum atrial septal defect
GO:0060420,regulation of heart growth,HP:0000006,Autosomal dominant inheritance
GO:0060420,regulation of heart growth,HP:0000149,Ovarian gonadoblastoma
GO:0060420,regulation of heart growth,HP:0001684,Secundum atrial septal defect
GO:0060420,regulation of heart growth,HP:0004814,Fava bean-induced hemolytic anemia
GO:0060421,positive regulation of heart growth,HP:0000149,Ovarian gonadoblastoma
GO:0060425,lung morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0060443,mammary gland morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0060479,lung cell differentiation,HP:0002930,Thyroid hormone receptor defect
GO:0060485,mesenchyme development,HP:0000006,Autosomal dominant inheritance
GO:0060485,mesenchyme development,HP:0000149,Ovarian gonadoblastoma
GO:0060485,mesenchyme development,HP:0001053,Hypopigmented skin patches
GO:0060485,mesenchyme development,HP:0001100,Heterochromia iridis
GO:0060485,mesenchyme development,HP:0002226,White eyebrow
GO:0060485,mesenchyme development,HP:0002408,Cerebral arteriovenous malformation
GO:0060485,mesenchyme development,HP:0003250,Aplasia of the vagina
GO:0060485,mesenchyme development,HP:0005116,Arterial tortuosity
GO:0060487,lung epithelial cell differentiation,HP:0002930,Thyroid hormone receptor defect
GO:0060512,prostate gland morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0060537,muscle tissue development,HP:0000006,Autosomal dominant inheritance
GO:0060537,muscle tissue development,HP:0000149,Ovarian gonadoblastoma
GO:0060537,muscle tissue development,HP:0000501,Glaucoma
GO:0060537,muscle tissue development,HP:0000668,Hypodontia
GO:0060537,muscle tissue development,HP:0001644,Dilated cardiomyopathy
GO:0060537,muscle tissue development,HP:0001684,Secundum atrial septal defect
GO:0060537,muscle tissue development,HP:0001723,Restrictive cardiomyopathy
GO:0060537,muscle tissue development,HP:0003391,Gowers sign
GO:0060537,muscle tissue development,HP:0004383,Hypoplastic left heart
GO:0060537,muscle tissue development,HP:0004814,Fava bean-induced hemolytic anemia
GO:0060537,muscle tissue development,HP:0005116,Arterial tortuosity
GO:0060537,muscle tissue development,HP:0009183,Joint contracture of the 5th finger
GO:0060537,muscle tissue development,HP:0010445,Primum atrial septal defect
GO:0060538,skeletal muscle organ development,HP:0000006,Autosomal dominant inheritance
GO:0060538,skeletal muscle organ development,HP:0000149,Ovarian gonadoblastoma
GO:0060541,respiratory system development,HP:0000006,Autosomal dominant inheritance
GO:0060541,respiratory system development,HP:0000149,Ovarian gonadoblastoma
GO:0060541,respiratory system development,HP:0000243,Trigonocephaly
GO:0060562,epithelial tube morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0060562,epithelial tube morphogenesis,HP:0000149,Ovarian gonadoblastoma
GO:0060562,epithelial tube morphogenesis,HP:0000243,Trigonocephaly
GO:0060562,epithelial tube morphogenesis,HP:0002408,Cerebral arteriovenous malformation
GO:0060562,epithelial tube morphogenesis,HP:0005116,Arterial tortuosity
GO:0060562,epithelial tube morphogenesis,HP:0010445,Primum atrial septal defect
GO:0060602,branch elongation of an epithelium,HP:0000074,Ureteropelvic junction obstruction
GO:0060603,mammary gland duct morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0060627,regulation of vesicle-mediated transport,HP:0001054,Numerous nevi
GO:0060627,regulation of vesicle-mediated transport,HP:0001300,Parkinsonism
GO:0060644,mammary gland epithelial cell differentiation,HP:0001528,Hemihypertrophy
GO:0060675,ureteric bud morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0060675,ureteric bud morphogenesis,HP:0000149,Ovarian gonadoblastoma
GO:0060688,regulation of morphogenesis of a branching structure,HP:0000006,Autosomal dominant inheritance
GO:0060688,regulation of morphogenesis of a branching structure,HP:0000074,Ureteropelvic junction obstruction
GO:0060740,prostate gland epithelium morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0060828,regulation of canonical Wnt signaling pathway,HP:0000006,Autosomal dominant inheritance
GO:0060840,artery development,HP:0000006,Autosomal dominant inheritance
GO:0060840,artery development,HP:0002408,Cerebral arteriovenous malformation
GO:0060841,venous blood vessel development,HP:0002408,Cerebral arteriovenous malformation
GO:0060993,kidney morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0060993,kidney morphogenesis,HP:0000149,Ovarian gonadoblastoma
GO:0061005,cell differentiation involved in kidney development,HP:0000100,Nephrotic syndrome
GO:0061005,cell differentiation involved in kidney development,HP:0000149,Ovarian gonadoblastoma
GO:0061035,regulation of cartilage development,HP:0000006,Autosomal dominant inheritance
GO:0061035,regulation of cartilage development,HP:0005116,Arterial tortuosity
GO:0061035,regulation of cartilage development,HP:0005736,Short tibia
GO:0061035,regulation of cartilage development,HP:0008368,Tarsal synostosis
GO:0061036,positive regulation of cartilage development,HP:0005736,Short tibia
GO:0061037,negative regulation of cartilage development,HP:0008368,Tarsal synostosis
GO:0061041,regulation of wound healing,HP:0002204,Pulmonary embolism
GO:0061041,regulation of wound healing,HP:0005305,Cerebral venous thrombosis
GO:0061041,regulation of wound healing,HP:0100724,Hypercoagulability
GO:0061045,negative regulation of wound healing,HP:0100724,Hypercoagulability
GO:0061117,negative regulation of heart growth,HP:0004814,Fava bean-induced hemolytic anemia
GO:0061138,morphogenesis of a branching epithelium,HP:0000006,Autosomal dominant inheritance
GO:0061138,morphogenesis of a branching epithelium,HP:0000074,Ureteropelvic junction obstruction
GO:0061138,morphogenesis of a branching epithelium,HP:0000149,Ovarian gonadoblastoma
GO:0061138,morphogenesis of a branching epithelium,HP:0000243,Trigonocephaly
GO:0061138,morphogenesis of a branching epithelium,HP:0000668,Hypodontia
GO:0061180,mammary gland epithelium development,HP:0000006,Autosomal dominant inheritance
GO:0061180,mammary gland epithelium development,HP:0001528,Hemihypertrophy
GO:0061180,mammary gland epithelium development,HP:0001894,Thrombocytosis
GO:0061217,regulation of mesonephros development,HP:0000149,Ovarian gonadoblastoma
GO:0061311,cell surface receptor signaling pathway involved in heart development,HP:0000006,Autosomal dominant inheritance
GO:0061318,renal filtration cell differentiation,HP:0000100,Nephrotic syndrome
GO:0061318,renal filtration cell differentiation,HP:0000149,Ovarian gonadoblastoma
GO:0061326,renal tubule development,HP:0000006,Autosomal dominant inheritance
GO:0061326,renal tubule development,HP:0000149,Ovarian gonadoblastoma
GO:0061326,renal tubule development,HP:0008659,Multiple small medullary renal cysts
GO:0061333,renal tubule morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0061333,renal tubule morphogenesis,HP:0000149,Ovarian gonadoblastoma
GO:0061337,cardiac conduction,HP:0000006,Autosomal dominant inheritance
GO:0061337,cardiac conduction,HP:0001279,Syncope
GO:0061337,cardiac conduction,HP:0001645,Sudden cardiac death
GO:0061337,cardiac conduction,HP:0001657,Prolonged QT interval
GO:0061337,cardiac conduction,HP:0001663,Ventricular fibrillation
GO:0061337,cardiac conduction,HP:0001699,Sudden death
GO:0061337,cardiac conduction,HP:0001962,Palpitations
GO:0061337,cardiac conduction,HP:0004749,Atrial flutter
GO:0061337,cardiac conduction,HP:0004756,Ventricular tachycardia
GO:0061337,cardiac conduction,HP:0005110,Atrial fibrillation
GO:0061337,cardiac conduction,HP:0012232,Shortened QT interval
GO:0061351,neural precursor cell proliferation,HP:0000243,Trigonocephaly
GO:0061351,neural precursor cell proliferation,HP:0001274,Agenesis of corpus callosum
GO:0061371,determination of heart left/right asymmetry,HP:0010445,Primum atrial septal defect
GO:0061383,trabecula morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0061384,heart trabecula morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0061436,establishment of skin barrier,HP:0000668,Hypodontia
GO:0061437,renal system vasculature development,HP:0000149,Ovarian gonadoblastoma
GO:0061440,kidney vasculature development,HP:0000149,Ovarian gonadoblastoma
GO:0061448,connective tissue development,HP:0000006,Autosomal dominant inheritance
GO:0061448,connective tissue development,HP:0000149,Ovarian gonadoblastoma
GO:0061448,connective tissue development,HP:0000243,Trigonocephaly
GO:0061448,connective tissue development,HP:0000272,Malar flattening
GO:0061448,connective tissue development,HP:0000926,Platyspondyly
GO:0061448,connective tissue development,HP:0001156,Brachydactyly syndrome
GO:0061448,connective tissue development,HP:0002676,Cloverleaf skull
GO:0061448,connective tissue development,HP:0002677,Small foramen magnum
GO:0061448,connective tissue development,HP:0005116,Arterial tortuosity
GO:0061448,connective tissue development,HP:0005731,Cortical irregularity
GO:0061448,connective tissue development,HP:0005736,Short tibia
GO:0061448,connective tissue development,HP:0008368,Tarsal synostosis
GO:0061448,connective tissue development,HP:0010049,Short metacarpal
GO:0061448,connective tissue development,HP:0011800,Midface retrusion
GO:0061458,reproductive system development,HP:0000006,Autosomal dominant inheritance
GO:0061458,reproductive system development,HP:0000013,Hypoplasia of the uterus
GO:0061458,reproductive system development,HP:0000149,Ovarian gonadoblastoma
GO:0061458,reproductive system development,HP:0000150,Gonadoblastoma
GO:0061458,reproductive system development,HP:0000668,Hypodontia
GO:0061458,reproductive system development,HP:0001470,Sex-limited autosomal dominant
GO:0061458,reproductive system development,HP:0008668,"Gonadal dysgenesis, male"
GO:0061458,reproductive system development,HP:0011682,Perimembranous ventricular septal defect
GO:0061458,reproductive system development,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0061458,reproductive system development,HP:0012245,Sex reversal
GO:0061512,protein localization to cilium,HP:0000510,Rod-cone dystrophy
GO:0061564,axon development,HP:0000006,Autosomal dominant inheritance
GO:0061564,axon development,HP:0000012,Urinary urgency
GO:0061564,axon development,HP:0001054,Numerous nevi
GO:0061564,axon development,HP:0001894,Thrombocytosis
GO:0061564,axon development,HP:0002300,Mutism
GO:0061615,glycolytic process through fructose-6-phosphate,HP:0000952,Jaundice
GO:0061615,glycolytic process through fructose-6-phosphate,HP:0001081,Cholelithiasis
GO:0061615,glycolytic process through fructose-6-phosphate,HP:0001082,Cholecystitis
GO:0061620,glycolytic process through glucose-6-phosphate,HP:0000952,Jaundice
GO:0061620,glycolytic process through glucose-6-phosphate,HP:0001081,Cholelithiasis
GO:0061620,glycolytic process through glucose-6-phosphate,HP:0001082,Cholecystitis
GO:0061621,canonical glycolysis,HP:0000952,Jaundice
GO:0061621,canonical glycolysis,HP:0001081,Cholelithiasis
GO:0061621,canonical glycolysis,HP:0001082,Cholecystitis
GO:0061718,glucose catabolic process to pyruvate,HP:0000952,Jaundice
GO:0061718,glucose catabolic process to pyruvate,HP:0001081,Cholelithiasis
GO:0061718,glucose catabolic process to pyruvate,HP:0001082,Cholecystitis
GO:0065002,intracellular protein transmembrane transport,HP:0001250,Seizures
GO:0065002,intracellular protein transmembrane transport,HP:0008935,Generalized neonatal hypotonia
GO:0065002,intracellular protein transmembrane transport,HP:0010655,Epiphyseal stippling
GO:0070071,proton-transporting two-sector ATPase complex assembly,HP:0000007,Autosomal recessive inheritance
GO:0070071,proton-transporting two-sector ATPase complex assembly,HP:0001508,Failure to thrive
GO:0070085,glycosylation,HP:0000007,Autosomal recessive inheritance
GO:0070085,glycosylation,HP:0000158,Macroglossia
GO:0070085,glycosylation,HP:0001083,Ectopia lentis
GO:0070085,glycosylation,HP:0001321,Cerebellar hypoplasia
GO:0070085,glycosylation,HP:0002350,Cerebellar cyst
GO:0070085,glycosylation,HP:0003236,Elevated serum creatine phosphokinase
GO:0070085,glycosylation,HP:0003391,Gowers sign
GO:0070085,glycosylation,HP:0003560,Muscular dystrophy
GO:0070085,glycosylation,HP:0003642,Type I transferrin isoform profile
GO:0070085,glycosylation,HP:0003741,Congenital muscular dystrophy
GO:0070085,glycosylation,HP:0006765,Chondrosarcoma
GO:0070085,glycosylation,HP:0007260,Type II lissencephaly
GO:0070085,glycosylation,HP:0007973,Retinal dysplasia
GO:0070085,glycosylation,HP:0010970,Blood group antigen abnormality
GO:0070166,enamel mineralization,HP:0000705,Amelogenesis imperfecta
GO:0070252,actin-mediated cell contraction,HP:0000006,Autosomal dominant inheritance
GO:0070252,actin-mediated cell contraction,HP:0001279,Syncope
GO:0070252,actin-mediated cell contraction,HP:0001644,Dilated cardiomyopathy
GO:0070252,actin-mediated cell contraction,HP:0001645,Sudden cardiac death
GO:0070252,actin-mediated cell contraction,HP:0001657,Prolonged QT interval
GO:0070252,actin-mediated cell contraction,HP:0001663,Ventricular fibrillation
GO:0070252,actin-mediated cell contraction,HP:0001664,Torsade de pointes
GO:0070252,actin-mediated cell contraction,HP:0003391,Gowers sign
GO:0070252,actin-mediated cell contraction,HP:0003458,EMG: myopathic abnormalities
GO:0070252,actin-mediated cell contraction,HP:0003803,Type 1 muscle fiber predominance
GO:0070252,actin-mediated cell contraction,HP:0004749,Atrial flutter
GO:0070252,actin-mediated cell contraction,HP:0005110,Atrial fibrillation
GO:0070252,actin-mediated cell contraction,HP:0010445,Primum atrial septal defect
GO:0070252,actin-mediated cell contraction,HP:0012232,Shortened QT interval
GO:0070286,axonemal dynein complex assembly,HP:0000246,Sinusitis
GO:0070286,axonemal dynein complex assembly,HP:0000403,Recurrent otitis media
GO:0070286,axonemal dynein complex assembly,HP:0000789,Infertility
GO:0070286,axonemal dynein complex assembly,HP:0001696,Situs inversus totalis
GO:0070286,axonemal dynein complex assembly,HP:0002110,Bronchiectasis
GO:0070286,axonemal dynein complex assembly,HP:0004469,Chronic bronchitis
GO:0070286,axonemal dynein complex assembly,HP:0011108,Recurrent sinusitis
GO:0070286,axonemal dynein complex assembly,HP:0011109,Chronic sinusitis
GO:0070286,axonemal dynein complex assembly,HP:0012263,Immotile cilia
GO:0070286,axonemal dynein complex assembly,HP:0012265,Ciliary dyskinesia
GO:0070286,axonemal dynein complex assembly,HP:0100582,Nasal polyposis
GO:0070286,axonemal dynein complex assembly,HP:0200073,Respiratory insufficiency due to defective ciliary clearance
GO:0070286,axonemal dynein complex assembly,HP:0012384,Rhinitis
GO:0070482,response to oxygen levels,HP:0000006,Autosomal dominant inheritance
GO:0070482,response to oxygen levels,HP:0003390,Sensory axonal neuropathy
GO:0070482,response to oxygen levels,HP:0005116,Arterial tortuosity
GO:0070482,response to oxygen levels,HP:0010982,Polygenic inheritance
GO:0070486,leukocyte aggregation,HP:0001047,Atopic dermatitis
GO:0070486,leukocyte aggregation,HP:0001528,Hemihypertrophy
GO:0070486,leukocyte aggregation,HP:0002716,Lymphadenopathy
GO:0070486,leukocyte aggregation,HP:0002721,Immunodeficiency
GO:0070489,T cell aggregation,HP:0001047,Atopic dermatitis
GO:0070489,T cell aggregation,HP:0001528,Hemihypertrophy
GO:0070489,T cell aggregation,HP:0002716,Lymphadenopathy
GO:0070489,T cell aggregation,HP:0002721,Immunodeficiency
GO:0070509,calcium ion import,HP:0000006,Autosomal dominant inheritance
GO:0070509,calcium ion import,HP:0003391,Gowers sign
GO:0070527,platelet aggregation,HP:0001902,Giant platelets
GO:0070527,platelet aggregation,HP:0003010,Prolonged bleeding time
GO:0070588,calcium ion transmembrane transport,HP:0000006,Autosomal dominant inheritance
GO:0070588,calcium ion transmembrane transport,HP:0001279,Syncope
GO:0070588,calcium ion transmembrane transport,HP:0003391,Gowers sign
GO:0070588,calcium ion transmembrane transport,HP:0004814,Fava bean-induced hemolytic anemia
GO:0070613,regulation of protein processing,HP:0001902,Giant platelets
GO:0070613,regulation of protein processing,HP:0002725,Systemic lupus erythematosus
GO:0070613,regulation of protein processing,HP:0004431,Complement deficiency
GO:0070613,regulation of protein processing,HP:0005421,Decreased serum complement C3
GO:0070661,leukocyte proliferation,HP:0002716,Lymphadenopathy
GO:0070661,leukocyte proliferation,HP:0002718,Recurrent bacterial infections
GO:0070661,leukocyte proliferation,HP:0002721,Immunodeficiency
GO:0070661,leukocyte proliferation,HP:0002849,Absence of lymph node germinal center
GO:0070663,regulation of leukocyte proliferation,HP:0002721,Immunodeficiency
GO:0070663,regulation of leukocyte proliferation,HP:0002849,Absence of lymph node germinal center
GO:0070838,divalent metal ion transport,HP:0000006,Autosomal dominant inheritance
GO:0070838,divalent metal ion transport,HP:0000012,Urinary urgency
GO:0070838,divalent metal ion transport,HP:0001279,Syncope
GO:0070838,divalent metal ion transport,HP:0003391,Gowers sign
GO:0070838,divalent metal ion transport,HP:0004814,Fava bean-induced hemolytic anemia
GO:0070875,positive regulation of glycogen metabolic process,HP:0001528,Hemihypertrophy
GO:0070997,neuron death,HP:0000006,Autosomal dominant inheritance
GO:0070997,neuron death,HP:0000012,Urinary urgency
GO:0070997,neuron death,HP:0000668,Hypodontia
GO:0070997,neuron death,HP:0001300,Parkinsonism
GO:0070997,neuron death,HP:0001528,Hemihypertrophy
GO:0070997,neuron death,HP:0001894,Thrombocytosis
GO:0070997,neuron death,HP:0004814,Fava bean-induced hemolytic anemia
GO:0071214,cellular response to abiotic stimulus,HP:0000150,Gonadoblastoma
GO:0071214,cellular response to abiotic stimulus,HP:0001099,Fundus atrophy
GO:0071214,cellular response to abiotic stimulus,HP:0005465,Facial hyperostosis
GO:0071241,cellular response to inorganic substance,HP:0011907,Reduced alpha/beta synthesis ratio
GO:0071260,cellular response to mechanical stimulus,HP:0000150,Gonadoblastoma
GO:0071260,cellular response to mechanical stimulus,HP:0005465,Facial hyperostosis
GO:0071320,cellular response to cAMP,HP:0000149,Ovarian gonadoblastoma
GO:0071320,cellular response to cAMP,HP:0001279,Syncope
GO:0071322,cellular response to carbohydrate stimulus,HP:0005959,Impaired gluconeogenesis
GO:0071326,cellular response to monosaccharide stimulus,HP:0005959,Impaired gluconeogenesis
GO:0071331,cellular response to hexose stimulus,HP:0005959,Impaired gluconeogenesis
GO:0071371,cellular response to gonadotropin stimulus,HP:0000149,Ovarian gonadoblastoma
GO:0071375,cellular response to peptide hormone stimulus,HP:0001083,Ectopia lentis
GO:0071375,cellular response to peptide hormone stimulus,HP:0001528,Hemihypertrophy
GO:0071375,cellular response to peptide hormone stimulus,HP:0001894,Thrombocytosis
GO:0071375,cellular response to peptide hormone stimulus,HP:0008258,Congenital adrenal hyperplasia
GO:0071378,cellular response to growth hormone stimulus,HP:0001894,Thrombocytosis
GO:0071396,cellular response to lipid,HP:0001894,Thrombocytosis
GO:0071407,cellular response to organic cyclic compound,HP:0000006,Autosomal dominant inheritance
GO:0071407,cellular response to organic cyclic compound,HP:0000149,Ovarian gonadoblastoma
GO:0071407,cellular response to organic cyclic compound,HP:0001472,Familial predisposition
GO:0071407,cellular response to organic cyclic compound,HP:0001894,Thrombocytosis
GO:0071417,cellular response to organonitrogen compound,HP:0000006,Autosomal dominant inheritance
GO:0071417,cellular response to organonitrogen compound,HP:0000149,Ovarian gonadoblastoma
GO:0071417,cellular response to organonitrogen compound,HP:0001083,Ectopia lentis
GO:0071417,cellular response to organonitrogen compound,HP:0001528,Hemihypertrophy
GO:0071417,cellular response to organonitrogen compound,HP:0001894,Thrombocytosis
GO:0071417,cellular response to organonitrogen compound,HP:0008258,Congenital adrenal hyperplasia
GO:0071435,potassium ion export,HP:0001279,Syncope
GO:0071435,potassium ion export,HP:0001645,Sudden cardiac death
GO:0071435,potassium ion export,HP:0001657,Prolonged QT interval
GO:0071435,potassium ion export,HP:0001664,Torsade de pointes
GO:0071478,cellular response to radiation,HP:0000668,Hypodontia
GO:0071482,cellular response to light stimulus,HP:0000668,Hypodontia
GO:0071482,cellular response to light stimulus,HP:0007642,Congenital stationary night blindness
GO:0071496,cellular response to external stimulus,HP:0000150,Gonadoblastoma
GO:0071496,cellular response to external stimulus,HP:0005465,Facial hyperostosis
GO:0071559,response to transforming growth factor beta,HP:0000006,Autosomal dominant inheritance
GO:0071559,response to transforming growth factor beta,HP:0001083,Ectopia lentis
GO:0071559,response to transforming growth factor beta,HP:0001634,Mitral valve prolapse
GO:0071559,response to transforming growth factor beta,HP:0001653,Mitral regurgitation
GO:0071559,response to transforming growth factor beta,HP:0002408,Cerebral arteriovenous malformation
GO:0071559,response to transforming growth factor beta,HP:0005116,Arterial tortuosity
GO:0071560,cellular response to transforming growth factor beta stimulus,HP:0000006,Autosomal dominant inheritance
GO:0071560,cellular response to transforming growth factor beta stimulus,HP:0001083,Ectopia lentis
GO:0071560,cellular response to transforming growth factor beta stimulus,HP:0001634,Mitral valve prolapse
GO:0071560,cellular response to transforming growth factor beta stimulus,HP:0001653,Mitral regurgitation
GO:0071560,cellular response to transforming growth factor beta stimulus,HP:0002408,Cerebral arteriovenous malformation
GO:0071560,cellular response to transforming growth factor beta stimulus,HP:0005116,Arterial tortuosity
GO:0071593,lymphocyte aggregation,HP:0001047,Atopic dermatitis
GO:0071593,lymphocyte aggregation,HP:0001528,Hemihypertrophy
GO:0071593,lymphocyte aggregation,HP:0002716,Lymphadenopathy
GO:0071593,lymphocyte aggregation,HP:0002721,Immunodeficiency
GO:0071604,transforming growth factor beta production,HP:0005116,Arterial tortuosity
GO:0071634,regulation of transforming growth factor beta production,HP:0005116,Arterial tortuosity
GO:0071695,anatomical structure maturation,HP:0002677,Small foramen magnum
GO:0071772,response to BMP,HP:0000006,Autosomal dominant inheritance
GO:0071772,response to BMP,HP:0001083,Ectopia lentis
GO:0071772,response to BMP,HP:0001684,Secundum atrial septal defect
GO:0071772,response to BMP,HP:0002408,Cerebral arteriovenous malformation
GO:0071772,response to BMP,HP:0008368,Tarsal synostosis
GO:0071773,cellular response to BMP stimulus,HP:0000006,Autosomal dominant inheritance
GO:0071773,cellular response to BMP stimulus,HP:0001083,Ectopia lentis
GO:0071773,cellular response to BMP stimulus,HP:0001684,Secundum atrial septal defect
GO:0071773,cellular response to BMP stimulus,HP:0002408,Cerebral arteriovenous malformation
GO:0071773,cellular response to BMP stimulus,HP:0008368,Tarsal synostosis
GO:0071774,response to fibroblast growth factor,HP:0000006,Autosomal dominant inheritance
GO:0071774,response to fibroblast growth factor,HP:0002676,Cloverleaf skull
GO:0071774,response to fibroblast growth factor,HP:0002677,Small foramen magnum
GO:0071774,response to fibroblast growth factor,HP:0003319,Abnormality of the cervical spine
GO:0071804,cellular potassium ion transport,HP:0000006,Autosomal dominant inheritance
GO:0071804,cellular potassium ion transport,HP:0001279,Syncope
GO:0071804,cellular potassium ion transport,HP:0001657,Prolonged QT interval
GO:0071805,potassium ion transmembrane transport,HP:0000006,Autosomal dominant inheritance
GO:0071805,potassium ion transmembrane transport,HP:0001279,Syncope
GO:0071805,potassium ion transmembrane transport,HP:0001657,Prolonged QT interval
GO:0071825,protein-lipid complex subunit organization,HP:0012184,Hyperalphalipoproteinemia
GO:0071827,plasma lipoprotein particle organization,HP:0012184,Hyperalphalipoproteinemia
GO:0071900,regulation of protein serine/threonine kinase activity,HP:0000006,Autosomal dominant inheritance
GO:0071900,regulation of protein serine/threonine kinase activity,HP:0001054,Numerous nevi
GO:0071900,regulation of protein serine/threonine kinase activity,HP:0001894,Thrombocytosis
GO:0071900,regulation of protein serine/threonine kinase activity,HP:0002849,Absence of lymph node germinal center
GO:0071900,regulation of protein serine/threonine kinase activity,HP:0003764,Nevus
GO:0071902,positive regulation of protein serine/threonine kinase activity,HP:0002849,Absence of lymph node germinal center
GO:0071941,nitrogen cycle metabolic process,HP:0001254,Lethargy
GO:0071941,nitrogen cycle metabolic process,HP:0001259,Coma
GO:0071941,nitrogen cycle metabolic process,HP:0001950,Respiratory alkalosis
GO:0071941,nitrogen cycle metabolic process,HP:0001951,Episodic ammonia intoxication
GO:0071941,nitrogen cycle metabolic process,HP:0001987,Hyperammonemia
GO:0071941,nitrogen cycle metabolic process,HP:0002038,Protein avoidance
GO:0071941,nitrogen cycle metabolic process,HP:0002181,Cerebral edema
GO:0072001,renal system development,HP:0000006,Autosomal dominant inheritance
GO:0072001,renal system development,HP:0000074,Ureteropelvic junction obstruction
GO:0072001,renal system development,HP:0000100,Nephrotic syndrome
GO:0072001,renal system development,HP:0000149,Ovarian gonadoblastoma
GO:0072001,renal system development,HP:0000243,Trigonocephaly
GO:0072001,renal system development,HP:0001083,Ectopia lentis
GO:0072001,renal system development,HP:0003774,Stage 5 chronic kidney disease
GO:0072001,renal system development,HP:0005116,Arterial tortuosity
GO:0072001,renal system development,HP:0005217,Duplication of internal organs
GO:0072001,renal system development,HP:0008659,Multiple small medullary renal cysts
GO:0072001,renal system development,HP:0100775,Dural ectasia
GO:0072006,nephron development,HP:0000006,Autosomal dominant inheritance
GO:0072006,nephron development,HP:0000093,Proteinuria
GO:0072006,nephron development,HP:0000100,Nephrotic syndrome
GO:0072006,nephron development,HP:0000149,Ovarian gonadoblastoma
GO:0072006,nephron development,HP:0008659,Multiple small medullary renal cysts
GO:0072009,nephron epithelium development,HP:0000006,Autosomal dominant inheritance
GO:0072009,nephron epithelium development,HP:0000100,Nephrotic syndrome
GO:0072009,nephron epithelium development,HP:0000149,Ovarian gonadoblastoma
GO:0072009,nephron epithelium development,HP:0008659,Multiple small medullary renal cysts
GO:0072010,glomerular epithelium development,HP:0000100,Nephrotic syndrome
GO:0072010,glomerular epithelium development,HP:0000149,Ovarian gonadoblastoma
GO:0072012,glomerulus vasculature development,HP:0000149,Ovarian gonadoblastoma
GO:0072017,distal tubule development,HP:0008659,Multiple small medullary renal cysts
GO:0072028,nephron morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0072028,nephron morphogenesis,HP:0000149,Ovarian gonadoblastoma
GO:0072073,kidney epithelium development,HP:0000006,Autosomal dominant inheritance
GO:0072073,kidney epithelium development,HP:0000100,Nephrotic syndrome
GO:0072073,kidney epithelium development,HP:0000149,Ovarian gonadoblastoma
GO:0072073,kidney epithelium development,HP:0000243,Trigonocephaly
GO:0072073,kidney epithelium development,HP:0008659,Multiple small medullary renal cysts
GO:0072074,kidney mesenchyme development,HP:0000149,Ovarian gonadoblastoma
GO:0072075,metanephric mesenchyme development,HP:0000149,Ovarian gonadoblastoma
GO:0072078,nephron tubule morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0072078,nephron tubule morphogenesis,HP:0000149,Ovarian gonadoblastoma
GO:0072080,nephron tubule development,HP:0000006,Autosomal dominant inheritance
GO:0072080,nephron tubule development,HP:0000149,Ovarian gonadoblastoma
GO:0072080,nephron tubule development,HP:0008659,Multiple small medullary renal cysts
GO:0072088,nephron epithelium morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0072088,nephron epithelium morphogenesis,HP:0000149,Ovarian gonadoblastoma
GO:0072089,stem cell proliferation,HP:0000006,Autosomal dominant inheritance
GO:0072089,stem cell proliferation,HP:0000243,Trigonocephaly
GO:0072091,regulation of stem cell proliferation,HP:0000006,Autosomal dominant inheritance
GO:0072109,glomerular mesangium development,HP:0000149,Ovarian gonadoblastoma
GO:0072111,cell proliferation involved in kidney development,HP:0000149,Ovarian gonadoblastoma
GO:0072112,glomerular visceral epithelial cell differentiation,HP:0000100,Nephrotic syndrome
GO:0072112,glomerular visceral epithelial cell differentiation,HP:0000149,Ovarian gonadoblastoma
GO:0072132,mesenchyme morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0072132,mesenchyme morphogenesis,HP:0002408,Cerebral arteriovenous malformation
GO:0072132,mesenchyme morphogenesis,HP:0005116,Arterial tortuosity
GO:0072163,mesonephric epithelium development,HP:0000006,Autosomal dominant inheritance
GO:0072163,mesonephric epithelium development,HP:0000149,Ovarian gonadoblastoma
GO:0072163,mesonephric epithelium development,HP:0000243,Trigonocephaly
GO:0072164,mesonephric tubule development,HP:0000006,Autosomal dominant inheritance
GO:0072164,mesonephric tubule development,HP:0000149,Ovarian gonadoblastoma
GO:0072164,mesonephric tubule development,HP:0000243,Trigonocephaly
GO:0072171,mesonephric tubule morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0072171,mesonephric tubule morphogenesis,HP:0000149,Ovarian gonadoblastoma
GO:0072203,cell proliferation involved in metanephros development,HP:0000149,Ovarian gonadoblastoma
GO:0072207,metanephric epithelium development,HP:0000100,Nephrotic syndrome
GO:0072207,metanephric epithelium development,HP:0000149,Ovarian gonadoblastoma
GO:0072210,metanephric nephron development,HP:0000100,Nephrotic syndrome
GO:0072210,metanephric nephron development,HP:0000149,Ovarian gonadoblastoma
GO:0072215,regulation of metanephros development,HP:0000149,Ovarian gonadoblastoma
GO:0072224,metanephric glomerulus development,HP:0000100,Nephrotic syndrome
GO:0072224,metanephric glomerulus development,HP:0000149,Ovarian gonadoblastoma
GO:0072273,metanephric nephron morphogenesis,HP:0000149,Ovarian gonadoblastoma
GO:0072311,glomerular epithelial cell differentiation,HP:0000100,Nephrotic syndrome
GO:0072311,glomerular epithelial cell differentiation,HP:0000149,Ovarian gonadoblastoma
GO:0072329,monocarboxylic acid catabolic process,HP:0001254,Lethargy
GO:0072329,monocarboxylic acid catabolic process,HP:0001528,Hemihypertrophy
GO:0072329,monocarboxylic acid catabolic process,HP:0002910,Elevated hepatic transaminases
GO:0072376,protein activation cascade,HP:0000132,Menorrhagia
GO:0072376,protein activation cascade,HP:0002725,Systemic lupus erythematosus
GO:0072376,protein activation cascade,HP:0003645,Prolonged partial thromboplastin time
GO:0072376,protein activation cascade,HP:0004431,Complement deficiency
GO:0072376,protein activation cascade,HP:0005261,Joint hemorrhage
GO:0072376,protein activation cascade,HP:0005421,Decreased serum complement C3
GO:0072376,protein activation cascade,HP:0012233,Intramuscular hematoma
GO:0072378,"blood coagulation, fibrin clot formation",HP:0000132,Menorrhagia
GO:0072378,"blood coagulation, fibrin clot formation",HP:0000421,Epistaxis
GO:0072378,"blood coagulation, fibrin clot formation",HP:0003645,Prolonged partial thromboplastin time
GO:0072378,"blood coagulation, fibrin clot formation",HP:0005261,Joint hemorrhage
GO:0072378,"blood coagulation, fibrin clot formation",HP:0012233,Intramuscular hematoma
GO:0072503,cellular divalent inorganic cation homeostasis,HP:0000006,Autosomal dominant inheritance
GO:0072503,cellular divalent inorganic cation homeostasis,HP:0001894,Thrombocytosis
GO:0072503,cellular divalent inorganic cation homeostasis,HP:0003391,Gowers sign
GO:0072506,trivalent inorganic anion homeostasis,HP:0000117,Renal phosphate wasting
GO:0072507,divalent inorganic cation homeostasis,HP:0000006,Autosomal dominant inheritance
GO:0072507,divalent inorganic cation homeostasis,HP:0001894,Thrombocytosis
GO:0072507,divalent inorganic cation homeostasis,HP:0003391,Gowers sign
GO:0072511,divalent inorganic cation transport,HP:0000006,Autosomal dominant inheritance
GO:0072511,divalent inorganic cation transport,HP:0000012,Urinary urgency
GO:0072511,divalent inorganic cation transport,HP:0001279,Syncope
GO:0072511,divalent inorganic cation transport,HP:0003391,Gowers sign
GO:0072511,divalent inorganic cation transport,HP:0004814,Fava bean-induced hemolytic anemia
GO:0072524,pyridine-containing compound metabolic process,HP:0000952,Jaundice
GO:0072524,pyridine-containing compound metabolic process,HP:0001082,Cholecystitis
GO:0072524,pyridine-containing compound metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0072593,reactive oxygen species metabolic process,HP:0000012,Urinary urgency
GO:0072593,reactive oxygen species metabolic process,HP:0001894,Thrombocytosis
GO:0072593,reactive oxygen species metabolic process,HP:0002716,Lymphadenopathy
GO:0072593,reactive oxygen species metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0072657,protein localization to membrane,HP:0000668,Hypodontia
GO:0072657,protein localization to membrane,HP:0001139,Choroideremia
GO:0072657,protein localization to membrane,HP:0001528,Hemihypertrophy
GO:0072657,protein localization to membrane,HP:0001972,Macrocytic anemia
GO:0072657,protein localization to membrane,HP:0003391,Gowers sign
GO:0072657,protein localization to membrane,HP:0004749,Atrial flutter
GO:0072657,protein localization to membrane,HP:0005518,Increased mean corpuscular volume
GO:0072662,protein localization to peroxisome,HP:0001250,Seizures
GO:0072662,protein localization to peroxisome,HP:0008935,Generalized neonatal hypotonia
GO:0072662,protein localization to peroxisome,HP:0010655,Epiphyseal stippling
GO:0072663,establishment of protein localization to peroxisome,HP:0001250,Seizures
GO:0072663,establishment of protein localization to peroxisome,HP:0008935,Generalized neonatal hypotonia
GO:0072663,establishment of protein localization to peroxisome,HP:0010655,Epiphyseal stippling
GO:0080171,lytic vacuole organization,HP:0002074,Increased neuronal autofluorescent lipopigment
GO:0080171,lytic vacuole organization,HP:0003205,Curvilinear intracellular accumulation of autofluorescent lipopigment storage material
GO:0080171,lytic vacuole organization,HP:0003208,Fingerprint intracellular accumulation of autofluorescent lipopigment storage material
GO:0086001,cardiac muscle cell action potential,HP:0000006,Autosomal dominant inheritance
GO:0086001,cardiac muscle cell action potential,HP:0001279,Syncope
GO:0086001,cardiac muscle cell action potential,HP:0001645,Sudden cardiac death
GO:0086001,cardiac muscle cell action potential,HP:0001657,Prolonged QT interval
GO:0086001,cardiac muscle cell action potential,HP:0001663,Ventricular fibrillation
GO:0086001,cardiac muscle cell action potential,HP:0001664,Torsade de pointes
GO:0086001,cardiac muscle cell action potential,HP:0001962,Palpitations
GO:0086001,cardiac muscle cell action potential,HP:0004749,Atrial flutter
GO:0086001,cardiac muscle cell action potential,HP:0005110,Atrial fibrillation
GO:0086001,cardiac muscle cell action potential,HP:0011663,Right ventricular cardiomyopathy
GO:0086001,cardiac muscle cell action potential,HP:0012232,Shortened QT interval
GO:0086002,cardiac muscle cell action potential involved in contraction,HP:0000006,Autosomal dominant inheritance
GO:0086002,cardiac muscle cell action potential involved in contraction,HP:0001279,Syncope
GO:0086002,cardiac muscle cell action potential involved in contraction,HP:0001645,Sudden cardiac death
GO:0086002,cardiac muscle cell action potential involved in contraction,HP:0001657,Prolonged QT interval
GO:0086002,cardiac muscle cell action potential involved in contraction,HP:0001663,Ventricular fibrillation
GO:0086002,cardiac muscle cell action potential involved in contraction,HP:0001664,Torsade de pointes
GO:0086002,cardiac muscle cell action potential involved in contraction,HP:0001962,Palpitations
GO:0086002,cardiac muscle cell action potential involved in contraction,HP:0004749,Atrial flutter
GO:0086002,cardiac muscle cell action potential involved in contraction,HP:0005110,Atrial fibrillation
GO:0086002,cardiac muscle cell action potential involved in contraction,HP:0011663,Right ventricular cardiomyopathy
GO:0086002,cardiac muscle cell action potential involved in contraction,HP:0012232,Shortened QT interval
GO:0086003,cardiac muscle cell contraction,HP:0000006,Autosomal dominant inheritance
GO:0086003,cardiac muscle cell contraction,HP:0001279,Syncope
GO:0086003,cardiac muscle cell contraction,HP:0001645,Sudden cardiac death
GO:0086003,cardiac muscle cell contraction,HP:0001657,Prolonged QT interval
GO:0086003,cardiac muscle cell contraction,HP:0001663,Ventricular fibrillation
GO:0086003,cardiac muscle cell contraction,HP:0001664,Torsade de pointes
GO:0086003,cardiac muscle cell contraction,HP:0001962,Palpitations
GO:0086003,cardiac muscle cell contraction,HP:0004308,Ventricular arrhythmia
GO:0086003,cardiac muscle cell contraction,HP:0004749,Atrial flutter
GO:0086003,cardiac muscle cell contraction,HP:0005110,Atrial fibrillation
GO:0086003,cardiac muscle cell contraction,HP:0010445,Primum atrial septal defect
GO:0086003,cardiac muscle cell contraction,HP:0011663,Right ventricular cardiomyopathy
GO:0086003,cardiac muscle cell contraction,HP:0012232,Shortened QT interval
GO:0086004,regulation of cardiac muscle cell contraction,HP:0000006,Autosomal dominant inheritance
GO:0086004,regulation of cardiac muscle cell contraction,HP:0001279,Syncope
GO:0086004,regulation of cardiac muscle cell contraction,HP:0001645,Sudden cardiac death
GO:0086004,regulation of cardiac muscle cell contraction,HP:0004308,Ventricular arrhythmia
GO:0086004,regulation of cardiac muscle cell contraction,HP:0011663,Right ventricular cardiomyopathy
GO:0086005,ventricular cardiac muscle cell action potential,HP:0000006,Autosomal dominant inheritance
GO:0086005,ventricular cardiac muscle cell action potential,HP:0001279,Syncope
GO:0086005,ventricular cardiac muscle cell action potential,HP:0001645,Sudden cardiac death
GO:0086005,ventricular cardiac muscle cell action potential,HP:0001657,Prolonged QT interval
GO:0086005,ventricular cardiac muscle cell action potential,HP:0001663,Ventricular fibrillation
GO:0086005,ventricular cardiac muscle cell action potential,HP:0001664,Torsade de pointes
GO:0086005,ventricular cardiac muscle cell action potential,HP:0004308,Ventricular arrhythmia
GO:0086005,ventricular cardiac muscle cell action potential,HP:0004749,Atrial flutter
GO:0086005,ventricular cardiac muscle cell action potential,HP:0005110,Atrial fibrillation
GO:0086005,ventricular cardiac muscle cell action potential,HP:0011663,Right ventricular cardiomyopathy
GO:0086009,membrane repolarization,HP:0000006,Autosomal dominant inheritance
GO:0086009,membrane repolarization,HP:0001279,Syncope
GO:0086009,membrane repolarization,HP:0001645,Sudden cardiac death
GO:0086009,membrane repolarization,HP:0001657,Prolonged QT interval
GO:0086009,membrane repolarization,HP:0001663,Ventricular fibrillation
GO:0086009,membrane repolarization,HP:0001664,Torsade de pointes
GO:0086010,membrane depolarization during action potential,HP:0000006,Autosomal dominant inheritance
GO:0086010,membrane depolarization during action potential,HP:0001279,Syncope
GO:0086010,membrane depolarization during action potential,HP:0001657,Prolonged QT interval
GO:0086010,membrane depolarization during action potential,HP:0002069,Generalized tonic-clonic seizures
GO:0086010,membrane depolarization during action potential,HP:0004749,Atrial flutter
GO:0086012,membrane depolarization during cardiac muscle cell action potential,HP:0000006,Autosomal dominant inheritance
GO:0086012,membrane depolarization during cardiac muscle cell action potential,HP:0001279,Syncope
GO:0086012,membrane depolarization during cardiac muscle cell action potential,HP:0001657,Prolonged QT interval
GO:0086012,membrane depolarization during cardiac muscle cell action potential,HP:0004749,Atrial flutter
GO:0086014,atrial cardiac muscle cell action potential,HP:0001279,Syncope
GO:0086014,atrial cardiac muscle cell action potential,HP:0004749,Atrial flutter
GO:0086014,atrial cardiac muscle cell action potential,HP:0005110,Atrial fibrillation
GO:0086019,cell-cell signaling involved in cardiac conduction,HP:0001279,Syncope
GO:0086019,cell-cell signaling involved in cardiac conduction,HP:0001645,Sudden cardiac death
GO:0086019,cell-cell signaling involved in cardiac conduction,HP:0001657,Prolonged QT interval
GO:0086019,cell-cell signaling involved in cardiac conduction,HP:0004749,Atrial flutter
GO:0086019,cell-cell signaling involved in cardiac conduction,HP:0005110,Atrial fibrillation
GO:0086026,atrial cardiac muscle cell to AV node cell signaling,HP:0001279,Syncope
GO:0086026,atrial cardiac muscle cell to AV node cell signaling,HP:0004749,Atrial flutter
GO:0086026,atrial cardiac muscle cell to AV node cell signaling,HP:0005110,Atrial fibrillation
GO:0086065,cell communication involved in cardiac conduction,HP:0000006,Autosomal dominant inheritance
GO:0086065,cell communication involved in cardiac conduction,HP:0001279,Syncope
GO:0086065,cell communication involved in cardiac conduction,HP:0001645,Sudden cardiac death
GO:0086065,cell communication involved in cardiac conduction,HP:0001657,Prolonged QT interval
GO:0086065,cell communication involved in cardiac conduction,HP:0001663,Ventricular fibrillation
GO:0086065,cell communication involved in cardiac conduction,HP:0001699,Sudden death
GO:0086065,cell communication involved in cardiac conduction,HP:0004749,Atrial flutter
GO:0086065,cell communication involved in cardiac conduction,HP:0004756,Ventricular tachycardia
GO:0086065,cell communication involved in cardiac conduction,HP:0005110,Atrial fibrillation
GO:0086065,cell communication involved in cardiac conduction,HP:0011663,Right ventricular cardiomyopathy
GO:0086066,atrial cardiac muscle cell to AV node cell communication,HP:0001279,Syncope
GO:0086066,atrial cardiac muscle cell to AV node cell communication,HP:0004749,Atrial flutter
GO:0086066,atrial cardiac muscle cell to AV node cell communication,HP:0005110,Atrial fibrillation
GO:0086069,bundle of His cell to Purkinje myocyte communication,HP:0001279,Syncope
GO:0086069,bundle of His cell to Purkinje myocyte communication,HP:0002224,Woolly hair
GO:0086069,bundle of His cell to Purkinje myocyte communication,HP:0004749,Atrial flutter
GO:0086069,bundle of His cell to Purkinje myocyte communication,HP:0011663,Right ventricular cardiomyopathy
GO:0086091,regulation of heart rate by cardiac conduction,HP:0000006,Autosomal dominant inheritance
GO:0086091,regulation of heart rate by cardiac conduction,HP:0001279,Syncope
GO:0086091,regulation of heart rate by cardiac conduction,HP:0001645,Sudden cardiac death
GO:0086091,regulation of heart rate by cardiac conduction,HP:0001657,Prolonged QT interval
GO:0086091,regulation of heart rate by cardiac conduction,HP:0001663,Ventricular fibrillation
GO:0086091,regulation of heart rate by cardiac conduction,HP:0001664,Torsade de pointes
GO:0086091,regulation of heart rate by cardiac conduction,HP:0001962,Palpitations
GO:0086091,regulation of heart rate by cardiac conduction,HP:0004749,Atrial flutter
GO:0086091,regulation of heart rate by cardiac conduction,HP:0005110,Atrial fibrillation
GO:0086091,regulation of heart rate by cardiac conduction,HP:0012232,Shortened QT interval
GO:0090066,regulation of anatomical structure size,HP:0001955,Unexplained fevers
GO:0090066,regulation of anatomical structure size,HP:0003391,Gowers sign
GO:0090066,regulation of anatomical structure size,HP:0005465,Facial hyperostosis
GO:0090066,regulation of anatomical structure size,HP:0012727,Thoracic aortic aneurysm
GO:0090087,regulation of peptide transport,HP:0000006,Autosomal dominant inheritance
GO:0090087,regulation of peptide transport,HP:0000007,Autosomal recessive inheritance
GO:0090087,regulation of peptide transport,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0090087,regulation of peptide transport,HP:0001249,Intellectual disability
GO:0090087,regulation of peptide transport,HP:0001250,Seizures
GO:0090087,regulation of peptide transport,HP:0001252,Muscular hypotonia
GO:0090087,regulation of peptide transport,HP:0001260,Dysarthria
GO:0090087,regulation of peptide transport,HP:0001263,Global developmental delay
GO:0090087,regulation of peptide transport,HP:0001325,Hypoglycemic coma
GO:0090087,regulation of peptide transport,HP:0001425,Heterogeneous
GO:0090087,regulation of peptide transport,HP:0001662,Bradycardia
GO:0090087,regulation of peptide transport,HP:0001894,Thrombocytosis
GO:0090087,regulation of peptide transport,HP:0002173,Hypoglycemic seizures
GO:0090087,regulation of peptide transport,HP:0004904,Maturity-onset diabetes of the young
GO:0090087,regulation of peptide transport,HP:0010705,4-5 finger syndactyly
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,HP:0000006,Autosomal dominant inheritance
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,HP:0001083,Ectopia lentis
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,HP:0002408,Cerebral arteriovenous malformation
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,HP:0005116,Arterial tortuosity
GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,HP:0000006,Autosomal dominant inheritance
GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,HP:0002408,Cerebral arteriovenous malformation
GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,HP:0000006,Autosomal dominant inheritance
GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,HP:0001083,Ectopia lentis
GO:0090130,tissue migration,HP:0000006,Autosomal dominant inheritance
GO:0090130,tissue migration,HP:0000034,Hydrocele testis
GO:0090130,tissue migration,HP:0001528,Hemihypertrophy
GO:0090132,epithelium migration,HP:0000006,Autosomal dominant inheritance
GO:0090132,epithelium migration,HP:0000034,Hydrocele testis
GO:0090132,epithelium migration,HP:0001528,Hemihypertrophy
GO:0090183,regulation of kidney development,HP:0000006,Autosomal dominant inheritance
GO:0090183,regulation of kidney development,HP:0000149,Ovarian gonadoblastoma
GO:0090184,positive regulation of kidney development,HP:0000006,Autosomal dominant inheritance
GO:0090184,positive regulation of kidney development,HP:0000149,Ovarian gonadoblastoma
GO:0090185,negative regulation of kidney development,HP:0000149,Ovarian gonadoblastoma
GO:0090192,regulation of glomerulus development,HP:0000149,Ovarian gonadoblastoma
GO:0090257,regulation of muscle system process,HP:0000006,Autosomal dominant inheritance
GO:0090257,regulation of muscle system process,HP:0001279,Syncope
GO:0090257,regulation of muscle system process,HP:0001644,Dilated cardiomyopathy
GO:0090257,regulation of muscle system process,HP:0001645,Sudden cardiac death
GO:0090257,regulation of muscle system process,HP:0001657,Prolonged QT interval
GO:0090257,regulation of muscle system process,HP:0001699,Sudden death
GO:0090257,regulation of muscle system process,HP:0004749,Atrial flutter
GO:0090257,regulation of muscle system process,HP:0004756,Ventricular tachycardia
GO:0090257,regulation of muscle system process,HP:0004814,Fava bean-induced hemolytic anemia
GO:0090257,regulation of muscle system process,HP:0005110,Atrial fibrillation
GO:0090276,regulation of peptide hormone secretion,HP:0000825,Hyperinsulinemic hypoglycemia
GO:0090276,regulation of peptide hormone secretion,HP:0001894,Thrombocytosis
GO:0090276,regulation of peptide hormone secretion,HP:0004904,Maturity-onset diabetes of the young
GO:0090277,positive regulation of peptide hormone secretion,HP:0001894,Thrombocytosis
GO:0090287,regulation of cellular response to growth factor stimulus,HP:0000006,Autosomal dominant inheritance
GO:0090287,regulation of cellular response to growth factor stimulus,HP:0001083,Ectopia lentis
GO:0090287,regulation of cellular response to growth factor stimulus,HP:0002408,Cerebral arteriovenous malformation
GO:0090287,regulation of cellular response to growth factor stimulus,HP:0004635,Cervical C5/C6 vertebrae fusion
GO:0090288,negative regulation of cellular response to growth factor stimulus,HP:0000006,Autosomal dominant inheritance
GO:0090288,negative regulation of cellular response to growth factor stimulus,HP:0001083,Ectopia lentis
GO:0090596,sensory organ morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:0090596,sensory organ morphogenesis,HP:0000243,Trigonocephaly
GO:0090596,sensory organ morphogenesis,HP:0000501,Glaucoma
GO:0090596,sensory organ morphogenesis,HP:0000510,Rod-cone dystrophy
GO:0090596,sensory organ morphogenesis,HP:0001083,Ectopia lentis
GO:0090596,sensory organ morphogenesis,HP:0005217,Duplication of internal organs
GO:0090596,sensory organ morphogenesis,HP:0008499,High-grade hypermetropia
GO:0090596,sensory organ morphogenesis,HP:0012038,Corneal guttata
GO:0097006,regulation of plasma lipoprotein particle levels,HP:0003124,Hypercholesterolemia
GO:0097006,regulation of plasma lipoprotein particle levels,HP:0012184,Hyperalphalipoproteinemia
GO:0097094,craniofacial suture morphogenesis,HP:0000243,Trigonocephaly
GO:0097186,amelogenesis,HP:0000705,Amelogenesis imperfecta
GO:0097191,extrinsic apoptotic signaling pathway,HP:0000006,Autosomal dominant inheritance
GO:0097191,extrinsic apoptotic signaling pathway,HP:0001894,Thrombocytosis
GO:0097191,extrinsic apoptotic signaling pathway,HP:0002677,Small foramen magnum
GO:0097191,extrinsic apoptotic signaling pathway,HP:0005116,Arterial tortuosity
GO:0097193,intrinsic apoptotic signaling pathway,HP:0000408,Progressive sensorineural hearing impairment
GO:0097193,intrinsic apoptotic signaling pathway,HP:0000668,Hypodontia
GO:0097193,intrinsic apoptotic signaling pathway,HP:0001894,Thrombocytosis
GO:0097305,response to alcohol,HP:0004814,Fava bean-induced hemolytic anemia
GO:0097479,synaptic vesicle localization,HP:0000012,Urinary urgency
GO:0097479,synaptic vesicle localization,HP:0001054,Numerous nevi
GO:0097480,establishment of synaptic vesicle localization,HP:0000012,Urinary urgency
GO:0097485,neuron projection guidance,HP:0000006,Autosomal dominant inheritance
GO:0097499,protein localization to non-motile cilium,HP:0000510,Rod-cone dystrophy
GO:0097502,mannosylation,HP:0000007,Autosomal recessive inheritance
GO:0097502,mannosylation,HP:0000158,Macroglossia
GO:0097502,mannosylation,HP:0001321,Cerebellar hypoplasia
GO:0097502,mannosylation,HP:0003236,Elevated serum creatine phosphokinase
GO:0097502,mannosylation,HP:0003560,Muscular dystrophy
GO:0097502,mannosylation,HP:0003741,Congenital muscular dystrophy
GO:0097502,mannosylation,HP:0007260,Type II lissencephaly
GO:0097502,mannosylation,HP:0007973,Retinal dysplasia
GO:0098534,centriole assembly,HP:0000252,Microcephaly
GO:0098534,centriole assembly,HP:0000340,Sloping forehead
GO:0098656,anion transmembrane transport,HP:0001528,Hemihypertrophy
GO:0098656,anion transmembrane transport,HP:0002150,Hypercalciuria
GO:0098661,inorganic anion transmembrane transport,HP:0002150,Hypercalciuria
GO:0098727,maintenance of cell number,HP:0000006,Autosomal dominant inheritance
GO:0098727,maintenance of cell number,HP:0030084,Clinodactyly
GO:0098743,cell aggregation,HP:0000926,Platyspondyly
GO:0098773,skin epidermis development,HP:0000535,Sparse and thin eyebrow
GO:0098773,skin epidermis development,HP:0000668,Hypodontia
GO:0098773,skin epidermis development,HP:0001006,Hypotrichosis
GO:0098773,skin epidermis development,HP:0002561,Absent nipple
GO:0098840,protein transport along microtubule,HP:0000510,Rod-cone dystrophy
GO:0098840,protein transport along microtubule,HP:0000774,Narrow chest
GO:0098868,bone growth,HP:0002677,Small foramen magnum
GO:0098868,bone growth,HP:0003015,Flared metaphysis
GO:0098900,regulation of action potential,HP:0001279,Syncope
GO:0098900,regulation of action potential,HP:0001645,Sudden cardiac death
GO:0098900,regulation of action potential,HP:0001657,Prolonged QT interval
GO:0098900,regulation of action potential,HP:0004308,Ventricular arrhythmia
GO:0098900,regulation of action potential,HP:0011663,Right ventricular cardiomyopathy
GO:0098901,regulation of cardiac muscle cell action potential,HP:0001279,Syncope
GO:0098901,regulation of cardiac muscle cell action potential,HP:0002224,Woolly hair
GO:0098901,regulation of cardiac muscle cell action potential,HP:0004308,Ventricular arrhythmia
GO:0098901,regulation of cardiac muscle cell action potential,HP:0011663,Right ventricular cardiomyopathy
GO:0098911,regulation of ventricular cardiac muscle cell action potential,HP:0002224,Woolly hair
GO:0098911,regulation of ventricular cardiac muscle cell action potential,HP:0004308,Ventricular arrhythmia
GO:0098911,regulation of ventricular cardiac muscle cell action potential,HP:0011663,Right ventricular cardiomyopathy
GO:0099622,cardiac muscle cell membrane repolarization,HP:0000006,Autosomal dominant inheritance
GO:0099622,cardiac muscle cell membrane repolarization,HP:0001279,Syncope
GO:0099622,cardiac muscle cell membrane repolarization,HP:0001645,Sudden cardiac death
GO:0099622,cardiac muscle cell membrane repolarization,HP:0001657,Prolonged QT interval
GO:0099622,cardiac muscle cell membrane repolarization,HP:0001663,Ventricular fibrillation
GO:0099622,cardiac muscle cell membrane repolarization,HP:0001664,Torsade de pointes
GO:0099622,cardiac muscle cell membrane repolarization,HP:0005110,Atrial fibrillation
GO:0099623,regulation of cardiac muscle cell membrane repolarization,HP:0000006,Autosomal dominant inheritance
GO:0099623,regulation of cardiac muscle cell membrane repolarization,HP:0001279,Syncope
GO:0099623,regulation of cardiac muscle cell membrane repolarization,HP:0001645,Sudden cardiac death
GO:0099623,regulation of cardiac muscle cell membrane repolarization,HP:0001657,Prolonged QT interval
GO:0099623,regulation of cardiac muscle cell membrane repolarization,HP:0001663,Ventricular fibrillation
GO:0099623,regulation of cardiac muscle cell membrane repolarization,HP:0001664,Torsade de pointes
GO:0099623,regulation of cardiac muscle cell membrane repolarization,HP:0005110,Atrial fibrillation
GO:0099625,ventricular cardiac muscle cell membrane repolarization,HP:0000006,Autosomal dominant inheritance
GO:0099625,ventricular cardiac muscle cell membrane repolarization,HP:0001279,Syncope
GO:0099625,ventricular cardiac muscle cell membrane repolarization,HP:0001645,Sudden cardiac death
GO:0099625,ventricular cardiac muscle cell membrane repolarization,HP:0001657,Prolonged QT interval
GO:0099625,ventricular cardiac muscle cell membrane repolarization,HP:0001663,Ventricular fibrillation
GO:0099625,ventricular cardiac muscle cell membrane repolarization,HP:0001664,Torsade de pointes
GO:0198738,cell-cell signaling by wnt,HP:0000006,Autosomal dominant inheritance
GO:0198738,cell-cell signaling by wnt,HP:0000074,Ureteropelvic junction obstruction
GO:0198738,cell-cell signaling by wnt,HP:0000668,Hypodontia
GO:1900046,regulation of hemostasis,HP:0002204,Pulmonary embolism
GO:1900046,regulation of hemostasis,HP:0005305,Cerebral venous thrombosis
GO:1900046,regulation of hemostasis,HP:0100724,Hypercoagulability
GO:1900047,negative regulation of hemostasis,HP:0002204,Pulmonary embolism
GO:1900047,negative regulation of hemostasis,HP:0100724,Hypercoagulability
GO:1900180,regulation of protein localization to nucleus,HP:0000006,Autosomal dominant inheritance
GO:1900180,regulation of protein localization to nucleus,HP:0001894,Thrombocytosis
GO:1900180,regulation of protein localization to nucleus,HP:0005116,Arterial tortuosity
GO:1900182,positive regulation of protein localization to nucleus,HP:0001894,Thrombocytosis
GO:1900182,positive regulation of protein localization to nucleus,HP:0005116,Arterial tortuosity
GO:1901016,regulation of potassium ion transmembrane transporter activity,HP:0001279,Syncope
GO:1901016,regulation of potassium ion transmembrane transporter activity,HP:0001657,Prolonged QT interval
GO:1901136,carbohydrate derivative catabolic process,HP:0000280,Coarse facial features
GO:1901136,carbohydrate derivative catabolic process,HP:0000943,Dysostosis multiplex
GO:1901136,carbohydrate derivative catabolic process,HP:0001654,Abnormality of the heart valves
GO:1901136,carbohydrate derivative catabolic process,HP:0001744,Splenomegaly
GO:1901136,carbohydrate derivative catabolic process,HP:0002159,Heparan sulfate excretion in urine
GO:1901136,carbohydrate derivative catabolic process,HP:0002208,Coarse hair
GO:1901136,carbohydrate derivative catabolic process,HP:0002240,Hepatomegaly
GO:1901136,carbohydrate derivative catabolic process,HP:0002788,Recurrent upper respiratory tract infections
GO:1901213,regulation of transcription from RNA polymerase II promoter involved in heart development,HP:0008368,Tarsal synostosis
GO:1901214,regulation of neuron death,HP:0000012,Urinary urgency
GO:1901214,regulation of neuron death,HP:0000668,Hypodontia
GO:1901214,regulation of neuron death,HP:0001528,Hemihypertrophy
GO:1901214,regulation of neuron death,HP:0001894,Thrombocytosis
GO:1901214,regulation of neuron death,HP:0004814,Fava bean-induced hemolytic anemia
GO:1901215,negative regulation of neuron death,HP:0000012,Urinary urgency
GO:1901215,negative regulation of neuron death,HP:0001528,Hemihypertrophy
GO:1901215,negative regulation of neuron death,HP:0001894,Thrombocytosis
GO:1901342,regulation of vasculature development,HP:0000006,Autosomal dominant inheritance
GO:1901342,regulation of vasculature development,HP:0000149,Ovarian gonadoblastoma
GO:1901342,regulation of vasculature development,HP:0002408,Cerebral arteriovenous malformation
GO:1901343,negative regulation of vasculature development,HP:0000149,Ovarian gonadoblastoma
GO:1901379,regulation of potassium ion transmembrane transport,HP:0001279,Syncope
GO:1901379,regulation of potassium ion transmembrane transport,HP:0001657,Prolonged QT interval
GO:1901380,negative regulation of potassium ion transmembrane transport,HP:0001279,Syncope
GO:1901381,positive regulation of potassium ion transmembrane transport,HP:0001279,Syncope
GO:1901381,positive regulation of potassium ion transmembrane transport,HP:0001645,Sudden cardiac death
GO:1901381,positive regulation of potassium ion transmembrane transport,HP:0001657,Prolonged QT interval
GO:1901565,organonitrogen compound catabolic process,HP:0000007,Autosomal recessive inheritance
GO:1901565,organonitrogen compound catabolic process,HP:0000943,Dysostosis multiplex
GO:1901565,organonitrogen compound catabolic process,HP:0001744,Splenomegaly
GO:1901565,organonitrogen compound catabolic process,HP:0002159,Heparan sulfate excretion in urine
GO:1901565,organonitrogen compound catabolic process,HP:0002208,Coarse hair
GO:1901565,organonitrogen compound catabolic process,HP:0002240,Hepatomegaly
GO:1901565,organonitrogen compound catabolic process,HP:0002716,Lymphadenopathy
GO:1901565,organonitrogen compound catabolic process,HP:0003231,Hypertyrosinemia
GO:1901565,organonitrogen compound catabolic process,HP:0003607,4-Hydroxyphenylacetic aciduria
GO:1901605,alpha-amino acid metabolic process,HP:0000007,Autosomal recessive inheritance
GO:1901605,alpha-amino acid metabolic process,HP:0001951,Episodic ammonia intoxication
GO:1901605,alpha-amino acid metabolic process,HP:0001987,Hyperammonemia
GO:1901605,alpha-amino acid metabolic process,HP:0003231,Hypertyrosinemia
GO:1901605,alpha-amino acid metabolic process,HP:0003607,4-Hydroxyphenylacetic aciduria
GO:1901606,alpha-amino acid catabolic process,HP:0003231,Hypertyrosinemia
GO:1901606,alpha-amino acid catabolic process,HP:0003607,4-Hydroxyphenylacetic aciduria
GO:1901607,alpha-amino acid biosynthetic process,HP:0001951,Episodic ammonia intoxication
GO:1901607,alpha-amino acid biosynthetic process,HP:0001987,Hyperammonemia
GO:1901615,organic hydroxy compound metabolic process,HP:0001300,Parkinsonism
GO:1901615,organic hydroxy compound metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:1901615,organic hydroxy compound metabolic process,HP:0008191,Thyroid agenesis
GO:1901615,organic hydroxy compound metabolic process,HP:0008258,Congenital adrenal hyperplasia
GO:1901615,organic hydroxy compound metabolic process,HP:0010874,Tendon xanthomatosis
GO:1901615,organic hydroxy compound metabolic process,HP:0200044,Porokeratosis
GO:1901617,organic hydroxy compound biosynthetic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:1901617,organic hydroxy compound biosynthetic process,HP:0008258,Congenital adrenal hyperplasia
GO:1901617,organic hydroxy compound biosynthetic process,HP:0200044,Porokeratosis
GO:1901652,response to peptide,HP:0000006,Autosomal dominant inheritance
GO:1901652,response to peptide,HP:0000825,Hyperinsulinemic hypoglycemia
GO:1901652,response to peptide,HP:0001083,Ectopia lentis
GO:1901652,response to peptide,HP:0001528,Hemihypertrophy
GO:1901652,response to peptide,HP:0001894,Thrombocytosis
GO:1901652,response to peptide,HP:0005465,Facial hyperostosis
GO:1901652,response to peptide,HP:0008258,Congenital adrenal hyperplasia
GO:1901653,cellular response to peptide,HP:0001083,Ectopia lentis
GO:1901653,cellular response to peptide,HP:0001528,Hemihypertrophy
GO:1901653,cellular response to peptide,HP:0001894,Thrombocytosis
GO:1901653,cellular response to peptide,HP:0008258,Congenital adrenal hyperplasia
GO:1901657,glycosyl compound metabolic process,HP:0000952,Jaundice
GO:1901657,glycosyl compound metabolic process,HP:0001082,Cholecystitis
GO:1901722,regulation of cell proliferation involved in kidney development,HP:0000149,Ovarian gonadoblastoma
GO:1901861,regulation of muscle tissue development,HP:0000006,Autosomal dominant inheritance
GO:1901861,regulation of muscle tissue development,HP:0004814,Fava bean-induced hemolytic anemia
GO:1901862,negative regulation of muscle tissue development,HP:0000006,Autosomal dominant inheritance
GO:1901862,negative regulation of muscle tissue development,HP:0004814,Fava bean-induced hemolytic anemia
GO:1902105,regulation of leukocyte differentiation,HP:0000006,Autosomal dominant inheritance
GO:1902105,regulation of leukocyte differentiation,HP:0001083,Ectopia lentis
GO:1902105,regulation of leukocyte differentiation,HP:0002090,Pneumonia
GO:1902105,regulation of leukocyte differentiation,HP:0002716,Lymphadenopathy
GO:1902105,regulation of leukocyte differentiation,HP:0003095,Septic arthritis
GO:1902115,regulation of organelle assembly,HP:0004684,Talipes valgus
GO:1902305,regulation of sodium ion transmembrane transport,HP:0001279,Syncope
GO:1902305,regulation of sodium ion transmembrane transport,HP:0001663,Ventricular fibrillation
GO:1902305,regulation of sodium ion transmembrane transport,HP:0004749,Atrial flutter
GO:1902476,chloride transmembrane transport,HP:0000121,Nephrocalcinosis
GO:1902532,negative regulation of intracellular signal transduction,HP:0000006,Autosomal dominant inheritance
GO:1902532,negative regulation of intracellular signal transduction,HP:0000408,Progressive sensorineural hearing impairment
GO:1902532,negative regulation of intracellular signal transduction,HP:0002716,Lymphadenopathy
GO:1902532,negative regulation of intracellular signal transduction,HP:0003391,Gowers sign
GO:1902593,single-organism nuclear import,HP:0000006,Autosomal dominant inheritance
GO:1902593,single-organism nuclear import,HP:0001894,Thrombocytosis
GO:1902593,single-organism nuclear import,HP:0004749,Atrial flutter
GO:1902593,single-organism nuclear import,HP:0005116,Arterial tortuosity
GO:1902652,secondary alcohol metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:1902652,secondary alcohol metabolic process,HP:0008258,Congenital adrenal hyperplasia
GO:1902652,secondary alcohol metabolic process,HP:0200044,Porokeratosis
GO:1902653,secondary alcohol biosynthetic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:1902653,secondary alcohol biosynthetic process,HP:0200044,Porokeratosis
GO:1902692,regulation of neuroblast proliferation,HP:0000006,Autosomal dominant inheritance
GO:1903034,regulation of response to wounding,HP:0001054,Numerous nevi
GO:1903034,regulation of response to wounding,HP:0002204,Pulmonary embolism
GO:1903034,regulation of response to wounding,HP:0005305,Cerebral venous thrombosis
GO:1903034,regulation of response to wounding,HP:0100724,Hypercoagulability
GO:1903035,negative regulation of response to wounding,HP:0100724,Hypercoagulability
GO:1903037,regulation of leukocyte cell-cell adhesion,HP:0001528,Hemihypertrophy
GO:1903037,regulation of leukocyte cell-cell adhesion,HP:0002716,Lymphadenopathy
GO:1903037,regulation of leukocyte cell-cell adhesion,HP:0002721,Immunodeficiency
GO:1903039,positive regulation of leukocyte cell-cell adhesion,HP:0001528,Hemihypertrophy
GO:1903039,positive regulation of leukocyte cell-cell adhesion,HP:0002716,Lymphadenopathy
GO:1903039,positive regulation of leukocyte cell-cell adhesion,HP:0002721,Immunodeficiency
GO:1903115,regulation of actin filament-based movement,HP:0000006,Autosomal dominant inheritance
GO:1903115,regulation of actin filament-based movement,HP:0001279,Syncope
GO:1903115,regulation of actin filament-based movement,HP:0001645,Sudden cardiac death
GO:1903115,regulation of actin filament-based movement,HP:0004308,Ventricular arrhythmia
GO:1903115,regulation of actin filament-based movement,HP:0011663,Right ventricular cardiomyopathy
GO:1903169,regulation of calcium ion transmembrane transport,HP:0001279,Syncope
GO:1903169,regulation of calcium ion transmembrane transport,HP:0004814,Fava bean-induced hemolytic anemia
GO:1903317,regulation of protein maturation,HP:0001902,Giant platelets
GO:1903317,regulation of protein maturation,HP:0002725,Systemic lupus erythematosus
GO:1903317,regulation of protein maturation,HP:0004431,Complement deficiency
GO:1903317,regulation of protein maturation,HP:0005421,Decreased serum complement C3
GO:1903319,positive regulation of protein maturation,HP:0001902,Giant platelets
GO:1903409,reactive oxygen species biosynthetic process,HP:0001894,Thrombocytosis
GO:1903426,regulation of reactive oxygen species biosynthetic process,HP:0001894,Thrombocytosis
GO:1903509,liposaccharide metabolic process,HP:0000007,Autosomal recessive inheritance
GO:1903509,liposaccharide metabolic process,HP:0000280,Coarse facial features
GO:1903509,liposaccharide metabolic process,HP:0001250,Seizures
GO:1903509,liposaccharide metabolic process,HP:0001252,Muscular hypotonia
GO:1903509,liposaccharide metabolic process,HP:0001336,Myoclonus
GO:1903509,liposaccharide metabolic process,HP:0001744,Splenomegaly
GO:1903509,liposaccharide metabolic process,HP:0002059,Cerebral atrophy
GO:1903509,liposaccharide metabolic process,HP:0002240,Hepatomegaly
GO:1903509,liposaccharide metabolic process,HP:0008166,Decreased beta-galactosidase activity
GO:1903509,liposaccharide metabolic process,HP:0010729,Cherry red spot of the macula
GO:1903510,mucopolysaccharide metabolic process,HP:0001654,Abnormality of the heart valves
GO:1903522,regulation of blood circulation,HP:0000006,Autosomal dominant inheritance
GO:1903522,regulation of blood circulation,HP:0001279,Syncope
GO:1903522,regulation of blood circulation,HP:0001644,Dilated cardiomyopathy
GO:1903522,regulation of blood circulation,HP:0001645,Sudden cardiac death
GO:1903522,regulation of blood circulation,HP:0001657,Prolonged QT interval
GO:1903522,regulation of blood circulation,HP:0001663,Ventricular fibrillation
GO:1903522,regulation of blood circulation,HP:0001699,Sudden death
GO:1903522,regulation of blood circulation,HP:0001894,Thrombocytosis
GO:1903522,regulation of blood circulation,HP:0004749,Atrial flutter
GO:1903522,regulation of blood circulation,HP:0004756,Ventricular tachycardia
GO:1903522,regulation of blood circulation,HP:0005110,Atrial fibrillation
GO:1903522,regulation of blood circulation,HP:0005465,Facial hyperostosis
GO:1903522,regulation of blood circulation,HP:0010445,Primum atrial septal defect
GO:1903522,regulation of blood circulation,HP:0012232,Shortened QT interval
GO:1903524,positive regulation of blood circulation,HP:0005465,Facial hyperostosis
GO:1903532,positive regulation of secretion by cell,HP:0000006,Autosomal dominant inheritance
GO:1903532,positive regulation of secretion by cell,HP:0000012,Urinary urgency
GO:1903532,positive regulation of secretion by cell,HP:0001894,Thrombocytosis
GO:1903533,regulation of protein targeting,HP:0001894,Thrombocytosis
GO:1903706,regulation of hemopoiesis,HP:0000006,Autosomal dominant inheritance
GO:1903706,regulation of hemopoiesis,HP:0001083,Ectopia lentis
GO:1903706,regulation of hemopoiesis,HP:0002090,Pneumonia
GO:1903706,regulation of hemopoiesis,HP:0002716,Lymphadenopathy
GO:1903706,regulation of hemopoiesis,HP:0003095,Septic arthritis
GO:1903779,regulation of cardiac conduction,HP:0000006,Autosomal dominant inheritance
GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,HP:0000006,Autosomal dominant inheritance
GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,HP:0001083,Ectopia lentis
GO:1903959,regulation of anion transmembrane transport,HP:0000114,Proximal tubulopathy
GO:1903959,regulation of anion transmembrane transport,HP:0001528,Hemihypertrophy
GO:1903959,regulation of anion transmembrane transport,HP:0002150,Hypercalciuria
GO:1903959,regulation of anion transmembrane transport,HP:0003126,Low-molecular-weight proteinuria
GO:1904019,epithelial cell apoptotic process,HP:0001894,Thrombocytosis
GO:1904019,epithelial cell apoptotic process,HP:0002849,Absence of lymph node germinal center
GO:1904062,regulation of cation transmembrane transport,HP:0000006,Autosomal dominant inheritance
GO:1904062,regulation of cation transmembrane transport,HP:0001279,Syncope
GO:1904062,regulation of cation transmembrane transport,HP:0001645,Sudden cardiac death
GO:1904062,regulation of cation transmembrane transport,HP:0001657,Prolonged QT interval
GO:1904062,regulation of cation transmembrane transport,HP:0001663,Ventricular fibrillation
GO:1904062,regulation of cation transmembrane transport,HP:0001664,Torsade de pointes
GO:1904062,regulation of cation transmembrane transport,HP:0004749,Atrial flutter
GO:1904062,regulation of cation transmembrane transport,HP:0004814,Fava bean-induced hemolytic anemia
GO:1904062,regulation of cation transmembrane transport,HP:0005110,Atrial fibrillation
GO:1904062,regulation of cation transmembrane transport,HP:0012232,Shortened QT interval
GO:1904063,negative regulation of cation transmembrane transport,HP:0001279,Syncope
GO:1904063,negative regulation of cation transmembrane transport,HP:0001657,Prolonged QT interval
GO:1904064,positive regulation of cation transmembrane transport,HP:0001279,Syncope
GO:1904064,positive regulation of cation transmembrane transport,HP:0001657,Prolonged QT interval
GO:1904064,positive regulation of cation transmembrane transport,HP:0004814,Fava bean-induced hemolytic anemia
GO:1904427,positive regulation of calcium ion transmembrane transport,HP:0004814,Fava bean-induced hemolytic anemia
GO:1904589,regulation of protein import,HP:0001894,Thrombocytosis
GO:1904591,positive regulation of protein import,HP:0001894,Thrombocytosis
GO:1904705,regulation of vascular smooth muscle cell proliferation,HP:0001894,Thrombocytosis
GO:1904888,cranial skeletal system development,HP:0000243,Trigonocephaly
GO:1904888,cranial skeletal system development,HP:0005116,Arterial tortuosity
GO:1904888,cranial skeletal system development,HP:0005217,Duplication of internal organs
GO:1905207,regulation of cardiocyte differentiation,HP:0004814,Fava bean-induced hemolytic anemia
GO:1905314,semi-lunar valve development,HP:0000006,Autosomal dominant inheritance
GO:1905330,regulation of morphogenesis of an epithelium,HP:0000074,Ureteropelvic junction obstruction
GO:1990267,response to transition metal nanoparticle,HP:0001300,Parkinsonism
GO:1990267,response to transition metal nanoparticle,HP:0004814,Fava bean-induced hemolytic anemia
GO:1990267,response to transition metal nanoparticle,HP:0011999,Paranoia
GO:1990874,vascular smooth muscle cell proliferation,HP:0001894,Thrombocytosis
GO:2000021,regulation of ion homeostasis,HP:0000006,Autosomal dominant inheritance
GO:2000021,regulation of ion homeostasis,HP:0001279,Syncope
GO:2000021,regulation of ion homeostasis,HP:0004749,Atrial flutter
GO:2000027,regulation of organ morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:2000027,regulation of organ morphogenesis,HP:0000074,Ureteropelvic junction obstruction
GO:2000027,regulation of organ morphogenesis,HP:0000149,Ovarian gonadoblastoma
GO:2000116,regulation of cysteine-type endopeptidase activity,HP:0000668,Hypodontia
GO:2000116,regulation of cysteine-type endopeptidase activity,HP:0001894,Thrombocytosis
GO:2000147,positive regulation of cell motility,HP:0000006,Autosomal dominant inheritance
GO:2000147,positive regulation of cell motility,HP:0001528,Hemihypertrophy
GO:2000147,positive regulation of cell motility,HP:0001894,Thrombocytosis
GO:2000147,positive regulation of cell motility,HP:0005116,Arterial tortuosity
GO:2000147,positive regulation of cell motility,HP:0012233,Intramuscular hematoma
GO:2000177,regulation of neural precursor cell proliferation,HP:0000006,Autosomal dominant inheritance
GO:2000177,regulation of neural precursor cell proliferation,HP:0001360,Holoprosencephaly
GO:2000179,positive regulation of neural precursor cell proliferation,HP:0001360,Holoprosencephaly
GO:2000241,regulation of reproductive process,HP:0000149,Ovarian gonadoblastoma
GO:2000241,regulation of reproductive process,HP:0012245,Sex reversal
GO:2000243,positive regulation of reproductive process,HP:0000149,Ovarian gonadoblastoma
GO:2000243,positive regulation of reproductive process,HP:0012245,Sex reversal
GO:2000257,regulation of protein activation cascade,HP:0002725,Systemic lupus erythematosus
GO:2000257,regulation of protein activation cascade,HP:0004431,Complement deficiency
GO:2000257,regulation of protein activation cascade,HP:0005381,Recurrent meningococcal disease
GO:2000257,regulation of protein activation cascade,HP:0005421,Decreased serum complement C3
GO:2000377,regulation of reactive oxygen species metabolic process,HP:0000012,Urinary urgency
GO:2000377,regulation of reactive oxygen species metabolic process,HP:0001894,Thrombocytosis
GO:2000377,regulation of reactive oxygen species metabolic process,HP:0004814,Fava bean-induced hemolytic anemia
GO:2000379,positive regulation of reactive oxygen species metabolic process,HP:0001894,Thrombocytosis
GO:2000725,regulation of cardiac muscle cell differentiation,HP:0004814,Fava bean-induced hemolytic anemia
GO:2000736,regulation of stem cell differentiation,HP:0000006,Autosomal dominant inheritance
GO:2000826,regulation of heart morphogenesis,HP:0000006,Autosomal dominant inheritance
GO:2001057,reactive nitrogen species metabolic process,HP:0001894,Thrombocytosis
GO:2001233,regulation of apoptotic signaling pathway,HP:0000006,Autosomal dominant inheritance
GO:2001233,regulation of apoptotic signaling pathway,HP:0000408,Progressive sensorineural hearing impairment
GO:2001233,regulation of apoptotic signaling pathway,HP:0001894,Thrombocytosis
GO:2001233,regulation of apoptotic signaling pathway,HP:0005116,Arterial tortuosity
GO:2001252,positive regulation of chromosome organization,HP:0005528,Bone marrow hypocellularity
GO:2001252,positive regulation of chromosome organization,HP:0011907,Reduced alpha/beta synthesis ratio
GO:2001257,regulation of cation channel activity,HP:0001279,Syncope
GO:2001258,negative regulation of cation channel activity,HP:0001279,Syncope
